data_2l8d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l8d _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.477 ' O ' HG11 ' A' ' 31' ' ' VAL . . . . . . . . 0 C--O 1.218 -0.553 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -127.51 134.2 49.8 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 94.78 -8.83 70.97 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -172.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 31' ' ' VAL . 24.8 tt0 -78.43 138.03 38.28 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.488 1.115 . . . . 0.0 112.071 -175.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 30' ' ' GLN . 4.3 p -91.1 128.12 43.08 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.273 174.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 m -135.49 -175.23 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.662 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 96.0 mmm -107.95 132.74 53.18 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.22 135.6 8.25 Favored Glycine 0 C--N 1.281 -2.484 0 C-N-CA 120.27 -0.966 . . . . 0.0 111.073 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 35.3 ttm180 -74.42 143.05 44.92 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 123.846 0.859 . . . . 0.0 109.626 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 . . . . . 0 N--CA 1.435 -1.177 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 175.539 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 18.3 mt . . . . . 0 CA--C 1.491 -1.304 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -113.35 131.16 56.08 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.543 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -117.92 172.84 7.13 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -95.33 125.22 39.8 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.1 m -135.34 163.28 36.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 60.8 tt0 -122.37 130.11 52.78 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 173.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 11' ' ' ALA . 7.6 p -72.42 128.1 35.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 123.321 0.388 . . . . 0.0 110.532 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.8 p -108.76 -46.47 3.64 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-O 120.711 0.291 . . . . 0.0 111.621 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -144.35 179.49 7.21 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.216 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -155.34 127.68 7.78 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -88.43 122.67 32.18 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 173.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -96.32 -13.91 22.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.27 -52.28 7.91 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.071 0.463 . . . . 0.0 110.257 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.9 m -99.7 -1.05 38.87 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.286 0.565 . . . . 0.0 111.085 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 59.61 71.35 0.58 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.115 0.966 . . . . 0.0 111.79 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -125.28 138.64 54.09 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.507 ' CE1' ' HB3' ' A' ' 55' ' ' GLU . 11.2 m-85 -108.93 130.04 55.44 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.0 m -93.25 128.63 39.32 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.4 159.67 42.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 22.9 ttmm -119.63 133.81 55.49 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -88.77 167.43 13.3 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 123.643 0.59 . . . . 0.0 111.533 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -61.14 -22.57 64.81 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.339 1.055 . . . . 0.0 110.679 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.23 -0.1 34.88 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.476 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.32 -37.46 3.38 Favored Glycine 0 CA--C 1.509 -0.336 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.5 m -58.86 134.97 57.37 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 124.851 1.26 . . . . 0.0 110.771 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -108.67 151.16 26.53 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.6 tp -139.92 159.32 42.44 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.6 135.28 51.47 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 171.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.8 170.25 16.1 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -82.29 161.8 22.5 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.507 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -60.87 -30.22 70.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.933 0.397 . . . . 0.0 111.422 174.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 m -69.75 -12.04 61.32 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.542 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -95.77 -12.52 25.23 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mt -102.37 135.47 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.736 -176.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -130.02 168.46 16.68 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.798 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 C--N 1.313 -1.004 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.439 -179.86 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.813 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -56.54 127.39 31.02 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.6 0.562 . . . . 0.0 111.796 -174.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.18 -8.09 48.63 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.474 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -77.01 138.82 39.83 Favored 'General case' 0 N--CA 1.431 -1.377 0 O-C-N 122.567 -0.372 . . . . 0.0 110.11 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 p -94.05 127.09 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.1 m -135.45 179.05 4.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.696 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.0 mtp -111.24 132.74 54.12 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.84 150.89 19.16 Favored Glycine 0 C--N 1.285 -2.284 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.326 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 29.5 ttp180 -85.35 139.85 31.25 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.948 0.404 . . . . 0.0 110.625 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 41.1 t-105 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 175.635 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 11.5 mt . . . . . 0 CA--C 1.5 -0.943 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.514 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 67.0 m-85 -127.84 107.27 9.73 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 123.707 0.629 . . . . 0.0 110.037 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -98.64 163.8 12.5 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.959 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.76 124.09 39.63 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.43 164.94 31.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.168 -172.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -114.74 130.8 56.89 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.3 p -71.16 128.42 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.0 m -108.5 -35.43 6.48 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.049 -172.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.8 t -156.63 174.54 15.31 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -149.22 117.88 6.59 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 123.426 0.69 . . . . 0.0 109.507 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -88.08 122.23 31.41 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -97.69 -8.63 28.31 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.762 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.48 -49.67 9.67 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.293 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.4 t -98.61 -2.19 39.09 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.991 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 70.7 m80 59.71 63.4 1.51 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.979 0.912 . . . . 0.0 111.945 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -127.45 127.86 44.8 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.854 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -98.08 120.12 37.91 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.6 m -87.62 130.42 34.78 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.67 157.6 41.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -108.18 133.04 53.0 Favored 'General case' 0 C--O 1.264 1.829 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -97.18 154.93 17.07 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 124.237 0.961 . . . . 0.0 110.215 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -61.95 -25.03 67.35 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.814 0.846 . . . . 0.0 109.384 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.64 -0.69 21.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.354 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.91 -18.59 50.23 Favored Glycine 0 CA--C 1.504 -0.654 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.136 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.6 m -78.65 130.38 35.8 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 123.046 0.538 . . . . 0.0 109.919 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.41 148.66 25.23 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 170.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.2 tp -140.52 152.06 45.27 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -173.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.63 134.5 51.87 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 170.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.23 164.86 28.94 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.254 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.84 166.98 17.48 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -30.88 70.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.427 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -74.5 -1.51 21.6 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.201 0.524 . . . . 0.0 111.943 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -101.06 -13.24 18.3 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.7 mt -102.57 133.37 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.627 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -122.61 168.79 11.74 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 113.987 -1.46 . . . . 0.0 107.602 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.302 -1.499 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.828 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.476 ' HA ' HG11 ' A' ' 31' ' ' VAL . 4.1 p30 -72.88 139.46 46.9 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.822 0.344 . . . . 0.0 111.363 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.86 -13.24 34.84 Favored Glycine 0 N--CA 1.429 -1.776 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.093 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -77.9 147.32 35.1 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.2 127.33 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 174.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 m -135.04 174.97 12.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.953 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.1 mtp -111.61 132.88 54.25 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 172.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.43 149.86 19.56 Favored Glycine 0 C--N 1.278 -2.655 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.927 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.425 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 47.2 ttp85 -79.7 137.12 36.96 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 . . . . . 0 N--CA 1.426 -1.665 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 176.583 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 N--CA 1.44 -0.952 0 N-CA-C 110.755 -0.091 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 57.4 m-85 -110.55 129.19 55.85 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.529 0.68 . . . . 0.0 111.242 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -122.87 156.56 34.38 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.608 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.89 124.93 35.12 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.66 169.54 20.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 122.98 0.512 . . . . 0.0 110.087 -174.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -115.26 130.48 56.92 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 173.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.476 HG11 ' HA ' ' A' ' 12' ' ' ASP . 7.3 p -72.39 128.65 35.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.8 t -108.89 -31.41 7.68 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.619 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -165.53 -176.9 4.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -148.97 132.37 16.6 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 123.548 0.739 . . . . 0.0 109.667 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -97.49 121.43 39.38 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -86.41 -21.91 26.86 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.94 -49.49 51.36 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.032 0.444 . . . . 0.0 110.496 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.6 m -97.47 -2.03 42.93 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.71 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 59.98 45.68 11.88 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.54 0.686 . . . . 0.0 110.84 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.95 134.55 52.49 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.372 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.602 ' CE1' ' HB3' ' A' ' 55' ' ' GLU . 26.9 m-85 -102.47 127.49 49.49 Favored 'General case' 0 CA--C 1.48 -1.745 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.3 m -93.06 129.16 39.11 Favored 'General case' 0 N--CA 1.4 -2.933 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -125.0 159.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -121.32 135.5 55.09 Favored 'General case' 0 C--N 1.272 -2.775 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -90.17 162.3 15.33 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.408 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -61.8 -24.05 66.61 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.628 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -82.42 0.7 40.92 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.474 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.12 -31.52 7.88 Favored Glycine 0 C--O 1.238 0.357 0 C-N-CA 121.506 -0.378 . . . . 0.0 112.377 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 m -56.11 130.03 42.47 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 124.917 1.287 . . . . 0.0 111.03 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.2 150.46 25.08 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.978 175.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.9 tp -139.86 152.87 46.81 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.538 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.07 134.61 51.98 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.18 173.75 11.18 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 123.136 0.574 . . . . 0.0 111.244 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -82.72 157.02 23.46 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.62 0.248 . . . . 0.0 110.492 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.602 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -61.25 -31.09 70.88 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.169 0.509 . . . . 0.0 110.906 173.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.0 m -73.15 -12.05 60.75 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.723 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -95.4 -5.89 42.17 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.8 mt -102.62 133.6 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-O 121.296 0.569 . . . . 0.0 111.285 -176.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -124.43 161.9 25.05 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 173.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.1 mt . . . . . 0 C--N 1.297 -1.683 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.898 179.658 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.452 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -60.44 121.68 12.71 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.397 0.618 . . . . 0.0 112.161 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.487 ' H ' HG13 ' A' ' 31' ' ' VAL . . . 115.68 -14.34 17.47 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.647 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.413 ' O ' HG11 ' A' ' 31' ' ' VAL . 26.5 tt0 -77.02 141.05 40.51 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-N 116.893 0.347 . . . . 0.0 111.42 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.87 127.74 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 106.689 -1.596 . . . . 0.0 106.689 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.6 173.54 14.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.568 -173.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.414 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 47.0 ttm -111.2 131.85 54.79 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 172.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.8 149.96 19.45 Favored Glycine 0 C--N 1.283 -2.415 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.246 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.404 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 48.5 ttp180 -89.41 146.7 24.49 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 123.634 0.774 . . . . 0.0 109.0 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 . . . . . 0 C--N 1.306 -1.319 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.747 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.433 -1.312 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.404 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 50.5 m-85 -118.23 142.53 47.37 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.552 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -135.17 164.95 26.54 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -95.73 124.54 39.8 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.1 m -135.42 173.84 13.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.531 -172.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -115.25 131.26 56.98 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.855 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.487 HG13 ' H ' ' A' ' 13' ' ' GLY . 11.2 p -71.26 127.73 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -103.2 -44.36 5.21 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.445 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -157.73 173.12 17.31 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -150.52 126.02 10.19 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 123.372 0.669 . . . . 0.0 109.54 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -96.93 122.23 39.68 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 171.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -84.32 -28.36 27.14 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -174.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.85 -48.87 43.04 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.813 0.339 . . . . 0.0 111.194 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.4 m -94.54 -1.86 52.62 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.674 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 60.01 63.72 1.39 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.373 1.069 . . . . 0.0 111.736 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -128.55 125.66 38.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.688 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -97.94 118.35 34.32 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.7 m -94.17 129.98 40.55 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.82 158.6 37.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -109.71 133.5 53.06 Favored 'General case' 0 C--O 1.271 2.225 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -93.22 162.19 14.11 Favored 'General case' 0 CA--C 1.496 -1.104 0 O-C-N 124.584 1.177 . . . . 0.0 110.75 175.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -62.2 -24.19 67.07 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.1 -0.954 . . . . 0.0 112.004 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -78.65 -0.19 28.99 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.423 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.6 -2.83 86.35 Favored Glycine 0 C--O 1.221 -0.707 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 m -79.32 129.96 34.97 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 122.967 0.507 . . . . 0.0 110.016 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -90.46 152.13 21.09 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 172.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.4 tp -137.77 145.03 41.93 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.03 133.98 52.62 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 173.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.07 172.59 12.46 Favored 'General case' 0 C--N 1.276 -2.627 0 O-C-N 123.763 0.665 . . . . 0.0 110.666 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -83.87 166.11 18.18 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.51 -32.81 70.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.041 0.448 . . . . 0.0 110.567 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.6 m -77.37 -6.43 53.29 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.058 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -88.69 -18.89 26.94 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.1 mt -100.97 130.76 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.298 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' A' ' 17' ' ' MET . 74.1 mtt85 -135.0 158.73 43.58 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.258 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.7 mt . . . . . 0 C--N 1.29 -2.019 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 168.546 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.942 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -77.3 146.22 36.95 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.136 -175.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.424 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 98.17 -9.52 63.3 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.444 ' O ' HG13 ' A' ' 31' ' ' VAL . 10.2 tp10 -78.67 143.39 36.34 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 122.493 0.317 . . . . 0.0 111.249 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 30' ' ' GLN . 5.5 p -94.91 126.64 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 173.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 59' ' ' ARG . 16.9 m -135.13 -177.7 2.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.314 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 87.7 mtp -111.92 131.72 55.2 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 173.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.99 143.95 14.69 Favored Glycine 0 C--N 1.27 -3.116 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -76.05 141.14 42.14 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 . . . . . 0 N--CA 1.428 -1.532 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 N--CA 1.435 -1.196 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -111.99 133.2 54.31 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.444 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -122.97 155.19 37.28 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.551 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -85.25 125.37 32.82 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.15 163.71 35.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 63.1 tt0 -119.3 130.21 55.27 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 174.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 14' ' ' GLU . 8.1 p -72.27 130.56 35.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.5 t -119.68 -29.56 5.01 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.18 -176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.414 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 16.2 m -144.07 157.18 44.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -139.63 121.89 15.94 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.338 0.113 . . . . 0.0 110.697 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.8 122.33 41.9 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 174.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -83.09 -20.4 34.96 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.001 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.04 -50.82 37.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.0 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 m -97.07 -2.57 42.98 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.27 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 t60 58.98 46.73 13.14 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.494 1.118 . . . . 0.0 108.6 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mp -114.1 142.34 46.33 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.117 -175.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -111.99 128.15 56.09 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.414 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 7.0 m -93.19 129.08 39.33 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 176.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.91 159.54 28.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -120.97 133.83 55.28 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -92.95 162.28 14.13 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.823 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -62.24 -21.38 65.12 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.29 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.06 -0.6 32.04 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.128 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.12 -1.06 86.38 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.5 m -79.26 135.31 36.73 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 123.888 0.875 . . . . 0.0 110.934 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -100.48 151.5 21.49 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 171.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 tp -138.86 145.47 40.03 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.23 133.36 53.31 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 172.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.485 ' CD1' HD11 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -141.45 167.21 22.71 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -84.27 157.44 21.56 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.965 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.47 -25.48 66.06 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 176.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 m -70.7 -6.29 36.11 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.469 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -112.96 7.05 18.06 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.485 HD11 ' CD1' ' A' ' 53' ' ' LEU . 41.0 mt -118.48 135.39 59.04 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.658 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.462 ' HD2' ' C ' ' A' ' 58' ' ' ILE . 3.7 mpt_? -129.08 166.44 19.26 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 171.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mp . . . . . 0 C--N 1.294 -1.833 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.33 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -74.51 131.86 41.37 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.099 0.476 . . . . 0.0 111.352 -175.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.509 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 107.51 -11.31 39.21 Favored Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.6 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -77.43 152.64 34.2 Favored 'General case' 0 C--O 1.241 0.625 0 O-C-N 122.823 -0.222 . . . . 0.0 111.079 -175.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.29 127.29 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.02 177.93 6.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.965 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.0 mmm -111.33 131.97 54.76 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.51 149.08 19.74 Favored Glycine 0 C--N 1.286 -2.229 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.158 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.486 ' HD3' ' OD2' ' A' ' 57' ' ' ASP . 23.1 ttt-85 -82.62 134.75 35.17 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 123.131 0.572 . . . . 0.0 111.123 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 . . . . . 0 C--N 1.315 -0.918 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 175.411 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.1 mt . . . . . 0 N--CA 1.432 -1.339 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 19' ' ' ARG . 17.3 m-85 -109.33 128.94 55.49 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.565 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -118.8 172.39 7.55 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -85.49 126.03 33.51 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 123.376 0.422 . . . . 0.0 109.895 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.38 163.79 34.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.959 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -113.29 130.51 56.23 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.509 HG12 ' H ' ' A' ' 13' ' ' GLY . 8.8 p -72.28 128.6 35.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 176.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.0 t -119.12 -28.45 5.47 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.61 -0.836 . . . . 0.0 112.062 -173.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.2 m -151.62 169.17 22.8 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 121.921 -0.487 . . . . 0.0 109.917 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -148.91 129.14 13.69 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -97.48 122.75 40.9 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.87 -41.77 70.96 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 123.958 0.786 . . . . 0.0 111.788 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.89 -49.92 74.27 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.588 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -92.9 -2.0 56.23 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.429 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.3 m80 58.21 42.46 21.92 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -104.92 133.74 49.2 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.399 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -103.51 120.71 41.39 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 52' ' ' ALA . 7.1 m -93.71 129.46 40.03 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.6 158.89 26.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.291 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -113.56 132.54 55.67 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -97.6 150.52 21.05 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -62.69 -17.4 60.58 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 122.102 0.953 . . . . 0.0 109.823 173.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.27 -1.9 22.67 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.129 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.28 -31.67 5.6 Favored Glycine 0 N--CA 1.443 -0.862 0 O-C-N 121.836 -0.54 . . . . 0.0 111.814 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.3 m -71.0 130.02 40.51 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 123.82 0.848 . . . . 0.0 110.802 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -102.23 151.33 22.34 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.467 171.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.4 tp -139.42 145.5 38.96 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.461 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 42' ' ' THR . . . -110.7 134.55 52.36 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.243 171.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.4 176.84 8.54 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 123.641 0.777 . . . . 0.0 110.547 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -83.46 167.61 17.29 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 120.852 0.358 . . . . 0.0 111.408 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -60.08 -31.76 70.32 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.684 0.794 . . . . 0.0 110.998 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 m -76.62 -4.99 45.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.526 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.486 ' OD2' ' HD3' ' A' ' 19' ' ' ARG . 3.1 m-20 -105.63 3.38 29.11 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.335 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 mt -118.06 141.47 37.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 121.238 0.542 . . . . 0.0 111.09 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -129.52 168.16 16.79 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 172.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 C--N 1.309 -1.18 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.612 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.017 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -77.7 135.87 38.11 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 123.217 0.607 . . . . 0.0 112.182 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.575 ' H ' HG11 ' A' ' 31' ' ' VAL . . . 103.33 -14.35 54.69 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.433 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.547 ' O ' HG12 ' A' ' 31' ' ' VAL . 29.6 tt0 -79.17 156.74 28.08 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.862 0.465 . . . . 0.0 112.002 -174.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.0 p -90.87 129.04 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 172.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 m -134.1 171.55 17.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.9 mtp -111.11 132.3 54.39 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.236 173.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -125.49 146.3 16.11 Favored Glycine 0 C--N 1.281 -2.504 0 C-N-CA 120.184 -1.007 . . . . 0.0 111.668 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.417 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 75.5 ttt180 -79.89 132.11 36.01 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 . . . . . 0 N--CA 1.433 -1.302 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 175.7 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 N--CA 1.431 -1.398 0 CA-C-O 120.736 0.303 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.417 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 41.9 m-85 -104.19 132.22 50.67 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.076 175.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -119.88 157.86 27.85 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.569 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -95.59 125.25 40.06 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.6 m -135.51 163.83 34.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-O 120.892 0.377 . . . . 0.0 110.626 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -107.36 129.91 54.86 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.344 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.575 HG11 ' H ' ' A' ' 13' ' ' GLY . 6.2 p -72.29 127.06 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.697 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.7 m -112.38 -40.28 4.17 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.178 -170.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.2 t -151.74 -179.67 7.64 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -161.55 129.01 4.06 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 122.4 0.28 . . . . 0.0 110.761 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -91.95 122.09 34.14 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.06 -38.75 51.99 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 124.279 0.987 . . . . 0.0 109.816 -173.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.77 -57.3 13.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.428 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.6 m -98.87 -0.29 42.71 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.1 m80 66.59 43.92 2.39 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.631 0.772 . . . . 0.0 110.255 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.93 121.17 41.27 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.481 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 51.8 m-85 -93.8 122.89 36.75 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 m -92.92 129.21 38.91 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.85 158.61 37.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -107.66 133.13 52.54 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -97.89 165.41 11.94 Favored 'General case' 0 CA--C 1.508 -0.637 0 O-C-N 124.41 1.069 . . . . 0.0 111.53 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -61.57 -25.22 67.17 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 124.904 1.282 . . . . 0.0 110.415 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -83.44 -0.89 52.04 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.134 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.79 -33.27 5.29 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.979 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.8 m -56.06 131.25 46.99 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.885 1.274 . . . . 0.0 111.645 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -96.7 150.34 20.8 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 172.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.57 149.99 44.5 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 41' ' ' TYR . . . -109.56 135.3 50.76 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 172.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.69 166.17 25.48 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 123.18 0.592 . . . . 0.0 110.882 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.8 161.75 20.84 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.05 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -60.37 -30.69 69.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.6 t -74.52 -5.53 43.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.87 0.367 . . . . 0.0 110.743 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -95.86 -12.31 25.41 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 55.1 mt -99.76 143.01 14.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 120.967 0.413 . . . . 0.0 111.449 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -131.07 170.23 14.8 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 171.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.294 -1.831 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 173.938 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.547 0 CA-C-O 120.669 0.271 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -123.94 125.52 44.74 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 174.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.92 -5.22 68.81 Favored Glycine 0 C--N 1.311 -0.818 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.558 ' O ' HG13 ' A' ' 31' ' ' VAL . 43.3 tt0 -77.74 137.86 38.71 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 123.423 0.689 . . . . 0.0 110.265 -177.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.82 127.58 41.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 118.535 -1.266 . . . . 0.0 108.568 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.7 m -135.58 -176.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.918 -176.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 90.3 mtp -111.27 132.77 54.11 Favored 'General case' 0 C--O 1.204 -1.323 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -128.79 141.61 12.74 Favored Glycine 0 C--N 1.272 -2.986 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.562 ' HB3' ' OD1' ' A' ' 57' ' ' ASP . 15.6 ttp180 -75.1 144.34 42.93 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.46 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 . . . . . 0 N--CA 1.426 -1.671 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 173.59 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.4 mt . . . . . 0 N--CA 1.435 -1.188 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 34.8 m-85 -100.61 124.9 46.83 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.408 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -113.64 156.01 24.48 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -79.36 125.8 29.98 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.11 163.69 35.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -111.2 128.87 56.05 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 173.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 14' ' ' GLU . 10.8 p -73.8 136.95 24.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.6 t -122.37 -41.44 2.4 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 118.656 -1.218 . . . . 0.0 112.056 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.7 m -139.03 141.5 38.27 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.774 -0.771 . . . . 0.0 110.734 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -114.78 124.7 52.44 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.939 0.4 . . . . 0.0 111.161 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -96.25 122.59 39.27 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -97.42 -19.76 18.23 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.583 0.552 . . . . 0.0 111.528 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.44 -52.68 8.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.864 0.364 . . . . 0.0 111.429 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.7 m -99.5 -2.02 36.95 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.287 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 61.66 80.0 0.24 Allowed 'General case' 0 C--O 1.247 0.954 0 C-N-CA 123.667 0.787 . . . . 0.0 112.273 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -141.96 150.17 41.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.986 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.563 ' CE1' ' HB2' ' A' ' 55' ' ' GLU . 29.3 m-85 -119.63 116.93 27.01 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.5 m -87.01 129.0 35.07 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.49 160.0 32.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 124.308 1.005 . . . . 0.0 108.633 -176.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -124.95 135.74 53.11 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -95.01 159.04 15.21 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.571 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -61.3 -25.12 66.9 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.944 0.778 . . . . 0.0 110.418 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.53 -0.7 27.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.829 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.69 -39.34 2.77 Favored Glycine 0 C--O 1.248 1.0 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.513 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.0 m -54.77 136.14 46.61 Favored 'General case' 0 C--O 1.246 0.882 0 C-N-CA 124.395 1.078 . . . . 0.0 111.533 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -113.57 150.42 33.07 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.4 tp -139.5 145.66 39.01 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -175.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.3 133.66 52.77 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.404 ' CD1' HD13 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -141.74 172.52 12.58 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 123.369 0.667 . . . . 0.0 111.964 178.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 56' ' ' SER . 86.8 tttt -82.43 156.34 24.18 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 122.664 0.386 . . . . 0.0 110.031 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 41.5 tt0 -60.08 -31.95 70.49 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.948 0.88 . . . . 0.0 110.872 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.401 ' H ' ' HG2' ' A' ' 54' ' ' LYS . 4.0 m -76.6 -11.25 59.83 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.601 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.562 ' OD1' ' HB3' ' A' ' 19' ' ' ARG . 1.6 t70 -103.21 6.43 38.24 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -177.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.404 HD13 ' CD1' ' A' ' 53' ' ' LEU . 49.4 mt -110.9 149.26 13.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.072 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -131.34 158.66 40.1 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.9 mt . . . . . 0 C--N 1.318 -0.804 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.264 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.342 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -46.74 123.66 5.32 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.115 0.884 . . . . 0.0 111.387 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.31 -13.42 28.32 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.285 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.444 ' O ' HG11 ' A' ' 31' ' ' VAL . 7.6 tp10 -76.48 137.02 39.39 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 117.436 0.618 . . . . 0.0 109.571 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 p -95.19 127.68 46.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -135.37 -178.73 2.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 122.857 0.463 . . . . 0.0 111.159 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 83.4 mtp -110.85 133.01 53.71 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 57' ' ' ASP . . . -138.88 142.28 12.8 Favored Glycine 0 C--N 1.281 -2.496 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.796 -177.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HD3' ' OD1' ' A' ' 57' ' ' ASP . 33.9 ttt-85 -75.59 132.21 40.5 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 125.115 1.366 . . . . 0.0 110.92 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 16.4 t-105 . . . . . 0 C--N 1.303 -1.446 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 172.992 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 17.3 mt . . . . . 0 N--CA 1.428 -1.527 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.465 ' CE2' ' HG2' ' A' ' 59' ' ' ARG . 25.6 m-85 -108.07 115.8 30.79 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 113.865 -1.516 . . . . 0.0 107.42 175.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -108.53 172.51 6.8 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -84.72 126.13 33.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 m -134.98 164.04 34.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -126.1 131.23 52.14 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.179 -1.409 . . . . 0.0 108.706 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.444 HG11 ' O ' ' A' ' 14' ' ' GLU . 12.3 p -69.71 129.48 34.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.653 0.74 . . . . 0.0 110.92 -175.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.5 m -106.05 -39.14 6.08 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.925 -174.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.2 m -155.65 162.8 40.53 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -139.58 119.39 13.33 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 120.908 0.385 . . . . 0.0 110.613 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -91.1 123.12 34.32 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -100.8 -1.13 35.69 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.773 0.797 . . . . 0.0 110.185 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.34 -54.64 5.06 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.518 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.3 m -98.53 -2.1 39.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.038 0.446 . . . . 0.0 110.021 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 59.8 69.9 0.67 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.64 1.176 . . . . 0.0 113.204 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -131.97 135.4 46.54 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.694 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -97.93 117.52 32.45 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 52' ' ' ALA . 17.0 m -93.36 129.71 39.39 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.442 HG13 ' HA ' ' A' ' 31' ' ' VAL . 29.5 m -129.06 158.45 41.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -176.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 6.8 ttpm? -110.71 136.88 49.11 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -90.71 154.4 19.58 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.42 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.29 -20.96 63.5 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.814 1.246 . . . . 0.0 110.042 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.34 -1.0 31.14 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.594 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.78 -41.74 2.09 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.463 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.6 m -71.01 135.75 48.0 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.291 0.636 . . . . 0.0 111.501 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -94.85 153.16 17.85 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 173.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.9 tp -138.42 148.43 44.44 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.581 -176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 42' ' ' THR . . . -109.71 134.37 52.07 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 171.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.63 166.99 23.23 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.801 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -85.01 168.18 15.16 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.142 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.57 -30.57 69.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.485 0.66 . . . . 0.0 110.045 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.4 m -69.49 -11.62 60.98 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.09 0.956 . . . . 0.0 110.879 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.554 ' OD1' ' HD3' ' A' ' 19' ' ' ARG . 67.9 m-20 -100.91 1.99 40.4 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.411 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.2 mt -111.74 134.06 55.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.478 0.656 . . . . 0.0 112.491 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.465 ' HG2' ' CE2' ' A' ' 26' ' ' TYR . 56.1 mmt-85 -130.36 156.58 44.46 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 172.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 C--N 1.297 -1.7 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 172.857 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.181 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.469 ' HA ' HG13 ' A' ' 31' ' ' VAL . 10.3 p-10 -61.78 127.52 31.8 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.693 0.759 . . . . 0.0 112.319 -173.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.7 -14.44 17.39 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.478 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.48 ' O ' HG11 ' A' ' 31' ' ' VAL . 32.4 tt0 -77.25 136.74 38.55 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.0 p -94.84 127.53 46.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.7 m -135.34 -176.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.374 -175.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.4 mmm -110.33 131.73 54.8 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -128.49 141.84 12.96 Favored Glycine 0 C--N 1.273 -2.949 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -89.58 136.19 33.17 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 24.8 t-105 . . . . . 0 N--CA 1.434 -1.268 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.829 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.433 -1.276 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -107.85 136.48 47.5 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.471 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -128.92 157.77 40.67 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.013 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -86.16 125.57 33.6 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.02 163.22 37.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -175.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -122.32 130.35 53.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.48 HG11 ' O ' ' A' ' 14' ' ' GLU . 7.5 p -68.7 132.46 32.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.415 0.626 . . . . 0.0 111.181 -176.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.8 m -118.58 -38.21 3.17 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.237 -173.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.3 m -157.0 171.17 20.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -154.31 136.52 14.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 118.131 0.423 . . . . 0.0 111.734 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -97.39 121.73 39.62 Favored 'General case' 0 C--O 1.249 1.026 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 171.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -82.07 -23.72 35.65 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 124.073 0.858 . . . . 0.0 111.365 -170.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.0 -51.83 9.06 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.786 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.5 m -94.54 -0.6 54.47 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 33.4 m80 68.07 43.2 1.66 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.381 1.072 . . . . 0.0 110.916 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.76 115.83 30.91 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.882 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -96.08 127.11 41.8 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.7 m -92.95 129.21 38.94 Favored 'General case' 0 N--CA 1.404 -2.751 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.415 HG13 ' HA ' ' A' ' 31' ' ' VAL . 34.0 m -127.72 157.62 39.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -105.22 133.78 49.41 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -92.48 157.0 16.8 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.694 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.13 -23.08 66.35 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.786 0.803 . . . . 0.0 109.9 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.66 -1.94 10.35 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.46 1.104 . . . . 0.0 111.157 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.74 -23.81 18.08 Favored Glycine 0 C--O 1.227 -0.316 0 O-C-N 121.654 -0.654 . . . . 0.0 112.174 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.4 m -77.04 132.97 39.21 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 124.372 1.069 . . . . 0.0 111.259 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -93.79 150.19 20.59 Favored 'General case' 0 C--O 1.251 1.161 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.4 tp -139.48 149.97 44.62 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.24 134.72 51.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 173.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.453 ' CD1' HD11 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -141.32 166.21 25.39 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 124.114 0.966 . . . . 0.0 111.006 177.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 39' ' ' HIS . 97.5 mttt -82.91 161.42 21.85 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.618 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -60.69 -31.13 70.4 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.448 0.642 . . . . 0.0 110.8 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -75.57 -4.33 39.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.56 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -105.82 2.57 27.89 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.453 HD11 ' CD1' ' A' ' 53' ' ' LEU . 48.9 mt -114.03 146.97 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -132.45 159.2 40.02 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 172.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 C--O 1.255 1.364 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 170.47 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.017 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.15 -14.29 18.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.678 0.275 . . . . 0.0 110.308 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 73.43 -55.88 0.67 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.798 1.239 . . . . 0.0 112.728 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.35 86.85 0.73 Allowed Glycine 0 C--N 1.3 -1.455 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.0 tpt -159.05 79.26 2.89 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.126 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 8' ' ' ARG . 63.0 Cg_endo -80.22 -20.84 8.24 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 121.802 1.668 . . . . 0.0 112.079 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 177.24 -48.86 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.532 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -103.2 -166.39 1.26 Allowed 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 169.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -80.89 -28.61 35.89 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 98.6 m-85 -125.57 162.57 24.64 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.878 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.477 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -84.19 -167.76 1.89 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -127.51 134.2 49.8 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 94.78 -8.83 70.97 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -172.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 31' ' ' VAL . 24.8 tt0 -78.43 138.03 38.28 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.488 1.115 . . . . 0.0 112.071 -175.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 30' ' ' GLN . 4.3 p -91.1 128.12 43.08 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.273 174.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 m -135.49 -175.23 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.662 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 96.0 mmm -107.95 132.74 53.18 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.22 135.6 8.25 Favored Glycine 0 C--N 1.281 -2.484 0 C-N-CA 120.27 -0.966 . . . . 0.0 111.073 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 35.3 ttm180 -74.42 143.05 44.92 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 123.846 0.859 . . . . 0.0 109.626 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -81.67 123.57 80.48 Favored Pre-proline 0 N--CA 1.435 -1.177 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -36.75 -47.49 1.39 Allowed 'Trans proline' 0 CA--C 1.542 0.907 1 C-N-CA 125.584 4.189 . . . . 0.0 116.501 -173.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.28 -9.02 65.72 Favored Glycine 0 C--N 1.313 -0.701 0 C-N-CA 120.109 -1.044 . . . . 0.0 113.869 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.8 t -113.91 179.78 3.86 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.935 0.398 . . . . 0.0 110.31 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.8 m -107.12 0.44 9.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 172.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 18.3 mt -73.84 145.05 45.22 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.826 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -113.35 131.16 56.08 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.543 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -117.92 172.84 7.13 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -95.33 125.22 39.8 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.1 m -135.34 163.28 36.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 60.8 tt0 -122.37 130.11 52.78 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 173.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 11' ' ' ALA . 7.6 p -72.42 128.1 35.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 123.321 0.388 . . . . 0.0 110.532 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.8 p -108.76 -46.47 3.64 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-O 120.711 0.291 . . . . 0.0 111.621 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -144.35 179.49 7.21 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.216 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -155.34 127.68 7.78 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -88.43 122.67 32.18 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 173.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -96.32 -13.91 22.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.27 -52.28 7.91 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.071 0.463 . . . . 0.0 110.257 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.9 m -99.7 -1.05 38.87 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.286 0.565 . . . . 0.0 111.085 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 59.61 71.35 0.58 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.115 0.966 . . . . 0.0 111.79 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -125.28 138.64 54.09 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.507 ' CE1' ' HB3' ' A' ' 55' ' ' GLU . 11.2 m-85 -108.93 130.04 55.44 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.0 m -93.25 128.63 39.32 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.4 159.67 42.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 22.9 ttmm -119.63 133.81 55.49 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -88.77 167.43 13.3 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 123.643 0.59 . . . . 0.0 111.533 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -61.14 -22.57 64.81 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.339 1.055 . . . . 0.0 110.679 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.23 -0.1 34.88 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.476 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.32 -37.46 3.38 Favored Glycine 0 CA--C 1.509 -0.336 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.5 m -58.86 134.97 57.37 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 124.851 1.26 . . . . 0.0 110.771 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -108.67 151.16 26.53 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.6 tp -139.92 159.32 42.44 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.6 135.28 51.47 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 171.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.8 170.25 16.1 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -82.29 161.8 22.5 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.507 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -60.87 -30.22 70.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.933 0.397 . . . . 0.0 111.422 174.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 m -69.75 -12.04 61.32 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.542 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -95.77 -12.52 25.23 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mt -102.37 135.47 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.736 -176.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -130.02 168.46 16.68 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.798 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.52 153.99 22.0 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.439 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -54.9 -34.63 63.27 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 122.012 0.91 . . . . 0.0 108.901 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.4 t -142.09 136.07 29.76 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 170.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.8 t -74.45 -11.22 60.18 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.649 0.738 . . . . 0.0 109.12 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -93.89 96.49 9.76 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -120.11 133.04 55.62 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.592 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 . . . . . 0 C--N 1.299 -1.62 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.556 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.948 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.38 113.42 2.89 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.0 ttt -78.71 -35.41 44.94 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.465 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.1 -178.84 43.65 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 88.8 mtp -134.05 136.99 27.27 Favored Pre-proline 0 C--N 1.299 -1.609 0 CA-C-N 117.481 0.64 . . . . 0.0 110.129 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.43 -31.35 94.64 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.58 2.187 . . . . 0.0 110.368 171.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -72.77 127.54 32.84 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 172.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -68.96 91.41 0.47 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -171.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -76.13 -34.78 59.43 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 173.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -94.14 82.53 4.16 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 114.299 -1.319 . . . . 0.0 108.419 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.12 151.1 40.17 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.799 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -56.54 127.39 31.02 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.6 0.562 . . . . 0.0 111.796 -174.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.18 -8.09 48.63 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.474 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -77.01 138.82 39.83 Favored 'General case' 0 N--CA 1.431 -1.377 0 O-C-N 122.567 -0.372 . . . . 0.0 110.11 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 p -94.05 127.09 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.1 m -135.45 179.05 4.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.696 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.0 mtp -111.24 132.74 54.12 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.84 150.89 19.16 Favored Glycine 0 C--N 1.285 -2.284 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.326 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 29.5 ttp180 -85.35 139.85 31.25 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.948 0.404 . . . . 0.0 110.625 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 41.1 t-105 -81.55 120.82 78.98 Favored Pre-proline 0 N--CA 1.43 -1.457 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.12 126.89 21.63 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.877 3.051 . . . . 0.0 113.175 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.51 -37.56 3.48 Favored Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 m -95.75 175.69 6.42 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-O 121.158 0.504 . . . . 0.0 109.884 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.6 p -111.48 14.46 8.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 122.569 1.176 . . . . 0.0 108.141 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 11.5 mt -76.43 145.57 39.22 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.226 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.514 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 67.0 m-85 -127.84 107.27 9.73 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 123.707 0.629 . . . . 0.0 110.037 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -98.64 163.8 12.5 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.959 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.76 124.09 39.63 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.43 164.94 31.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.168 -172.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -114.74 130.8 56.89 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.3 p -71.16 128.42 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.0 m -108.5 -35.43 6.48 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.049 -172.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.8 t -156.63 174.54 15.31 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -149.22 117.88 6.59 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 123.426 0.69 . . . . 0.0 109.507 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -88.08 122.23 31.41 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -97.69 -8.63 28.31 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.762 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.48 -49.67 9.67 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.293 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.4 t -98.61 -2.19 39.09 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.991 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 70.7 m80 59.71 63.4 1.51 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.979 0.912 . . . . 0.0 111.945 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -127.45 127.86 44.8 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.854 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -98.08 120.12 37.91 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.6 m -87.62 130.42 34.78 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.67 157.6 41.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -108.18 133.04 53.0 Favored 'General case' 0 C--O 1.264 1.829 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -97.18 154.93 17.07 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 124.237 0.961 . . . . 0.0 110.215 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -61.95 -25.03 67.35 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.814 0.846 . . . . 0.0 109.384 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.64 -0.69 21.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.354 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.91 -18.59 50.23 Favored Glycine 0 CA--C 1.504 -0.654 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.136 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.6 m -78.65 130.38 35.8 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 123.046 0.538 . . . . 0.0 109.919 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.41 148.66 25.23 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 170.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.2 tp -140.52 152.06 45.27 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -173.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.63 134.5 51.87 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 170.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.23 164.86 28.94 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.254 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.84 166.98 17.48 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -30.88 70.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.427 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -74.5 -1.51 21.6 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.201 0.524 . . . . 0.0 111.943 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -101.06 -13.24 18.3 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.7 mt -102.57 133.37 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.627 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -122.61 168.79 11.74 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 113.987 -1.46 . . . . 0.0 107.602 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.4 mt -81.72 -175.3 5.49 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.431 ' HB3' ' HB2' ' A' ' 64' ' ' PHE . 63.5 tt0 -60.19 -18.87 51.28 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 122.976 0.511 . . . . 0.0 111.721 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.5 t 73.35 -46.78 0.65 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.09 1.356 . . . . 0.0 111.75 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.8 p -89.74 13.08 15.2 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.233 0.54 . . . . 0.0 109.962 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.431 ' HB2' ' HB3' ' A' ' 61' ' ' GLN . 58.7 t80 -65.91 104.94 1.19 Allowed 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -78.47 154.35 30.64 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.576 0.703 . . . . 0.0 112.454 -172.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 . . . . . 0 C--N 1.294 -1.823 0 CA-C-O 117.508 -1.234 . . . . 0.0 108.14 174.561 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.761 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.44 -45.47 62.56 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.352 0.596 . . . . 0.0 110.051 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 71.4 mtm -94.28 91.03 6.54 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.09 -43.61 2.19 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.046 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 63.2 mtm -137.74 88.94 15.71 Favored Pre-proline 0 C--N 1.313 -1.001 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -72.18 -32.88 10.07 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 121.904 1.736 . . . . 0.0 108.387 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 174.28 -56.93 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.502 ' HG2' ' CD2' ' A' ' 34' ' ' TYR . 91.0 mtt180 -114.01 130.46 56.54 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.566 172.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -87.29 -37.7 16.94 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 122.314 1.054 . . . . 0.0 108.476 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -119.07 130.04 55.4 Favored 'General case' 0 N--CA 1.41 -2.433 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.39 150.47 23.17 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.476 ' HA ' HG11 ' A' ' 31' ' ' VAL . 4.1 p30 -72.88 139.46 46.9 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.822 0.344 . . . . 0.0 111.363 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.86 -13.24 34.84 Favored Glycine 0 N--CA 1.429 -1.776 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.093 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -77.9 147.32 35.1 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.2 127.33 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 174.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 m -135.04 174.97 12.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.953 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.402 ' HG3' ' HA ' ' A' ' 61' ' ' GLN . 84.1 mtp -111.61 132.88 54.25 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 172.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.43 149.86 19.56 Favored Glycine 0 C--N 1.278 -2.655 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.927 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.425 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 47.2 ttp85 -79.7 137.12 36.96 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -82.44 122.1 78.72 Favored Pre-proline 0 N--CA 1.426 -1.665 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.477 ' CD ' HD22 ' A' ' 51' ' ' LEU . 31.0 Cg_endo -66.17 109.54 1.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.045 2.497 . . . . 0.0 111.147 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.59 -53.81 0.75 Allowed Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.934 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.4 p -86.81 -22.41 25.87 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.243 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.8 t 70.07 14.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.356 0 CA-C-O 122.616 1.198 . . . . 0.0 109.76 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt -87.68 159.18 18.62 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.755 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 57.4 m-85 -110.55 129.19 55.85 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.529 0.68 . . . . 0.0 111.242 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -122.87 156.56 34.38 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.608 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.89 124.93 35.12 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.66 169.54 20.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 122.98 0.512 . . . . 0.0 110.087 -174.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -115.26 130.48 56.92 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 173.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.476 HG11 ' HA ' ' A' ' 12' ' ' ASP . 7.3 p -72.39 128.65 35.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.8 t -108.89 -31.41 7.68 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.619 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -165.53 -176.9 4.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.502 ' CD2' ' HG2' ' A' ' 8' ' ' ARG . 30.5 t80 -148.97 132.37 16.6 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 123.548 0.739 . . . . 0.0 109.667 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -97.49 121.43 39.38 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -86.41 -21.91 26.86 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.94 -49.49 51.36 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.032 0.444 . . . . 0.0 110.496 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.6 m -97.47 -2.03 42.93 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.71 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 59.98 45.68 11.88 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.54 0.686 . . . . 0.0 110.84 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.95 134.55 52.49 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.372 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.602 ' CE1' ' HB3' ' A' ' 55' ' ' GLU . 26.9 m-85 -102.47 127.49 49.49 Favored 'General case' 0 CA--C 1.48 -1.745 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.3 m -93.06 129.16 39.11 Favored 'General case' 0 N--CA 1.4 -2.933 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -125.0 159.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -121.32 135.5 55.09 Favored 'General case' 0 C--N 1.272 -2.775 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -90.17 162.3 15.33 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.408 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -61.8 -24.05 66.61 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.628 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -82.42 0.7 40.92 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.474 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.12 -31.52 7.88 Favored Glycine 0 C--O 1.238 0.357 0 C-N-CA 121.506 -0.378 . . . . 0.0 112.377 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 m -56.11 130.03 42.47 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 124.917 1.287 . . . . 0.0 111.03 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.2 150.46 25.08 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.978 175.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.477 HD22 ' CD ' ' A' ' 21' ' ' PRO . 37.9 tp -139.86 152.87 46.81 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.538 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.07 134.61 51.98 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.18 173.75 11.18 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 123.136 0.574 . . . . 0.0 111.244 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -82.72 157.02 23.46 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.62 0.248 . . . . 0.0 110.492 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.602 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -61.25 -31.09 70.88 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.169 0.509 . . . . 0.0 110.906 173.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.0 m -73.15 -12.05 60.75 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.723 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -95.4 -5.89 42.17 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.8 mt -102.62 133.6 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-O 121.296 0.569 . . . . 0.0 111.285 -176.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -124.43 161.9 25.05 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 173.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.1 mt -78.01 164.04 25.41 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.898 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.402 ' HA ' ' HG3' ' A' ' 17' ' ' MET . 19.3 tm0? -60.5 -36.65 78.85 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.7 t -111.73 95.93 5.78 Favored 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 102.978 -2.971 . . . . 0.0 102.978 167.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -63.33 -18.78 64.0 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -169.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -91.27 97.19 10.97 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -81.27 109.79 16.12 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.865 0.84 . . . . 0.0 112.264 -175.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 . . . . . 0 N--CA 1.412 -2.351 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.908 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.601 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.88 179.98 4.46 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.7 tpt -89.09 128.22 35.75 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.33 -40.46 76.34 Favored Glycine 0 N--CA 1.468 0.775 0 O-C-N 123.699 0.624 . . . . 0.0 112.741 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.66 92.87 29.77 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 175.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.38 -46.05 16.27 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.05 2.5 . . . . 0.0 111.651 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -143.26 -55.42 0.4 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.448 ' HD2' ' OH ' ' A' ' 41' ' ' TYR . 46.6 mtm105 -127.43 153.25 46.51 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 173.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.46 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 7.4 tmtt? -98.34 -41.71 7.71 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -84.63 95.99 9.06 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.176 -170.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.43 150.75 23.58 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.533 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -60.44 121.68 12.71 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.397 0.618 . . . . 0.0 112.161 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.487 ' H ' HG13 ' A' ' 31' ' ' VAL . . . 115.68 -14.34 17.47 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.647 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.413 ' O ' HG11 ' A' ' 31' ' ' VAL . 26.5 tt0 -77.02 141.05 40.51 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-N 116.893 0.347 . . . . 0.0 111.42 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.87 127.74 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 106.689 -1.596 . . . . 0.0 106.689 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.6 173.54 14.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.568 -173.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.414 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 47.0 ttm -111.2 131.85 54.79 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 172.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.8 149.96 19.45 Favored Glycine 0 C--N 1.283 -2.415 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.246 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.404 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 48.5 ttp180 -89.41 146.7 24.49 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 123.634 0.774 . . . . 0.0 109.0 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -83.04 123.17 77.84 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.44 120.85 8.9 Favored 'Trans proline' 0 C--O 1.247 0.959 0 C-N-CA 123.356 2.704 . . . . 0.0 112.663 -175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.84 -21.62 33.72 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.398 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.8 m -112.02 176.88 4.84 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 122.262 0.225 . . . . 0.0 110.994 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.7 p -105.99 -7.56 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.658 0.742 . . . . 0.0 110.473 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.07 138.84 41.08 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.404 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 50.5 m-85 -118.23 142.53 47.37 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.552 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -135.17 164.95 26.54 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -95.73 124.54 39.8 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.1 m -135.42 173.84 13.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.531 -172.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -115.25 131.26 56.98 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.855 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.487 HG13 ' H ' ' A' ' 13' ' ' GLY . 11.2 p -71.26 127.73 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -103.2 -44.36 5.21 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.445 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -157.73 173.12 17.31 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -150.52 126.02 10.19 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 123.372 0.669 . . . . 0.0 109.54 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -96.93 122.23 39.68 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 171.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -84.32 -28.36 27.14 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -174.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.85 -48.87 43.04 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.813 0.339 . . . . 0.0 111.194 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.4 m -94.54 -1.86 52.62 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.674 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 60.01 63.72 1.39 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.373 1.069 . . . . 0.0 111.736 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -128.55 125.66 38.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.688 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.448 ' OH ' ' HD2' ' A' ' 8' ' ' ARG . 21.2 m-85 -97.94 118.35 34.32 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.7 m -94.17 129.98 40.55 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.82 158.6 37.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -109.71 133.5 53.06 Favored 'General case' 0 C--O 1.271 2.225 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -93.22 162.19 14.11 Favored 'General case' 0 CA--C 1.496 -1.104 0 O-C-N 124.584 1.177 . . . . 0.0 110.75 175.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -62.2 -24.19 67.07 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.1 -0.954 . . . . 0.0 112.004 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -78.65 -0.19 28.99 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.423 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.6 -2.83 86.35 Favored Glycine 0 C--O 1.221 -0.707 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 m -79.32 129.96 34.97 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 122.967 0.507 . . . . 0.0 110.016 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -90.46 152.13 21.09 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 172.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.4 tp -137.77 145.03 41.93 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.03 133.98 52.62 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 173.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.07 172.59 12.46 Favored 'General case' 0 C--N 1.276 -2.627 0 O-C-N 123.763 0.665 . . . . 0.0 110.666 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -83.87 166.11 18.18 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.51 -32.81 70.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.041 0.448 . . . . 0.0 110.567 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.6 m -77.37 -6.43 53.29 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.058 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -88.69 -18.89 26.94 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.1 mt -100.97 130.76 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.298 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' A' ' 17' ' ' MET . 74.1 mtt85 -135.0 158.73 43.58 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.258 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.7 mt -83.95 172.82 11.71 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 168.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -60.32 -31.35 70.2 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.6 m -116.98 22.95 12.23 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.568 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.4 m -77.22 134.93 38.47 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.538 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -152.75 167.09 30.16 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -123.17 84.68 2.3 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 173.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 . . . . . 0 C--O 1.244 0.777 0 C-N-CA 125.881 1.672 . . . . 0.0 110.27 -177.326 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.859 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.36 22.95 3.21 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.314 0.578 . . . . 0.0 109.556 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ptm -70.77 177.32 3.65 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.486 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.88 -108.14 2.45 Favored Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 -174.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.0 ttm 65.06 97.05 0.04 OUTLIER Pre-proline 0 C--N 1.319 -0.729 0 C-N-CA 124.072 0.949 . . . . 0.0 112.696 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -89.44 -158.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 122.639 2.226 . . . . 0.0 109.017 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -88.74 22.71 2.54 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.712 0.768 . . . . 0.0 111.101 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -155.94 84.4 1.02 Allowed 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.453 ' HE3' ' OH ' ' A' ' 10' ' ' TYR . 59.3 tttp -69.06 -29.11 67.16 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.815 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.453 ' OH ' ' HE3' ' A' ' 9' ' ' LYS . 89.2 m-85 -121.29 115.62 23.32 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.81 149.9 44.85 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -77.3 146.22 36.95 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.136 -175.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.424 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 98.17 -9.52 63.3 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.444 ' O ' HG13 ' A' ' 31' ' ' VAL . 10.2 tp10 -78.67 143.39 36.34 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 122.493 0.317 . . . . 0.0 111.249 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 30' ' ' GLN . 5.5 p -94.91 126.64 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 173.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 59' ' ' ARG . 16.9 m -135.13 -177.7 2.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.314 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 87.7 mtp -111.92 131.72 55.2 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 173.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.99 143.95 14.69 Favored Glycine 0 C--N 1.27 -3.116 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -76.05 141.14 42.14 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -79.9 120.8 81.06 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.27 94.43 0.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.029 2.486 . . . . 0.0 112.073 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.4 -43.78 0.61 Allowed Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.9 p -110.96 -171.71 1.88 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.8 p -105.73 8.04 9.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.017 0.913 . . . . 0.0 108.635 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.3 mt -74.38 143.35 44.86 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.851 -176.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -111.99 133.2 54.31 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.444 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -122.97 155.19 37.28 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.551 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -85.25 125.37 32.82 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.15 163.71 35.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 63.1 tt0 -119.3 130.21 55.27 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 174.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 14' ' ' GLU . 8.1 p -72.27 130.56 35.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.5 t -119.68 -29.56 5.01 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.18 -176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.414 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 16.2 m -144.07 157.18 44.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -139.63 121.89 15.94 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.338 0.113 . . . . 0.0 110.697 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.8 122.33 41.9 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 174.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -83.09 -20.4 34.96 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.001 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.04 -50.82 37.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.0 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 m -97.07 -2.57 42.98 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.27 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 t60 58.98 46.73 13.14 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.494 1.118 . . . . 0.0 108.6 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mp -114.1 142.34 46.33 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.117 -175.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.414 ' CE2' ' HB2' ' A' ' 10' ' ' TYR . 45.5 m-85 -111.99 128.15 56.09 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.414 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 7.0 m -93.19 129.08 39.33 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 176.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.91 159.54 28.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -120.97 133.83 55.28 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -92.95 162.28 14.13 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.823 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -62.24 -21.38 65.12 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.29 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.06 -0.6 32.04 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.128 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.12 -1.06 86.38 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.5 m -79.26 135.31 36.73 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 123.888 0.875 . . . . 0.0 110.934 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -100.48 151.5 21.49 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 171.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 tp -138.86 145.47 40.03 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.23 133.36 53.31 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 172.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.485 ' CD1' HD11 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -141.45 167.21 22.71 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -84.27 157.44 21.56 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.965 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.47 -25.48 66.06 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 176.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 m -70.7 -6.29 36.11 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.469 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -112.96 7.05 18.06 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.485 HD11 ' CD1' ' A' ' 53' ' ' LEU . 41.0 mt -118.48 135.39 59.04 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.658 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.462 ' HD2' ' C ' ' A' ' 58' ' ' ILE . 3.7 mpt_? -129.08 166.44 19.26 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 171.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mp -82.92 179.6 7.72 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -61.17 -28.65 69.28 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 172.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 m 59.87 22.7 11.68 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 124.949 1.299 . . . . 0.0 112.721 169.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.9 m -94.13 163.59 13.4 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -68.12 116.97 9.34 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.234 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -69.81 166.45 19.33 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.38 -173.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 N--CA 1.426 -1.659 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.065 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.09 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.26 103.74 7.57 Favored 'General case' 0 C--O 1.249 1.079 0 CA-C-O 121.309 0.576 . . . . 0.0 110.12 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.5 tmm? -122.66 112.56 18.11 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.74 -175.78 47.37 Favored Glycine 0 CA--C 1.491 -1.443 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 66.6 mtt -120.31 100.81 47.32 Favored Pre-proline 0 C--N 1.3 -1.576 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.02 -16.86 25.41 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.406 2.07 . . . . 0.0 112.602 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 58.1 t30 60.96 -89.39 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 124.907 1.283 . . . . 0.0 109.762 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -112.41 108.5 17.68 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -67.85 -35.68 78.98 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -114.04 127.29 55.88 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.09 150.3 37.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -74.51 131.86 41.37 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.099 0.476 . . . . 0.0 111.352 -175.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.509 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 107.51 -11.31 39.21 Favored Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.6 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -77.43 152.64 34.2 Favored 'General case' 0 C--O 1.241 0.625 0 O-C-N 122.823 -0.222 . . . . 0.0 111.079 -175.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.29 127.29 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.02 177.93 6.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.965 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.0 mmm -111.33 131.97 54.76 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.51 149.08 19.74 Favored Glycine 0 C--N 1.286 -2.229 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.158 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.486 ' HD3' ' OD2' ' A' ' 57' ' ' ASP . 23.1 ttt-85 -82.62 134.75 35.17 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 123.131 0.572 . . . . 0.0 111.123 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -83.55 121.93 76.63 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.57 124.66 15.93 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.198 2.599 . . . . 0.0 111.602 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.5 -25.12 22.41 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -176.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.3 m -112.7 169.47 8.88 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 p -112.26 6.67 8.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 122.502 1.144 . . . . 0.0 108.453 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.1 mt -90.01 144.16 26.15 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.355 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 19' ' ' ARG . 17.3 m-85 -109.33 128.94 55.49 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.565 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -118.8 172.39 7.55 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -85.49 126.03 33.51 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 123.376 0.422 . . . . 0.0 109.895 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.38 163.79 34.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.959 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -113.29 130.51 56.23 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.509 HG12 ' H ' ' A' ' 13' ' ' GLY . 8.8 p -72.28 128.6 35.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 176.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.0 t -119.12 -28.45 5.47 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.61 -0.836 . . . . 0.0 112.062 -173.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.2 m -151.62 169.17 22.8 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 121.921 -0.487 . . . . 0.0 109.917 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -148.91 129.14 13.69 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -97.48 122.75 40.9 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.87 -41.77 70.96 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 123.958 0.786 . . . . 0.0 111.788 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.89 -49.92 74.27 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.588 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -92.9 -2.0 56.23 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.429 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.3 m80 58.21 42.46 21.92 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -104.92 133.74 49.2 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.399 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -103.51 120.71 41.39 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 52' ' ' ALA . 7.1 m -93.71 129.46 40.03 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.6 158.89 26.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.291 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -113.56 132.54 55.67 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -97.6 150.52 21.05 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -62.69 -17.4 60.58 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 122.102 0.953 . . . . 0.0 109.823 173.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.27 -1.9 22.67 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.129 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.28 -31.67 5.6 Favored Glycine 0 N--CA 1.443 -0.862 0 O-C-N 121.836 -0.54 . . . . 0.0 111.814 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.3 m -71.0 130.02 40.51 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 123.82 0.848 . . . . 0.0 110.802 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -102.23 151.33 22.34 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.467 171.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.4 tp -139.42 145.5 38.96 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.461 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 42' ' ' THR . . . -110.7 134.55 52.36 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.243 171.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.4 176.84 8.54 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 123.641 0.777 . . . . 0.0 110.547 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -83.46 167.61 17.29 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 120.852 0.358 . . . . 0.0 111.408 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -60.08 -31.76 70.32 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.684 0.794 . . . . 0.0 110.998 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 m -76.62 -4.99 45.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.526 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.486 ' OD2' ' HD3' ' A' ' 19' ' ' ARG . 3.1 m-20 -105.63 3.38 29.11 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.335 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 mt -118.06 141.47 37.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 121.238 0.542 . . . . 0.0 111.09 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -129.52 168.16 16.79 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 172.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.0 mt -82.52 -176.21 6.12 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -53.28 -35.16 59.76 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.5 t -161.83 -72.19 0.06 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 174.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 p -137.54 -64.58 0.55 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.8 t80 63.05 14.89 8.0 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.038 1.335 . . . . 0.0 113.356 171.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -134.89 105.17 6.28 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 120.927 -1.108 . . . . 0.0 111.44 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--N 1.305 -1.338 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.957 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.842 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.09 135.02 39.88 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -129.8 -39.56 1.42 Allowed 'General case' 0 C--N 1.3 -1.543 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.91 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.27 85.76 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 118.19 -1.957 . . . . 0.0 115.898 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -115.32 95.47 42.79 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 170.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -86.73 -5.09 8.1 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 122.518 2.145 . . . . 0.0 111.072 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -81.82 167.38 19.09 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.931 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -63.62 145.31 55.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.463 ' NZ ' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -46.71 -48.58 20.24 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.085 0.954 . . . . 0.0 110.401 -175.216 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -127.4 135.55 50.63 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 172.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.89 150.38 24.14 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -77.7 135.87 38.11 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 123.217 0.607 . . . . 0.0 112.182 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.575 ' H ' HG11 ' A' ' 31' ' ' VAL . . . 103.33 -14.35 54.69 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.433 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.547 ' O ' HG12 ' A' ' 31' ' ' VAL . 29.6 tt0 -79.17 156.74 28.08 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.862 0.465 . . . . 0.0 112.002 -174.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.0 p -90.87 129.04 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 172.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 m -134.1 171.55 17.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.9 mtp -111.11 132.3 54.39 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.236 173.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -125.49 146.3 16.11 Favored Glycine 0 C--N 1.281 -2.504 0 C-N-CA 120.184 -1.007 . . . . 0.0 111.668 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.417 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 75.5 ttt180 -79.89 132.11 36.01 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -67.79 124.77 90.21 Favored Pre-proline 0 N--CA 1.433 -1.302 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -48.29 110.75 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 124.08 3.186 . . . . 0.0 114.137 -173.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.11 -22.02 40.79 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.909 -0.587 . . . . 0.0 113.024 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 m -97.49 174.74 6.51 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.7 p -103.42 -9.01 9.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 122.097 0.951 . . . . 0.0 109.244 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -65.43 123.84 20.68 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.176 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.417 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 41.9 m-85 -104.19 132.22 50.67 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.076 175.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -119.88 157.86 27.85 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.569 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -95.59 125.25 40.06 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.6 m -135.51 163.83 34.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-O 120.892 0.377 . . . . 0.0 110.626 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -107.36 129.91 54.86 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.344 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.575 HG11 ' H ' ' A' ' 13' ' ' GLY . 6.2 p -72.29 127.06 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.697 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.7 m -112.38 -40.28 4.17 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.178 -170.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.2 t -151.74 -179.67 7.64 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -161.55 129.01 4.06 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 122.4 0.28 . . . . 0.0 110.761 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -91.95 122.09 34.14 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.06 -38.75 51.99 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 124.279 0.987 . . . . 0.0 109.816 -173.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.77 -57.3 13.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.428 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.6 m -98.87 -0.29 42.71 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.1 m80 66.59 43.92 2.39 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.631 0.772 . . . . 0.0 110.255 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.93 121.17 41.27 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.481 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 51.8 m-85 -93.8 122.89 36.75 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 m -92.92 129.21 38.91 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.85 158.61 37.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -107.66 133.13 52.54 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -97.89 165.41 11.94 Favored 'General case' 0 CA--C 1.508 -0.637 0 O-C-N 124.41 1.069 . . . . 0.0 111.53 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -61.57 -25.22 67.17 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 124.904 1.282 . . . . 0.0 110.415 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -83.44 -0.89 52.04 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.134 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.79 -33.27 5.29 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.979 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.8 m -56.06 131.25 46.99 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.885 1.274 . . . . 0.0 111.645 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -96.7 150.34 20.8 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 172.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.57 149.99 44.5 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 41' ' ' TYR . . . -109.56 135.3 50.76 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 172.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.69 166.17 25.48 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 123.18 0.592 . . . . 0.0 110.882 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.8 161.75 20.84 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.05 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -60.37 -30.69 69.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.6 t -74.52 -5.53 43.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.87 0.367 . . . . 0.0 110.743 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -95.86 -12.31 25.41 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 55.1 mt -99.76 143.01 14.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 120.967 0.413 . . . . 0.0 111.449 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -131.07 170.23 14.8 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 171.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.1 mt -84.0 -162.95 0.71 Allowed 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.16 -35.93 18.03 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 176.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 m -150.51 -62.89 0.2 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.1 m -159.29 177.5 10.96 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -75.86 116.11 16.23 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 123.629 0.581 . . . . 0.0 109.767 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -97.19 113.45 25.05 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? . . . . . 0 C--N 1.303 -1.444 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -179.825 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.902 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.74 123.43 40.5 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.9 mtt -145.35 123.82 12.4 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.916 0.388 . . . . 0.0 110.638 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.97 -83.34 1.64 Allowed Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 114.816 0.686 . . . . 0.0 114.816 174.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 63.8 mtt -135.23 165.52 35.83 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -172.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -73.79 98.1 1.04 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 N-CA-C 105.085 -2.698 . . . . 0.0 105.085 162.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -82.24 -9.0 59.65 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -166.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.672 ' HA ' ' OH ' ' A' ' 41' ' ' TYR . 12.8 ttm180 64.6 59.06 0.98 Allowed 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 -166.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -72.74 -19.75 61.32 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 112.586 -2.097 . . . . 0.0 109.24 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -123.05 138.69 54.61 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.29 -153.42 0.11 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 123.718 0.636 . . . . 0.0 110.761 -175.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -123.94 125.52 44.74 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 174.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.92 -5.22 68.81 Favored Glycine 0 C--N 1.311 -0.818 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.558 ' O ' HG13 ' A' ' 31' ' ' VAL . 43.3 tt0 -77.74 137.86 38.71 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 123.423 0.689 . . . . 0.0 110.265 -177.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.82 127.58 41.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 118.535 -1.266 . . . . 0.0 108.568 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.7 m -135.58 -176.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.918 -176.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 90.3 mtp -111.27 132.77 54.11 Favored 'General case' 0 C--O 1.204 -1.323 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -128.79 141.61 12.74 Favored Glycine 0 C--N 1.272 -2.986 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.562 ' HB3' ' OD1' ' A' ' 57' ' ' ASP . 15.6 ttp180 -75.1 144.34 42.93 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.46 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -81.42 119.79 76.53 Favored Pre-proline 0 N--CA 1.426 -1.671 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 173.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.3 -25.38 38.6 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 C-N-CA 124.003 3.135 . . . . 0.0 114.214 -174.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -78.86 -34.93 32.79 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.19 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.0 p -111.8 -164.95 0.95 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.071 0.462 . . . . 0.0 110.346 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.7 m -114.16 10.07 7.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.4 mt -93.86 145.51 24.56 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 34.8 m-85 -100.61 124.9 46.83 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.408 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -113.64 156.01 24.48 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -79.36 125.8 29.98 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.11 163.69 35.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -111.2 128.87 56.05 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 173.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 14' ' ' GLU . 10.8 p -73.8 136.95 24.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.6 t -122.37 -41.44 2.4 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 118.656 -1.218 . . . . 0.0 112.056 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.7 m -139.03 141.5 38.27 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.774 -0.771 . . . . 0.0 110.734 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -114.78 124.7 52.44 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.939 0.4 . . . . 0.0 111.161 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -96.25 122.59 39.27 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -97.42 -19.76 18.23 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.583 0.552 . . . . 0.0 111.528 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.44 -52.68 8.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.864 0.364 . . . . 0.0 111.429 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.7 m -99.5 -2.02 36.95 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.287 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 61.66 80.0 0.24 Allowed 'General case' 0 C--O 1.247 0.954 0 C-N-CA 123.667 0.787 . . . . 0.0 112.273 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -141.96 150.17 41.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.986 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.672 ' OH ' ' HA ' ' A' ' 8' ' ' ARG . 29.3 m-85 -119.63 116.93 27.01 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.5 m -87.01 129.0 35.07 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.49 160.0 32.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 124.308 1.005 . . . . 0.0 108.633 -176.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -124.95 135.74 53.11 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -95.01 159.04 15.21 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.571 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -61.3 -25.12 66.9 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.944 0.778 . . . . 0.0 110.418 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.53 -0.7 27.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.829 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.69 -39.34 2.77 Favored Glycine 0 C--O 1.248 1.0 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.513 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.0 m -54.77 136.14 46.61 Favored 'General case' 0 C--O 1.246 0.882 0 C-N-CA 124.395 1.078 . . . . 0.0 111.533 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -113.57 150.42 33.07 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.4 tp -139.5 145.66 39.01 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -175.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.3 133.66 52.77 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.404 ' CD1' HD13 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -141.74 172.52 12.58 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 123.369 0.667 . . . . 0.0 111.964 178.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 56' ' ' SER . 86.8 tttt -82.43 156.34 24.18 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 122.664 0.386 . . . . 0.0 110.031 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 41.5 tt0 -60.08 -31.95 70.49 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.948 0.88 . . . . 0.0 110.872 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.401 ' H ' ' HG2' ' A' ' 54' ' ' LYS . 4.0 m -76.6 -11.25 59.83 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.601 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.562 ' OD1' ' HB3' ' A' ' 19' ' ' ARG . 1.6 t70 -103.21 6.43 38.24 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -177.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.404 HD13 ' CD1' ' A' ' 53' ' ' LEU . 49.4 mt -110.9 149.26 13.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.072 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -131.34 158.66 40.1 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.39 164.67 6.95 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -48.45 -32.32 7.6 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.3 m -143.11 -35.57 0.4 Allowed 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.707 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.0 t 60.96 34.85 19.27 Favored 'General case' 0 C--N 1.364 1.197 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -67.93 141.51 56.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 112.757 -2.019 . . . . 0.0 111.078 -171.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.505 ' HD3' ' C ' ' A' ' 65' ' ' LYS . 11.5 tmtt? -77.13 118.7 19.93 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 C--N 1.288 -2.089 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.709 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.94 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.77 103.91 12.5 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.466 0.651 . . . . 0.0 110.39 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -102.82 -25.59 13.45 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.908 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.21 -164.95 25.78 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.649 ' SD ' ' HA ' ' A' ' 9' ' ' LYS . 53.2 ttm -170.46 114.58 0.46 Allowed Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.04 158.79 41.78 Favored 'Trans proline' 0 C--O 1.251 1.141 0 C-N-CA 122.701 2.268 . . . . 0.0 112.059 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.416 ' C ' ' HD3' ' A' ' 8' ' ' ARG . 16.1 m120 74.58 -90.51 0.02 OUTLIER 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.693 1.197 . . . . 0.0 110.549 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.416 ' HD3' ' C ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -137.91 125.65 22.4 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.649 ' HA ' ' SD ' ' A' ' 5' ' ' MET . 77.0 tttt -82.34 -30.19 30.56 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -88.14 75.78 8.59 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.682 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.41 152.16 22.93 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -46.74 123.66 5.32 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.115 0.884 . . . . 0.0 111.387 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.31 -13.42 28.32 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.285 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.444 ' O ' HG11 ' A' ' 31' ' ' VAL . 7.6 tp10 -76.48 137.02 39.39 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 117.436 0.618 . . . . 0.0 109.571 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 p -95.19 127.68 46.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -135.37 -178.73 2.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 122.857 0.463 . . . . 0.0 111.159 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 83.4 mtp -110.85 133.01 53.71 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 57' ' ' ASP . . . -138.88 142.28 12.8 Favored Glycine 0 C--N 1.281 -2.496 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.796 -177.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HD3' ' OD1' ' A' ' 57' ' ' ASP . 33.9 ttt-85 -75.59 132.21 40.5 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 125.115 1.366 . . . . 0.0 110.92 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 23' ' ' SER . 16.4 t-105 -86.25 122.91 72.18 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 172.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.432 ' CD ' HD21 ' A' ' 51' ' ' LEU . 18.9 Cg_endo -58.72 107.42 0.34 Allowed 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 123.178 2.585 . . . . 0.0 112.613 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.78 -29.93 8.53 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.266 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 25' ' ' LEU . 17.0 m -88.89 -10.93 46.09 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 122.442 -0.446 . . . . 0.0 111.549 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.9 t 75.32 -34.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 125.394 1.478 . . . . 0.0 112.485 175.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 17.3 mt -70.66 149.16 47.28 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -175.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.465 ' CE2' ' HG2' ' A' ' 59' ' ' ARG . 25.6 m-85 -108.07 115.8 30.79 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 113.865 -1.516 . . . . 0.0 107.42 175.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -108.53 172.51 6.8 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -84.72 126.13 33.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 m -134.98 164.04 34.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -126.1 131.23 52.14 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.179 -1.409 . . . . 0.0 108.706 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.444 HG11 ' O ' ' A' ' 14' ' ' GLU . 12.3 p -69.71 129.48 34.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.653 0.74 . . . . 0.0 110.92 -175.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.5 m -106.05 -39.14 6.08 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.925 -174.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.2 m -155.65 162.8 40.53 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -139.58 119.39 13.33 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 120.908 0.385 . . . . 0.0 110.613 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -91.1 123.12 34.32 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -100.8 -1.13 35.69 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.773 0.797 . . . . 0.0 110.185 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.34 -54.64 5.06 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.518 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.3 m -98.53 -2.1 39.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.038 0.446 . . . . 0.0 110.021 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 59.8 69.9 0.67 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.64 1.176 . . . . 0.0 113.204 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -131.97 135.4 46.54 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.694 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -97.93 117.52 32.45 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 52' ' ' ALA . 17.0 m -93.36 129.71 39.39 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.442 HG13 ' HA ' ' A' ' 31' ' ' VAL . 29.5 m -129.06 158.45 41.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -176.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 6.8 ttpm? -110.71 136.88 49.11 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -90.71 154.4 19.58 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.42 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.29 -20.96 63.5 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.814 1.246 . . . . 0.0 110.042 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.34 -1.0 31.14 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.594 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.78 -41.74 2.09 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.463 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.6 m -71.01 135.75 48.0 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.291 0.636 . . . . 0.0 111.501 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -94.85 153.16 17.85 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 173.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.432 HD21 ' CD ' ' A' ' 21' ' ' PRO . 32.9 tp -138.42 148.43 44.44 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.581 -176.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 42' ' ' THR . . . -109.71 134.37 52.07 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 171.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.63 166.99 23.23 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.801 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -85.01 168.18 15.16 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.142 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.57 -30.57 69.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.485 0.66 . . . . 0.0 110.045 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.4 m -69.49 -11.62 60.98 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.09 0.956 . . . . 0.0 110.879 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.554 ' OD1' ' HD3' ' A' ' 19' ' ' ARG . 67.9 m-20 -100.91 1.99 40.4 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.411 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.2 mt -111.74 134.06 55.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.478 0.656 . . . . 0.0 112.491 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.465 ' HG2' ' CE2' ' A' ' 26' ' ' TYR . 56.1 mmt-85 -130.36 156.58 44.46 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 172.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mp -83.58 166.64 18.04 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 172.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -52.46 -35.38 52.43 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.1 m -113.98 14.87 18.51 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.119 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.5 m 52.32 71.77 0.45 Allowed 'General case' 0 C--N 1.355 0.833 0 CA-C-O 122.189 0.995 . . . . 0.0 108.892 -172.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -66.87 -46.12 75.99 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.188 -1.369 . . . . 0.0 113.555 -167.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 71.17 158.95 0.2 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.684 0.794 . . . . 0.0 110.653 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 . . . . . 0 C--N 1.31 -1.148 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.44 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.305 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.62 92.94 7.23 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.8 tpt -88.62 134.31 33.92 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.212 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.11 -174.39 42.98 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 65.1 mtt -124.34 94.74 44.56 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 117.37 0.585 . . . . 0.0 110.72 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.58 -26.6 4.67 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.749 2.299 . . . . 0.0 111.027 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -164.18 178.87 7.26 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 103.954 -2.61 . . . . 0.0 103.954 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.456 ' NE ' ' HD2' ' A' ' 34' ' ' TYR . 97.7 mtt180 -72.64 124.32 25.04 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.618 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -67.59 -55.34 13.78 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 176.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.513 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 36.3 m-85 -88.24 95.96 10.38 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.69 149.58 28.42 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.469 ' HA ' HG13 ' A' ' 31' ' ' VAL . 10.3 p-10 -61.78 127.52 31.8 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.693 0.759 . . . . 0.0 112.319 -173.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.7 -14.44 17.39 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.478 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.48 ' O ' HG11 ' A' ' 31' ' ' VAL . 32.4 tt0 -77.25 136.74 38.55 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.0 p -94.84 127.53 46.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.427 HG13 ' CD1' ' A' ' 10' ' ' TYR . 12.7 m -135.34 -176.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.374 -175.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.405 ' HG2' ' HA ' ' A' ' 61' ' ' GLN . 94.4 mmm -110.33 131.73 54.8 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 174.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -128.49 141.84 12.96 Favored Glycine 0 C--N 1.273 -2.949 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -89.58 136.19 33.17 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 24.8 t-105 -71.11 121.4 84.06 Favored Pre-proline 0 N--CA 1.434 -1.268 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.44 114.48 1.47 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 124.106 3.204 . . . . 0.0 114.299 -174.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.67 -30.52 9.35 Favored Glycine 0 C--O 1.242 0.656 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.379 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.3 m -96.13 175.5 6.44 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.3 p -105.65 -2.42 9.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 122.218 1.009 . . . . 0.0 108.986 176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.85 134.2 45.95 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -107.85 136.48 47.5 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.471 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -128.92 157.77 40.67 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.013 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -86.16 125.57 33.6 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.02 163.22 37.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -175.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -122.32 130.35 53.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.48 HG11 ' O ' ' A' ' 14' ' ' GLU . 7.5 p -68.7 132.46 32.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.415 0.626 . . . . 0.0 111.181 -176.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.8 m -118.58 -38.21 3.17 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.237 -173.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.3 m -157.0 171.17 20.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.456 ' HD2' ' NE ' ' A' ' 8' ' ' ARG . 44.0 t80 -154.31 136.52 14.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 118.131 0.423 . . . . 0.0 111.734 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -97.39 121.73 39.62 Favored 'General case' 0 C--O 1.249 1.026 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 171.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -82.07 -23.72 35.65 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 124.073 0.858 . . . . 0.0 111.365 -170.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.0 -51.83 9.06 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.786 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.5 m -94.54 -0.6 54.47 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 33.4 m80 68.07 43.2 1.66 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.381 1.072 . . . . 0.0 110.916 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.76 115.83 30.91 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.882 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.513 ' CE2' ' HB2' ' A' ' 10' ' ' TYR . 65.2 m-85 -96.08 127.11 41.8 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.7 m -92.95 129.21 38.94 Favored 'General case' 0 N--CA 1.404 -2.751 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.415 HG13 ' HA ' ' A' ' 31' ' ' VAL . 34.0 m -127.72 157.62 39.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -105.22 133.78 49.41 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -92.48 157.0 16.8 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.694 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.13 -23.08 66.35 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.786 0.803 . . . . 0.0 109.9 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.66 -1.94 10.35 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.46 1.104 . . . . 0.0 111.157 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.74 -23.81 18.08 Favored Glycine 0 C--O 1.227 -0.316 0 O-C-N 121.654 -0.654 . . . . 0.0 112.174 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.4 m -77.04 132.97 39.21 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 124.372 1.069 . . . . 0.0 111.259 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -93.79 150.19 20.59 Favored 'General case' 0 C--O 1.251 1.161 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.4 tp -139.48 149.97 44.62 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.24 134.72 51.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 173.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.453 ' CD1' HD11 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -141.32 166.21 25.39 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 124.114 0.966 . . . . 0.0 111.006 177.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 39' ' ' HIS . 97.5 mttt -82.91 161.42 21.85 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.618 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -60.69 -31.13 70.4 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.448 0.642 . . . . 0.0 110.8 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -75.57 -4.33 39.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.56 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -105.82 2.57 27.89 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.453 HD11 ' CD1' ' A' ' 53' ' ' LEU . 48.9 mt -114.03 146.97 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -132.45 159.2 40.02 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 172.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.6 mt -66.31 171.92 4.4 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 170.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.405 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 51.9 mt-30 -52.57 -37.69 58.44 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -175.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.8 t 176.03 -52.9 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.1 m -92.49 174.09 7.46 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.805 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -148.18 157.0 43.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 104.608 -2.368 . . . . 0.0 104.608 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -79.65 120.08 23.48 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.721 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 . . . . . 0 C--N 1.29 -1.979 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.296 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' HG11 ' A' ' 31' ' ' VAL . . . . . . . . 0 C--O 1.218 -0.553 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.475 ' HA ' HG13 ' A' ' 31' ' ' VAL . 6.7 p-10 -127.51 134.2 49.8 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.439 ' H ' HG13 ' A' ' 31' ' ' VAL . . . 94.78 -8.83 70.97 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -172.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.521 ' O ' HG12 ' A' ' 31' ' ' VAL . 24.8 tt0 -78.43 138.03 38.28 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.488 1.115 . . . . 0.0 112.071 -175.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 30' ' ' GLN . 4.3 p -91.1 128.12 43.08 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.273 174.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 m -135.49 -175.23 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.662 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 96.0 mmm -107.95 132.74 53.18 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.22 135.6 8.25 Favored Glycine 0 C--N 1.281 -2.484 0 C-N-CA 120.27 -0.966 . . . . 0.0 111.073 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 35.3 ttm180 -74.42 143.05 44.92 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 123.846 0.859 . . . . 0.0 109.626 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 . . . . . 0 N--CA 1.435 -1.177 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 175.539 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 18.3 mt . . . . . 0 CA--C 1.491 -1.304 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -113.35 131.16 56.08 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.543 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -117.92 172.84 7.13 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -95.33 125.22 39.8 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.1 m -135.34 163.28 36.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 60.8 tt0 -122.37 130.11 52.78 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 173.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 14' ' ' GLU . 7.6 p -72.42 128.1 35.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 123.321 0.388 . . . . 0.0 110.532 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.8 p -108.76 -46.47 3.64 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-O 120.711 0.291 . . . . 0.0 111.621 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -144.35 179.49 7.21 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.216 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -155.34 127.68 7.78 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 7.6 t70 -88.43 122.67 32.18 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 173.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -96.32 -13.91 22.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.27 -52.28 7.91 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.071 0.463 . . . . 0.0 110.257 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.416 ' HB2' HD23 ' A' ' 40' ' ' LEU . 15.9 m -99.7 -1.05 38.87 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.286 0.565 . . . . 0.0 111.085 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 59.61 71.35 0.58 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.115 0.966 . . . . 0.0 111.79 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.416 HD23 ' HB2' ' A' ' 38' ' ' SER . 4.6 mm? -125.28 138.64 54.09 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.529 ' CE1' ' HB3' ' A' ' 55' ' ' GLU . 11.2 m-85 -108.93 130.04 55.44 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.0 m -93.25 128.63 39.32 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 31' ' ' VAL . 35.9 m -130.4 159.67 42.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 22.9 ttmm -119.63 133.81 55.49 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -88.77 167.43 13.3 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 123.643 0.59 . . . . 0.0 111.533 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -61.14 -22.57 64.81 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.339 1.055 . . . . 0.0 110.679 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.23 -0.1 34.88 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.476 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.32 -37.46 3.38 Favored Glycine 0 CA--C 1.509 -0.336 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.5 m -58.86 134.97 57.37 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 124.851 1.26 . . . . 0.0 110.771 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -108.67 151.16 26.53 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.478 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.6 tp -139.92 159.32 42.44 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.6 135.28 51.47 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 171.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.8 170.25 16.1 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -82.29 161.8 22.5 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.529 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -60.87 -30.22 70.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.933 0.397 . . . . 0.0 111.422 174.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 m -69.75 -12.04 61.32 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.542 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -95.77 -12.52 25.23 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mt -102.37 135.47 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.736 -176.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -130.02 168.46 16.68 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.798 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 C--N 1.313 -1.004 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.439 -179.86 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.813 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.418 ' HA ' HG13 ' A' ' 31' ' ' VAL . 6.9 p-10 -56.54 127.39 31.02 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.6 0.562 . . . . 0.0 111.796 -174.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.18 -8.09 48.63 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.474 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.4 ' O ' HG12 ' A' ' 31' ' ' VAL . 8.9 tp10 -77.01 138.82 39.83 Favored 'General case' 0 N--CA 1.431 -1.377 0 O-C-N 122.567 -0.372 . . . . 0.0 110.11 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 p -94.05 127.09 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.1 m -135.45 179.05 4.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.696 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.0 mtp -111.24 132.74 54.12 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.84 150.89 19.16 Favored Glycine 0 C--N 1.285 -2.284 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.326 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 29.5 ttp180 -85.35 139.85 31.25 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.948 0.404 . . . . 0.0 110.625 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 41.1 t-105 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 175.635 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 11.5 mt . . . . . 0 CA--C 1.5 -0.943 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.521 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 67.0 m-85 -127.84 107.27 9.73 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 123.707 0.629 . . . . 0.0 110.037 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -98.64 163.8 12.5 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.959 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.76 124.09 39.63 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.43 164.94 31.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.168 -172.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -114.74 130.8 56.89 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 43' ' ' VAL . 14.3 p -71.16 128.42 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.0 m -108.5 -35.43 6.48 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.049 -172.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.8 t -156.63 174.54 15.31 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -149.22 117.88 6.59 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 123.426 0.69 . . . . 0.0 109.507 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -88.08 122.23 31.41 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -97.69 -8.63 28.31 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.762 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.48 -49.67 9.67 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.293 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.4 t -98.61 -2.19 39.09 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.991 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 59.71 63.4 1.51 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.979 0.912 . . . . 0.0 111.945 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -127.45 127.86 44.8 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.854 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -98.08 120.12 37.91 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.6 m -87.62 130.42 34.78 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 31' ' ' VAL . 34.7 m -128.67 157.6 41.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -108.18 133.04 53.0 Favored 'General case' 0 C--O 1.264 1.829 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -97.18 154.93 17.07 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 124.237 0.961 . . . . 0.0 110.215 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -61.95 -25.03 67.35 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.814 0.846 . . . . 0.0 109.384 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.64 -0.69 21.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.354 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.91 -18.59 50.23 Favored Glycine 0 CA--C 1.504 -0.654 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.136 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.6 m -78.65 130.38 35.8 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 123.046 0.538 . . . . 0.0 109.919 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.41 148.66 25.23 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 170.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.2 tp -140.52 152.06 45.27 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -173.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.63 134.5 51.87 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 170.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.23 164.86 28.94 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.254 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.84 166.98 17.48 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -30.88 70.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.427 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -74.5 -1.51 21.6 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.201 0.524 . . . . 0.0 111.943 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -101.06 -13.24 18.3 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.7 mt -102.57 133.37 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.627 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -122.61 168.79 11.74 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 113.987 -1.46 . . . . 0.0 107.602 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.302 -1.499 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.828 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.644 ' HA ' HG13 ' A' ' 31' ' ' VAL . 4.1 p30 -72.88 139.46 46.9 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.822 0.344 . . . . 0.0 111.363 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.86 -13.24 34.84 Favored Glycine 0 N--CA 1.429 -1.776 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.093 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.472 ' O ' HG12 ' A' ' 31' ' ' VAL . 8.7 tp10 -77.9 147.32 35.1 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.2 127.33 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 174.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 m -135.04 174.97 12.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.953 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.1 mtp -111.61 132.88 54.25 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 172.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.43 149.86 19.56 Favored Glycine 0 C--N 1.278 -2.655 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.927 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.432 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 47.2 ttp85 -79.7 137.12 36.96 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 . . . . . 0 N--CA 1.426 -1.665 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 176.583 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 N--CA 1.44 -0.952 0 N-CA-C 110.755 -0.091 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.432 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 57.4 m-85 -110.55 129.19 55.85 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.529 0.68 . . . . 0.0 111.242 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -122.87 156.56 34.38 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.608 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.89 124.93 35.12 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.66 169.54 20.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 122.98 0.512 . . . . 0.0 110.087 -174.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -115.26 130.48 56.92 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 173.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.644 HG13 ' HA ' ' A' ' 12' ' ' ASP . 7.3 p -72.39 128.65 35.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.8 t -108.89 -31.41 7.68 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.619 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -165.53 -176.9 4.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -148.97 132.37 16.6 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 123.548 0.739 . . . . 0.0 109.667 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -97.49 121.43 39.38 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -86.41 -21.91 26.86 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.94 -49.49 51.36 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.032 0.444 . . . . 0.0 110.496 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.6 m -97.47 -2.03 42.93 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.71 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 59.98 45.68 11.88 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.54 0.686 . . . . 0.0 110.84 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.95 134.55 52.49 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.372 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.617 ' CE1' ' HB3' ' A' ' 55' ' ' GLU . 26.9 m-85 -102.47 127.49 49.49 Favored 'General case' 0 CA--C 1.48 -1.745 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.3 m -93.06 129.16 39.11 Favored 'General case' 0 N--CA 1.4 -2.933 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -125.0 159.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -121.32 135.5 55.09 Favored 'General case' 0 C--N 1.272 -2.775 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -90.17 162.3 15.33 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.408 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -61.8 -24.05 66.61 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.628 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -82.42 0.7 40.92 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.474 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.12 -31.52 7.88 Favored Glycine 0 C--O 1.238 0.357 0 C-N-CA 121.506 -0.378 . . . . 0.0 112.377 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 m -56.11 130.03 42.47 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 124.917 1.287 . . . . 0.0 111.03 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.2 150.46 25.08 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.978 175.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.9 tp -139.86 152.87 46.81 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.538 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.07 134.61 51.98 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.18 173.75 11.18 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 123.136 0.574 . . . . 0.0 111.244 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -82.72 157.02 23.46 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.62 0.248 . . . . 0.0 110.492 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.617 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -61.25 -31.09 70.88 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.169 0.509 . . . . 0.0 110.906 173.478 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.0 m -73.15 -12.05 60.75 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.723 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -95.4 -5.89 42.17 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.8 mt -102.62 133.6 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-O 121.296 0.569 . . . . 0.0 111.285 -176.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -124.43 161.9 25.05 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 173.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.1 mt . . . . . 0 C--N 1.297 -1.683 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.898 179.658 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.452 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -60.44 121.68 12.71 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.397 0.618 . . . . 0.0 112.161 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.497 ' H ' HG13 ' A' ' 31' ' ' VAL . . . 115.68 -14.34 17.47 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.647 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 31' ' ' VAL . 26.5 tt0 -77.02 141.05 40.51 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-N 116.893 0.347 . . . . 0.0 111.42 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.87 127.74 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 106.689 -1.596 . . . . 0.0 106.689 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.6 173.54 14.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.568 -173.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.419 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 47.0 ttm -111.2 131.85 54.79 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 172.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.8 149.96 19.45 Favored Glycine 0 C--N 1.283 -2.415 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.246 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.413 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 48.5 ttp180 -89.41 146.7 24.49 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 123.634 0.774 . . . . 0.0 109.0 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 . . . . . 0 C--N 1.306 -1.319 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.747 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.433 -1.312 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 50.5 m-85 -118.23 142.53 47.37 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.552 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -135.17 164.95 26.54 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -95.73 124.54 39.8 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.1 m -135.42 173.84 13.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.531 -172.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -115.25 131.26 56.98 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.855 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.497 HG13 ' H ' ' A' ' 13' ' ' GLY . 11.2 p -71.26 127.73 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -103.2 -44.36 5.21 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.445 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -157.73 173.12 17.31 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -150.52 126.02 10.19 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 123.372 0.669 . . . . 0.0 109.54 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -96.93 122.23 39.68 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 171.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -84.32 -28.36 27.14 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -174.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.85 -48.87 43.04 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.813 0.339 . . . . 0.0 111.194 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.4 m -94.54 -1.86 52.62 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.674 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 43.4 t60 60.01 63.72 1.39 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.373 1.069 . . . . 0.0 111.736 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -128.55 125.66 38.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.688 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -97.94 118.35 34.32 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.7 m -94.17 129.98 40.55 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 31' ' ' VAL . 33.5 m -126.82 158.6 37.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -109.71 133.5 53.06 Favored 'General case' 0 C--O 1.271 2.225 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -93.22 162.19 14.11 Favored 'General case' 0 CA--C 1.496 -1.104 0 O-C-N 124.584 1.177 . . . . 0.0 110.75 175.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -62.2 -24.19 67.07 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.1 -0.954 . . . . 0.0 112.004 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -78.65 -0.19 28.99 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.423 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.6 -2.83 86.35 Favored Glycine 0 C--O 1.221 -0.707 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 m -79.32 129.96 34.97 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 122.967 0.507 . . . . 0.0 110.016 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -90.46 152.13 21.09 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 172.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.4 tp -137.77 145.03 41.93 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.03 133.98 52.62 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 173.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.07 172.59 12.46 Favored 'General case' 0 C--N 1.276 -2.627 0 O-C-N 123.763 0.665 . . . . 0.0 110.666 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -83.87 166.11 18.18 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.51 -32.81 70.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.041 0.448 . . . . 0.0 110.567 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.6 m -77.37 -6.43 53.29 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.058 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -88.69 -18.89 26.94 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.1 mt -100.97 130.76 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.298 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 17' ' ' MET . 74.1 mtt85 -135.0 158.73 43.58 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.258 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.7 mt . . . . . 0 C--N 1.29 -2.019 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 168.546 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.942 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.511 ' HA ' HG13 ' A' ' 31' ' ' VAL . 2.9 p30 -77.3 146.22 36.95 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.136 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.17 -9.52 63.3 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 31' ' ' VAL . 10.2 tp10 -78.67 143.39 36.34 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 122.493 0.317 . . . . 0.0 111.249 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 30' ' ' GLN . 5.5 p -94.91 126.64 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 173.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 59' ' ' ARG . 16.9 m -135.13 -177.7 2.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.314 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 87.7 mtp -111.92 131.72 55.2 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 173.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.99 143.95 14.69 Favored Glycine 0 C--N 1.27 -3.116 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -76.05 141.14 42.14 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 . . . . . 0 N--CA 1.428 -1.532 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.998 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 N--CA 1.435 -1.196 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -111.99 133.2 54.31 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.444 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -122.97 155.19 37.28 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.551 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -85.25 125.37 32.82 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.15 163.71 35.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 63.1 tt0 -119.3 130.21 55.27 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 174.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.511 HG13 ' HA ' ' A' ' 12' ' ' ASP . 8.1 p -72.27 130.56 35.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.5 t -119.68 -29.56 5.01 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.18 -176.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.45 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 16.2 m -144.07 157.18 44.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -139.63 121.89 15.94 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.338 0.113 . . . . 0.0 110.697 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.8 122.33 41.9 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 174.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -83.09 -20.4 34.96 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.001 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.04 -50.82 37.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.0 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 m -97.07 -2.57 42.98 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.27 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 t60 58.98 46.73 13.14 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.494 1.118 . . . . 0.0 108.6 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mp -114.1 142.34 46.33 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.117 -175.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.4 ' CE1' ' HB3' ' A' ' 55' ' ' GLU . 45.5 m-85 -111.99 128.15 56.09 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 7.0 m -93.19 129.08 39.33 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 176.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.91 159.54 28.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -120.97 133.83 55.28 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -92.95 162.28 14.13 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.823 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -62.24 -21.38 65.12 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.29 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.06 -0.6 32.04 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.128 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.12 -1.06 86.38 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.5 m -79.26 135.31 36.73 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 123.888 0.875 . . . . 0.0 110.934 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -100.48 151.5 21.49 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 171.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 tp -138.86 145.47 40.03 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.23 133.36 53.31 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 172.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.426 ' CD1' HD11 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -141.45 167.21 22.71 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -84.27 157.44 21.56 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.965 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.4 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -60.47 -25.48 66.06 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 176.416 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 m -70.7 -6.29 36.11 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.469 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -112.96 7.05 18.06 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.465 ' C ' ' HD2' ' A' ' 59' ' ' ARG . 41.0 mt -118.48 135.39 59.04 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.658 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.465 ' HD2' ' C ' ' A' ' 58' ' ' ILE . 3.7 mpt_? -129.08 166.44 19.26 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 171.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mp . . . . . 0 C--N 1.294 -1.833 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.33 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -74.51 131.86 41.37 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.099 0.476 . . . . 0.0 111.352 -175.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.537 ' H ' HG13 ' A' ' 31' ' ' VAL . . . 107.51 -11.31 39.21 Favored Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.6 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -77.43 152.64 34.2 Favored 'General case' 0 C--O 1.241 0.625 0 O-C-N 122.823 -0.222 . . . . 0.0 111.079 -175.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.29 127.29 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.02 177.93 6.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.965 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.0 mmm -111.33 131.97 54.76 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.51 149.08 19.74 Favored Glycine 0 C--N 1.286 -2.229 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.158 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.494 ' HD3' ' OD2' ' A' ' 57' ' ' ASP . 23.1 ttt-85 -82.62 134.75 35.17 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 123.131 0.572 . . . . 0.0 111.123 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 . . . . . 0 C--N 1.315 -0.918 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 175.411 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.1 mt . . . . . 0 N--CA 1.432 -1.339 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 19' ' ' ARG . 17.3 m-85 -109.33 128.94 55.49 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.565 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -118.8 172.39 7.55 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -85.49 126.03 33.51 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 123.376 0.422 . . . . 0.0 109.895 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.38 163.79 34.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.959 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -113.29 130.51 56.23 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.537 HG13 ' H ' ' A' ' 13' ' ' GLY . 8.8 p -72.28 128.6 35.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 176.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.0 t -119.12 -28.45 5.47 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.61 -0.836 . . . . 0.0 112.062 -173.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.426 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 50.2 m -151.62 169.17 22.8 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 121.921 -0.487 . . . . 0.0 109.917 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -148.91 129.14 13.69 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -97.48 122.75 40.9 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.87 -41.77 70.96 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 123.958 0.786 . . . . 0.0 111.788 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.89 -49.92 74.27 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.588 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -92.9 -2.0 56.23 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.429 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.3 m80 58.21 42.46 21.92 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -104.92 133.74 49.2 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.399 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -103.51 120.71 41.39 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 52' ' ' ALA . 7.1 m -93.71 129.46 40.03 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.6 158.89 26.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.291 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -113.56 132.54 55.67 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -97.6 150.52 21.05 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -62.69 -17.4 60.58 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 122.102 0.953 . . . . 0.0 109.823 173.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.27 -1.9 22.67 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.129 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.28 -31.67 5.6 Favored Glycine 0 N--CA 1.443 -0.862 0 O-C-N 121.836 -0.54 . . . . 0.0 111.814 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.3 m -71.0 130.02 40.51 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 123.82 0.848 . . . . 0.0 110.802 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -102.23 151.33 22.34 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.467 171.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.4 tp -139.42 145.5 38.96 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.461 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 42' ' ' THR . . . -110.7 134.55 52.36 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.243 171.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.4 176.84 8.54 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 123.641 0.777 . . . . 0.0 110.547 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -83.46 167.61 17.29 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 120.852 0.358 . . . . 0.0 111.408 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -60.08 -31.76 70.32 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.684 0.794 . . . . 0.0 110.998 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 m -76.62 -4.99 45.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.526 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.494 ' OD2' ' HD3' ' A' ' 19' ' ' ARG . 3.1 m-20 -105.63 3.38 29.11 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.335 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 mt -118.06 141.47 37.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 121.238 0.542 . . . . 0.0 111.09 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -129.52 168.16 16.79 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 172.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 C--N 1.309 -1.18 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.612 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.017 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -77.7 135.87 38.11 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 123.217 0.607 . . . . 0.0 112.182 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.611 ' H ' HG13 ' A' ' 31' ' ' VAL . . . 103.33 -14.35 54.69 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.433 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.542 ' O ' HG12 ' A' ' 31' ' ' VAL . 29.6 tt0 -79.17 156.74 28.08 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.862 0.465 . . . . 0.0 112.002 -174.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.0 p -90.87 129.04 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 172.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 m -134.1 171.55 17.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.9 mtp -111.11 132.3 54.39 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.236 173.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -125.49 146.3 16.11 Favored Glycine 0 C--N 1.281 -2.504 0 C-N-CA 120.184 -1.007 . . . . 0.0 111.668 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.426 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 75.5 ttt180 -79.89 132.11 36.01 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 . . . . . 0 N--CA 1.433 -1.302 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 175.7 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 N--CA 1.431 -1.398 0 CA-C-O 120.736 0.303 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 41.9 m-85 -104.19 132.22 50.67 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.076 175.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -119.88 157.86 27.85 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.569 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -95.59 125.25 40.06 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.6 m -135.51 163.83 34.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-O 120.892 0.377 . . . . 0.0 110.626 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -107.36 129.91 54.86 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.344 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.611 HG13 ' H ' ' A' ' 13' ' ' GLY . 6.2 p -72.29 127.06 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.697 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.7 m -112.38 -40.28 4.17 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.178 -170.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.2 t -151.74 -179.67 7.64 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -161.55 129.01 4.06 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 122.4 0.28 . . . . 0.0 110.761 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -91.95 122.09 34.14 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.06 -38.75 51.99 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 124.279 0.987 . . . . 0.0 109.816 -173.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.77 -57.3 13.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.428 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.6 m -98.87 -0.29 42.71 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.1 m80 66.59 43.92 2.39 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.631 0.772 . . . . 0.0 110.255 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.93 121.17 41.27 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.481 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 51.8 m-85 -93.8 122.89 36.75 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 m -92.92 129.21 38.91 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.428 HG12 ' HA ' ' A' ' 31' ' ' VAL . 35.8 m -126.85 158.61 37.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -107.66 133.13 52.54 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -97.89 165.41 11.94 Favored 'General case' 0 CA--C 1.508 -0.637 0 O-C-N 124.41 1.069 . . . . 0.0 111.53 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -61.57 -25.22 67.17 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 124.904 1.282 . . . . 0.0 110.415 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -83.44 -0.89 52.04 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.134 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.79 -33.27 5.29 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.979 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.8 m -56.06 131.25 46.99 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.885 1.274 . . . . 0.0 111.645 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -96.7 150.34 20.8 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 172.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.57 149.99 44.5 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 41' ' ' TYR . . . -109.56 135.3 50.76 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 172.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.69 166.17 25.48 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 123.18 0.592 . . . . 0.0 110.882 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.8 161.75 20.84 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.05 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -60.37 -30.69 69.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.6 t -74.52 -5.53 43.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.87 0.367 . . . . 0.0 110.743 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -95.86 -12.31 25.41 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 55.1 mt -99.76 143.01 14.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 120.967 0.413 . . . . 0.0 111.449 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -131.07 170.23 14.8 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 171.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.294 -1.831 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 173.938 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.547 0 CA-C-O 120.669 0.271 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -123.94 125.52 44.74 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 174.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.92 -5.22 68.81 Favored Glycine 0 C--N 1.311 -0.818 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.575 ' O ' HG12 ' A' ' 31' ' ' VAL . 43.3 tt0 -77.74 137.86 38.71 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 123.423 0.689 . . . . 0.0 110.265 -177.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.82 127.58 41.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 118.535 -1.266 . . . . 0.0 108.568 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.7 m -135.58 -176.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.918 -176.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 90.3 mtp -111.27 132.77 54.11 Favored 'General case' 0 C--O 1.204 -1.323 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -128.79 141.61 12.74 Favored Glycine 0 C--N 1.272 -2.986 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.573 ' HB3' ' OD1' ' A' ' 57' ' ' ASP . 15.6 ttp180 -75.1 144.34 42.93 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.46 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 . . . . . 0 N--CA 1.426 -1.671 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 173.59 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.4 mt . . . . . 0 N--CA 1.435 -1.188 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 34.8 m-85 -100.61 124.9 46.83 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.408 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -113.64 156.01 24.48 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -79.36 125.8 29.98 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.11 163.69 35.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -111.2 128.87 56.05 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 173.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 14' ' ' GLU . 10.8 p -73.8 136.95 24.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.6 t -122.37 -41.44 2.4 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 118.656 -1.218 . . . . 0.0 112.056 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.7 m -139.03 141.5 38.27 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.774 -0.771 . . . . 0.0 110.734 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -114.78 124.7 52.44 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.939 0.4 . . . . 0.0 111.161 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -96.25 122.59 39.27 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -97.42 -19.76 18.23 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.583 0.552 . . . . 0.0 111.528 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.44 -52.68 8.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.864 0.364 . . . . 0.0 111.429 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.7 m -99.5 -2.02 36.95 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.287 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 61.66 80.0 0.24 Allowed 'General case' 0 C--O 1.247 0.954 0 C-N-CA 123.667 0.787 . . . . 0.0 112.273 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -141.96 150.17 41.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.986 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.573 ' CE1' ' HB2' ' A' ' 55' ' ' GLU . 29.3 m-85 -119.63 116.93 27.01 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.5 m -87.01 129.0 35.07 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 31' ' ' VAL . 33.8 m -125.49 160.0 32.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 124.308 1.005 . . . . 0.0 108.633 -176.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HG3' ' HG2' ' A' ' 50' ' ' GLU . 50.3 tttp -124.95 135.74 53.11 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -95.01 159.04 15.21 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.571 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -61.3 -25.12 66.9 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.944 0.778 . . . . 0.0 110.418 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.53 -0.7 27.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.829 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.69 -39.34 2.77 Favored Glycine 0 C--O 1.248 1.0 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.513 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.0 m -54.77 136.14 46.61 Favored 'General case' 0 C--O 1.246 0.882 0 C-N-CA 124.395 1.078 . . . . 0.0 111.533 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.436 ' HG2' ' HG3' ' A' ' 44' ' ' LYS . 62.0 mt-10 -113.57 150.42 33.07 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.4 tp -139.5 145.66 39.01 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -175.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.3 133.66 52.77 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.74 172.52 12.58 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 123.369 0.667 . . . . 0.0 111.964 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.442 ' HG2' ' H ' ' A' ' 56' ' ' SER . 86.8 tttt -82.43 156.34 24.18 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 122.664 0.386 . . . . 0.0 110.031 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.573 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 41.5 tt0 -60.08 -31.95 70.49 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.948 0.88 . . . . 0.0 110.872 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.442 ' H ' ' HG2' ' A' ' 54' ' ' LYS . 4.0 m -76.6 -11.25 59.83 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.601 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.573 ' OD1' ' HB3' ' A' ' 19' ' ' ARG . 1.6 t70 -103.21 6.43 38.24 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -177.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mt -110.9 149.26 13.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.072 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -131.34 158.66 40.1 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.9 mt . . . . . 0 C--N 1.318 -0.804 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.264 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.342 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.405 ' HA ' HG13 ' A' ' 31' ' ' VAL . 4.4 p-10 -46.74 123.66 5.32 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.115 0.884 . . . . 0.0 111.387 -177.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.31 -13.42 28.32 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.285 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.463 ' O ' HG12 ' A' ' 31' ' ' VAL . 7.6 tp10 -76.48 137.02 39.39 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 117.436 0.618 . . . . 0.0 109.571 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 p -95.19 127.68 46.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -135.37 -178.73 2.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 122.857 0.463 . . . . 0.0 111.159 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 83.4 mtp -110.85 133.01 53.71 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 57' ' ' ASP . . . -138.88 142.28 12.8 Favored Glycine 0 C--N 1.281 -2.496 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.796 -177.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.562 ' HD3' ' OD1' ' A' ' 57' ' ' ASP . 33.9 ttt-85 -75.59 132.21 40.5 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 125.115 1.366 . . . . 0.0 110.92 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 16.4 t-105 . . . . . 0 C--N 1.303 -1.446 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 172.992 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 17.3 mt . . . . . 0 N--CA 1.428 -1.527 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.483 ' CE2' ' HG2' ' A' ' 59' ' ' ARG . 25.6 m-85 -108.07 115.8 30.79 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 113.865 -1.516 . . . . 0.0 107.42 175.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -108.53 172.51 6.8 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -84.72 126.13 33.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 m -134.98 164.04 34.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -126.1 131.23 52.14 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.179 -1.409 . . . . 0.0 108.706 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.521 ' HA ' HG12 ' A' ' 43' ' ' VAL . 12.3 p -69.71 129.48 34.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.653 0.74 . . . . 0.0 110.92 -175.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.5 m -106.05 -39.14 6.08 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.925 -174.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.2 m -155.65 162.8 40.53 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -139.58 119.39 13.33 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 120.908 0.385 . . . . 0.0 110.613 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -91.1 123.12 34.32 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -100.8 -1.13 35.69 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.773 0.797 . . . . 0.0 110.185 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.34 -54.64 5.06 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.518 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.3 m -98.53 -2.1 39.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.038 0.446 . . . . 0.0 110.021 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 59.8 69.9 0.67 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.64 1.176 . . . . 0.0 113.204 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -131.97 135.4 46.54 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.694 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -97.93 117.52 32.45 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 52' ' ' ALA . 17.0 m -93.36 129.71 39.39 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 31' ' ' VAL . 29.5 m -129.06 158.45 41.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -176.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 6.8 ttpm? -110.71 136.88 49.11 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -90.71 154.4 19.58 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.42 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.29 -20.96 63.5 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.814 1.246 . . . . 0.0 110.042 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.34 -1.0 31.14 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.594 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.78 -41.74 2.09 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.463 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.6 m -71.01 135.75 48.0 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.291 0.636 . . . . 0.0 111.501 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -94.85 153.16 17.85 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 173.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.9 tp -138.42 148.43 44.44 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.581 -176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 42' ' ' THR . . . -109.71 134.37 52.07 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 171.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -140.63 166.99 23.23 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.801 -178.688 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -85.01 168.18 15.16 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.142 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.57 -30.57 69.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.485 0.66 . . . . 0.0 110.045 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.4 m -69.49 -11.62 60.98 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.09 0.956 . . . . 0.0 110.879 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.562 ' OD1' ' HD3' ' A' ' 19' ' ' ARG . 67.9 m-20 -100.91 1.99 40.4 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.411 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.2 mt -111.74 134.06 55.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.478 0.656 . . . . 0.0 112.491 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.483 ' HG2' ' CE2' ' A' ' 26' ' ' TYR . 56.1 mmt-85 -130.36 156.58 44.46 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 172.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 C--N 1.297 -1.7 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 172.857 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.181 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.606 ' HA ' HG13 ' A' ' 31' ' ' VAL . 10.3 p-10 -61.78 127.52 31.8 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.693 0.759 . . . . 0.0 112.319 -173.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.7 -14.44 17.39 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.478 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.529 ' O ' HG12 ' A' ' 31' ' ' VAL . 32.4 tt0 -77.25 136.74 38.55 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.0 p -94.84 127.53 46.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.7 m -135.34 -176.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.374 -175.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.4 mmm -110.33 131.73 54.8 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -128.49 141.84 12.96 Favored Glycine 0 C--N 1.273 -2.949 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -89.58 136.19 33.17 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 24.8 t-105 . . . . . 0 N--CA 1.434 -1.268 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.829 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.433 -1.276 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -107.85 136.48 47.5 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.471 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -128.92 157.77 40.67 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.013 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -86.16 125.57 33.6 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.02 163.22 37.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -175.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -122.32 130.35 53.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.606 HG13 ' HA ' ' A' ' 12' ' ' ASP . 7.5 p -68.7 132.46 32.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.415 0.626 . . . . 0.0 111.181 -176.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.8 m -118.58 -38.21 3.17 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.237 -173.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.3 m -157.0 171.17 20.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -154.31 136.52 14.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 118.131 0.423 . . . . 0.0 111.734 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -97.39 121.73 39.62 Favored 'General case' 0 C--O 1.249 1.026 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 171.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -82.07 -23.72 35.65 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 124.073 0.858 . . . . 0.0 111.365 -170.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.0 -51.83 9.06 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.786 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.5 m -94.54 -0.6 54.47 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 33.4 m80 68.07 43.2 1.66 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.381 1.072 . . . . 0.0 110.916 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.76 115.83 30.91 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.882 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -96.08 127.11 41.8 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.7 m -92.95 129.21 38.94 Favored 'General case' 0 N--CA 1.404 -2.751 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 31' ' ' VAL . 34.0 m -127.72 157.62 39.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -105.22 133.78 49.41 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -92.48 157.0 16.8 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.694 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.13 -23.08 66.35 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.786 0.803 . . . . 0.0 109.9 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.66 -1.94 10.35 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.46 1.104 . . . . 0.0 111.157 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.74 -23.81 18.08 Favored Glycine 0 C--O 1.227 -0.316 0 O-C-N 121.654 -0.654 . . . . 0.0 112.174 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.4 m -77.04 132.97 39.21 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 124.372 1.069 . . . . 0.0 111.259 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -93.79 150.19 20.59 Favored 'General case' 0 C--O 1.251 1.161 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.4 tp -139.48 149.97 44.62 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.24 134.72 51.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 173.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.428 ' CD1' HD11 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -141.32 166.21 25.39 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 124.114 0.966 . . . . 0.0 111.006 177.652 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 39' ' ' HIS . 97.5 mttt -82.91 161.42 21.85 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.618 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -60.69 -31.13 70.4 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.448 0.642 . . . . 0.0 110.8 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -75.57 -4.33 39.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.56 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -105.82 2.57 27.89 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.428 HD11 ' CD1' ' A' ' 53' ' ' LEU . 48.9 mt -114.03 146.97 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -132.45 159.2 40.02 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 172.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 C--O 1.255 1.364 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 170.47 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.017 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.15 -14.29 18.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.678 0.275 . . . . 0.0 110.308 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 73.43 -55.88 0.67 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.798 1.239 . . . . 0.0 112.728 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.35 86.85 0.73 Allowed Glycine 0 C--N 1.3 -1.455 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.0 tpt -159.05 79.26 2.89 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.126 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' A' ' 8' ' ' ARG . 63.0 Cg_endo -80.22 -20.84 8.24 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 121.802 1.668 . . . . 0.0 112.079 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 177.24 -48.86 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.53 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -103.2 -166.39 1.26 Allowed 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 169.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -80.89 -28.61 35.89 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.43 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 98.6 m-85 -125.57 162.57 24.64 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.878 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -84.19 -167.76 1.89 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.475 ' HA ' HG13 ' A' ' 31' ' ' VAL . 6.7 p-10 -127.51 134.2 49.8 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.439 ' H ' HG13 ' A' ' 31' ' ' VAL . . . 94.78 -8.83 70.97 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -172.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.521 ' O ' HG12 ' A' ' 31' ' ' VAL . 24.8 tt0 -78.43 138.03 38.28 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.488 1.115 . . . . 0.0 112.071 -175.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 30' ' ' GLN . 4.3 p -91.1 128.12 43.08 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.273 174.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 m -135.49 -175.23 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.662 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 96.0 mmm -107.95 132.74 53.18 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.22 135.6 8.25 Favored Glycine 0 C--N 1.281 -2.484 0 C-N-CA 120.27 -0.966 . . . . 0.0 111.073 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 35.3 ttm180 -74.42 143.05 44.92 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 123.846 0.859 . . . . 0.0 109.626 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -81.67 123.57 80.48 Favored Pre-proline 0 N--CA 1.435 -1.177 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -36.75 -47.49 1.39 Allowed 'Trans proline' 0 CA--C 1.542 0.907 1 C-N-CA 125.584 4.189 . . . . 0.0 116.501 -173.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.28 -9.02 65.72 Favored Glycine 0 C--N 1.313 -0.701 0 C-N-CA 120.109 -1.044 . . . . 0.0 113.869 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.8 t -113.91 179.78 3.86 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.935 0.398 . . . . 0.0 110.31 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.8 m -107.12 0.44 9.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 172.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 18.3 mt -73.84 145.05 45.22 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.826 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -113.35 131.16 56.08 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.543 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -117.92 172.84 7.13 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -95.33 125.22 39.8 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.1 m -135.34 163.28 36.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 60.8 tt0 -122.37 130.11 52.78 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 173.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 14' ' ' GLU . 7.6 p -72.42 128.1 35.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 123.321 0.388 . . . . 0.0 110.532 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.8 p -108.76 -46.47 3.64 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-O 120.711 0.291 . . . . 0.0 111.621 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -144.35 179.49 7.21 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.216 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -155.34 127.68 7.78 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 7.6 t70 -88.43 122.67 32.18 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 173.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -96.32 -13.91 22.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.27 -52.28 7.91 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.071 0.463 . . . . 0.0 110.257 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.416 ' HB2' HD23 ' A' ' 40' ' ' LEU . 15.9 m -99.7 -1.05 38.87 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.286 0.565 . . . . 0.0 111.085 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 59.61 71.35 0.58 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.115 0.966 . . . . 0.0 111.79 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.416 HD23 ' HB2' ' A' ' 38' ' ' SER . 4.6 mm? -125.28 138.64 54.09 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.529 ' CE1' ' HB3' ' A' ' 55' ' ' GLU . 11.2 m-85 -108.93 130.04 55.44 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.0 m -93.25 128.63 39.32 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 31' ' ' VAL . 35.9 m -130.4 159.67 42.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 22.9 ttmm -119.63 133.81 55.49 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -88.77 167.43 13.3 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 123.643 0.59 . . . . 0.0 111.533 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -61.14 -22.57 64.81 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.339 1.055 . . . . 0.0 110.679 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.23 -0.1 34.88 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.476 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.32 -37.46 3.38 Favored Glycine 0 CA--C 1.509 -0.336 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.5 m -58.86 134.97 57.37 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 124.851 1.26 . . . . 0.0 110.771 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -108.67 151.16 26.53 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.478 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.6 tp -139.92 159.32 42.44 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.6 135.28 51.47 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 171.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.8 170.25 16.1 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -82.29 161.8 22.5 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.529 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -60.87 -30.22 70.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.933 0.397 . . . . 0.0 111.422 174.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 m -69.75 -12.04 61.32 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.542 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -95.77 -12.52 25.23 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mt -102.37 135.47 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.736 -176.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -130.02 168.46 16.68 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.798 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.52 153.99 22.0 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.439 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -54.9 -34.63 63.27 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 122.012 0.91 . . . . 0.0 108.901 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.4 t -142.09 136.07 29.76 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 170.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.8 t -74.45 -11.22 60.18 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.649 0.738 . . . . 0.0 109.12 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -93.89 96.49 9.76 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -120.11 133.04 55.62 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.592 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 . . . . . 0 C--N 1.299 -1.62 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.556 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.948 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.38 113.42 2.89 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.0 ttt -78.71 -35.41 44.94 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.465 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.1 -178.84 43.65 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 88.8 mtp -134.05 136.99 27.27 Favored Pre-proline 0 C--N 1.299 -1.609 0 CA-C-N 117.481 0.64 . . . . 0.0 110.129 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.43 -31.35 94.64 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.58 2.187 . . . . 0.0 110.368 171.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -72.77 127.54 32.84 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 172.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -68.96 91.41 0.47 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -171.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -76.13 -34.78 59.43 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 173.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -94.14 82.53 4.16 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 114.299 -1.319 . . . . 0.0 108.419 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.12 151.1 40.17 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.799 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.418 ' HA ' HG13 ' A' ' 31' ' ' VAL . 6.9 p-10 -56.54 127.39 31.02 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.6 0.562 . . . . 0.0 111.796 -174.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.18 -8.09 48.63 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.474 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.4 ' O ' HG12 ' A' ' 31' ' ' VAL . 8.9 tp10 -77.01 138.82 39.83 Favored 'General case' 0 N--CA 1.431 -1.377 0 O-C-N 122.567 -0.372 . . . . 0.0 110.11 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 p -94.05 127.09 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.1 m -135.45 179.05 4.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.696 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.0 mtp -111.24 132.74 54.12 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.84 150.89 19.16 Favored Glycine 0 C--N 1.285 -2.284 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.326 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 29.5 ttp180 -85.35 139.85 31.25 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.948 0.404 . . . . 0.0 110.625 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 41.1 t-105 -81.55 120.82 78.98 Favored Pre-proline 0 N--CA 1.43 -1.457 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.405 ' CD ' HD21 ' A' ' 51' ' ' LEU . 10.0 Cg_endo -52.12 126.89 21.63 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.877 3.051 . . . . 0.0 113.175 -176.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.51 -37.56 3.48 Favored Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 m -95.75 175.69 6.42 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-O 121.158 0.504 . . . . 0.0 109.884 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.6 p -111.48 14.46 8.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 122.569 1.176 . . . . 0.0 108.141 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 11.5 mt -76.43 145.57 39.22 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.226 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.521 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 67.0 m-85 -127.84 107.27 9.73 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 123.707 0.629 . . . . 0.0 110.037 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -98.64 163.8 12.5 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.959 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.76 124.09 39.63 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.43 164.94 31.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.168 -172.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -114.74 130.8 56.89 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 43' ' ' VAL . 14.3 p -71.16 128.42 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.0 m -108.5 -35.43 6.48 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.049 -172.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.8 t -156.63 174.54 15.31 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -149.22 117.88 6.59 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 123.426 0.69 . . . . 0.0 109.507 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -88.08 122.23 31.41 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -97.69 -8.63 28.31 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.762 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.48 -49.67 9.67 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.293 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.4 t -98.61 -2.19 39.09 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.991 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 70.7 m80 59.71 63.4 1.51 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.979 0.912 . . . . 0.0 111.945 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -127.45 127.86 44.8 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.854 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -98.08 120.12 37.91 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.6 m -87.62 130.42 34.78 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 31' ' ' VAL . 34.7 m -128.67 157.6 41.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -108.18 133.04 53.0 Favored 'General case' 0 C--O 1.264 1.829 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -97.18 154.93 17.07 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 124.237 0.961 . . . . 0.0 110.215 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -61.95 -25.03 67.35 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.814 0.846 . . . . 0.0 109.384 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.64 -0.69 21.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.354 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.91 -18.59 50.23 Favored Glycine 0 CA--C 1.504 -0.654 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.136 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.6 m -78.65 130.38 35.8 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 123.046 0.538 . . . . 0.0 109.919 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.41 148.66 25.23 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 170.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.405 HD21 ' CD ' ' A' ' 21' ' ' PRO . 46.2 tp -140.52 152.06 45.27 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -173.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.63 134.5 51.87 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 170.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.23 164.86 28.94 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.254 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.84 166.98 17.48 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -30.88 70.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.427 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -74.5 -1.51 21.6 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.201 0.524 . . . . 0.0 111.943 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -101.06 -13.24 18.3 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.7 mt -102.57 133.37 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.627 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -122.61 168.79 11.74 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 113.987 -1.46 . . . . 0.0 107.602 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.4 mt -81.72 -175.3 5.49 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 64' ' ' PHE . 63.5 tt0 -60.19 -18.87 51.28 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 122.976 0.511 . . . . 0.0 111.721 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.5 t 73.35 -46.78 0.65 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.09 1.356 . . . . 0.0 111.75 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.8 p -89.74 13.08 15.2 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.233 0.54 . . . . 0.0 109.962 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 61' ' ' GLN . 58.7 t80 -65.91 104.94 1.19 Allowed 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -78.47 154.35 30.64 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.576 0.703 . . . . 0.0 112.454 -172.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 . . . . . 0 C--N 1.294 -1.823 0 CA-C-O 117.508 -1.234 . . . . 0.0 108.14 174.561 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.761 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.44 -45.47 62.56 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.352 0.596 . . . . 0.0 110.051 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 71.4 mtm -94.28 91.03 6.54 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.09 -43.61 2.19 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.046 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 63.2 mtm -137.74 88.94 15.71 Favored Pre-proline 0 C--N 1.313 -1.001 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -72.18 -32.88 10.07 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 121.904 1.736 . . . . 0.0 108.387 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 174.28 -56.93 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.52 ' HG2' ' CD2' ' A' ' 34' ' ' TYR . 91.0 mtt180 -114.01 130.46 56.54 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.566 172.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -87.29 -37.7 16.94 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 122.314 1.054 . . . . 0.0 108.476 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -119.07 130.04 55.4 Favored 'General case' 0 N--CA 1.41 -2.433 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.39 150.47 23.17 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.644 ' HA ' HG13 ' A' ' 31' ' ' VAL . 4.1 p30 -72.88 139.46 46.9 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.822 0.344 . . . . 0.0 111.363 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.86 -13.24 34.84 Favored Glycine 0 N--CA 1.429 -1.776 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.093 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.472 ' O ' HG12 ' A' ' 31' ' ' VAL . 8.7 tp10 -77.9 147.32 35.1 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.2 127.33 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 174.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 m -135.04 174.97 12.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.953 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.406 ' HG3' ' HA ' ' A' ' 61' ' ' GLN . 84.1 mtp -111.61 132.88 54.25 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 172.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.43 149.86 19.56 Favored Glycine 0 C--N 1.278 -2.655 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.927 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.432 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 47.2 ttp85 -79.7 137.12 36.96 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -82.44 122.1 78.72 Favored Pre-proline 0 N--CA 1.426 -1.665 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.494 ' CD ' HD21 ' A' ' 51' ' ' LEU . 31.0 Cg_endo -66.17 109.54 1.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.045 2.497 . . . . 0.0 111.147 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.59 -53.81 0.75 Allowed Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.934 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.4 p -86.81 -22.41 25.87 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.243 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.8 t 70.07 14.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.356 0 CA-C-O 122.616 1.198 . . . . 0.0 109.76 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt -87.68 159.18 18.62 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.755 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.432 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 57.4 m-85 -110.55 129.19 55.85 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.529 0.68 . . . . 0.0 111.242 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -122.87 156.56 34.38 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.608 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.89 124.93 35.12 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.66 169.54 20.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 122.98 0.512 . . . . 0.0 110.087 -174.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -115.26 130.48 56.92 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 173.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.644 HG13 ' HA ' ' A' ' 12' ' ' ASP . 7.3 p -72.39 128.65 35.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.8 t -108.89 -31.41 7.68 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.619 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -165.53 -176.9 4.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.52 ' CD2' ' HG2' ' A' ' 8' ' ' ARG . 30.5 t80 -148.97 132.37 16.6 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 123.548 0.739 . . . . 0.0 109.667 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -97.49 121.43 39.38 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -86.41 -21.91 26.86 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.94 -49.49 51.36 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.032 0.444 . . . . 0.0 110.496 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.6 m -97.47 -2.03 42.93 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.71 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 59.98 45.68 11.88 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.54 0.686 . . . . 0.0 110.84 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.95 134.55 52.49 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.372 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.617 ' CE1' ' HB3' ' A' ' 55' ' ' GLU . 26.9 m-85 -102.47 127.49 49.49 Favored 'General case' 0 CA--C 1.48 -1.745 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.3 m -93.06 129.16 39.11 Favored 'General case' 0 N--CA 1.4 -2.933 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -125.0 159.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -121.32 135.5 55.09 Favored 'General case' 0 C--N 1.272 -2.775 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -90.17 162.3 15.33 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.408 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -61.8 -24.05 66.61 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.628 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -82.42 0.7 40.92 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.474 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.12 -31.52 7.88 Favored Glycine 0 C--O 1.238 0.357 0 C-N-CA 121.506 -0.378 . . . . 0.0 112.377 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 m -56.11 130.03 42.47 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 124.917 1.287 . . . . 0.0 111.03 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.2 150.46 25.08 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.978 175.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.494 HD21 ' CD ' ' A' ' 21' ' ' PRO . 37.9 tp -139.86 152.87 46.81 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.538 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.07 134.61 51.98 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.18 173.75 11.18 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 123.136 0.574 . . . . 0.0 111.244 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -82.72 157.02 23.46 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.62 0.248 . . . . 0.0 110.492 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.617 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -61.25 -31.09 70.88 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.169 0.509 . . . . 0.0 110.906 173.478 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.0 m -73.15 -12.05 60.75 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.723 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -95.4 -5.89 42.17 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.8 mt -102.62 133.6 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-O 121.296 0.569 . . . . 0.0 111.285 -176.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -124.43 161.9 25.05 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 173.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.1 mt -78.01 164.04 25.41 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.898 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.406 ' HA ' ' HG3' ' A' ' 17' ' ' MET . 19.3 tm0? -60.5 -36.65 78.85 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.7 t -111.73 95.93 5.78 Favored 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 102.978 -2.971 . . . . 0.0 102.978 167.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -63.33 -18.78 64.0 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -169.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -91.27 97.19 10.97 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -81.27 109.79 16.12 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.865 0.84 . . . . 0.0 112.264 -175.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 . . . . . 0 N--CA 1.412 -2.351 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.908 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.601 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.88 179.98 4.46 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.7 tpt -89.09 128.22 35.75 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.33 -40.46 76.34 Favored Glycine 0 N--CA 1.468 0.775 0 O-C-N 123.699 0.624 . . . . 0.0 112.741 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.66 92.87 29.77 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 175.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.38 -46.05 16.27 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.05 2.5 . . . . 0.0 111.651 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -143.26 -55.42 0.4 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.452 ' HD2' ' OH ' ' A' ' 41' ' ' TYR . 46.6 mtm105 -127.43 153.25 46.51 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 173.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.472 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 7.4 tmtt? -98.34 -41.71 7.71 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -84.63 95.99 9.06 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.176 -170.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.43 150.75 23.58 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.533 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -60.44 121.68 12.71 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.397 0.618 . . . . 0.0 112.161 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.497 ' H ' HG13 ' A' ' 31' ' ' VAL . . . 115.68 -14.34 17.47 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.647 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 31' ' ' VAL . 26.5 tt0 -77.02 141.05 40.51 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-N 116.893 0.347 . . . . 0.0 111.42 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.87 127.74 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 106.689 -1.596 . . . . 0.0 106.689 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.6 173.54 14.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.568 -173.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.419 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 47.0 ttm -111.2 131.85 54.79 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 172.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.8 149.96 19.45 Favored Glycine 0 C--N 1.283 -2.415 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.246 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.413 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 48.5 ttp180 -89.41 146.7 24.49 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 123.634 0.774 . . . . 0.0 109.0 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -83.04 123.17 77.84 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.496 ' HD2' HD21 ' A' ' 51' ' ' LEU . 11.0 Cg_endo -55.44 120.85 8.9 Favored 'Trans proline' 0 C--O 1.247 0.959 0 C-N-CA 123.356 2.704 . . . . 0.0 112.663 -175.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.84 -21.62 33.72 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.398 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.8 m -112.02 176.88 4.84 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 122.262 0.225 . . . . 0.0 110.994 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.7 p -105.99 -7.56 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.658 0.742 . . . . 0.0 110.473 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.07 138.84 41.08 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 50.5 m-85 -118.23 142.53 47.37 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.552 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -135.17 164.95 26.54 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -95.73 124.54 39.8 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.1 m -135.42 173.84 13.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.531 -172.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -115.25 131.26 56.98 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.855 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.497 HG13 ' H ' ' A' ' 13' ' ' GLY . 11.2 p -71.26 127.73 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -103.2 -44.36 5.21 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.445 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -157.73 173.12 17.31 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -150.52 126.02 10.19 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 123.372 0.669 . . . . 0.0 109.54 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -96.93 122.23 39.68 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 171.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -84.32 -28.36 27.14 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -174.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.85 -48.87 43.04 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.813 0.339 . . . . 0.0 111.194 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.4 m -94.54 -1.86 52.62 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.674 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 43.4 t60 60.01 63.72 1.39 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.373 1.069 . . . . 0.0 111.736 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -128.55 125.66 38.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.688 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.452 ' OH ' ' HD2' ' A' ' 8' ' ' ARG . 21.2 m-85 -97.94 118.35 34.32 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.7 m -94.17 129.98 40.55 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 31' ' ' VAL . 33.5 m -126.82 158.6 37.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -109.71 133.5 53.06 Favored 'General case' 0 C--O 1.271 2.225 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -93.22 162.19 14.11 Favored 'General case' 0 CA--C 1.496 -1.104 0 O-C-N 124.584 1.177 . . . . 0.0 110.75 175.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -62.2 -24.19 67.07 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.1 -0.954 . . . . 0.0 112.004 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -78.65 -0.19 28.99 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.423 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.6 -2.83 86.35 Favored Glycine 0 C--O 1.221 -0.707 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 m -79.32 129.96 34.97 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 122.967 0.507 . . . . 0.0 110.016 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -90.46 152.13 21.09 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 172.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.496 HD21 ' HD2' ' A' ' 21' ' ' PRO . 48.4 tp -137.77 145.03 41.93 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.03 133.98 52.62 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 173.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.07 172.59 12.46 Favored 'General case' 0 C--N 1.276 -2.627 0 O-C-N 123.763 0.665 . . . . 0.0 110.666 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -83.87 166.11 18.18 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.51 -32.81 70.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.041 0.448 . . . . 0.0 110.567 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.6 m -77.37 -6.43 53.29 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.058 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -88.69 -18.89 26.94 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.1 mt -100.97 130.76 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.298 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 17' ' ' MET . 74.1 mtt85 -135.0 158.73 43.58 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.258 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.46 HD11 ' HE3' ' A' ' 9' ' ' LYS . 77.7 mt -83.95 172.82 11.71 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 168.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -60.32 -31.35 70.2 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.6 m -116.98 22.95 12.23 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.568 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.4 m -77.22 134.93 38.47 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.538 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -152.75 167.09 30.16 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -123.17 84.68 2.3 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 173.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 . . . . . 0 C--O 1.244 0.777 0 C-N-CA 125.881 1.672 . . . . 0.0 110.27 -177.326 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.859 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.36 22.95 3.21 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.314 0.578 . . . . 0.0 109.556 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ptm -70.77 177.32 3.65 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.486 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.88 -108.14 2.45 Favored Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 -174.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.0 ttm 65.06 97.05 0.04 OUTLIER Pre-proline 0 C--N 1.319 -0.729 0 C-N-CA 124.072 0.949 . . . . 0.0 112.696 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -89.44 -158.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 122.639 2.226 . . . . 0.0 109.017 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -88.74 22.71 2.54 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.712 0.768 . . . . 0.0 111.101 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -155.94 84.4 1.02 Allowed 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HE3' ' OH ' ' A' ' 10' ' ' TYR . 59.3 tttp -69.06 -29.11 67.16 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.815 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.467 ' OH ' ' HE3' ' A' ' 9' ' ' LYS . 89.2 m-85 -121.29 115.62 23.32 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.81 149.9 44.85 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.511 ' HA ' HG13 ' A' ' 31' ' ' VAL . 2.9 p30 -77.3 146.22 36.95 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.136 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.17 -9.52 63.3 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 31' ' ' VAL . 10.2 tp10 -78.67 143.39 36.34 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 122.493 0.317 . . . . 0.0 111.249 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 30' ' ' GLN . 5.5 p -94.91 126.64 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 173.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 59' ' ' ARG . 16.9 m -135.13 -177.7 2.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.314 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 87.7 mtp -111.92 131.72 55.2 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 173.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.99 143.95 14.69 Favored Glycine 0 C--N 1.27 -3.116 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -76.05 141.14 42.14 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -79.9 120.8 81.06 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.413 ' CD ' HD21 ' A' ' 51' ' ' LEU . 36.2 Cg_endo -65.27 94.43 0.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.029 2.486 . . . . 0.0 112.073 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.4 -43.78 0.61 Allowed Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.9 p -110.96 -171.71 1.88 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.8 p -105.73 8.04 9.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.017 0.913 . . . . 0.0 108.635 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.3 mt -74.38 143.35 44.86 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.851 -176.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -111.99 133.2 54.31 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.444 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -122.97 155.19 37.28 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.551 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -85.25 125.37 32.82 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.15 163.71 35.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 63.1 tt0 -119.3 130.21 55.27 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 174.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.511 HG13 ' HA ' ' A' ' 12' ' ' ASP . 8.1 p -72.27 130.56 35.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.5 t -119.68 -29.56 5.01 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.18 -176.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.45 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 16.2 m -144.07 157.18 44.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -139.63 121.89 15.94 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.338 0.113 . . . . 0.0 110.697 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.8 122.33 41.9 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 174.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -83.09 -20.4 34.96 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.001 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.04 -50.82 37.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.0 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 m -97.07 -2.57 42.98 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.27 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 t60 58.98 46.73 13.14 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.494 1.118 . . . . 0.0 108.6 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mp -114.1 142.34 46.33 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.117 -175.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 10' ' ' TYR . 45.5 m-85 -111.99 128.15 56.09 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 7.0 m -93.19 129.08 39.33 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 176.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.91 159.54 28.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -120.97 133.83 55.28 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -92.95 162.28 14.13 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.823 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -62.24 -21.38 65.12 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.29 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.06 -0.6 32.04 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.128 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.12 -1.06 86.38 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.5 m -79.26 135.31 36.73 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 123.888 0.875 . . . . 0.0 110.934 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -100.48 151.5 21.49 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 171.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.413 HD21 ' CD ' ' A' ' 21' ' ' PRO . 29.5 tp -138.86 145.47 40.03 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.23 133.36 53.31 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 172.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' CD1' HD11 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -141.45 167.21 22.71 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -84.27 157.44 21.56 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.965 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.4 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -60.47 -25.48 66.06 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 176.416 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 m -70.7 -6.29 36.11 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.469 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -112.96 7.05 18.06 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.465 ' C ' ' HD2' ' A' ' 59' ' ' ARG . 41.0 mt -118.48 135.39 59.04 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.658 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.465 ' HD2' ' C ' ' A' ' 58' ' ' ILE . 3.7 mpt_? -129.08 166.44 19.26 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 171.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mp -82.92 179.6 7.72 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -61.17 -28.65 69.28 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 172.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 m 59.87 22.7 11.68 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 124.949 1.299 . . . . 0.0 112.721 169.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.9 m -94.13 163.59 13.4 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -68.12 116.97 9.34 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.234 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -69.81 166.45 19.33 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.38 -173.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 N--CA 1.426 -1.659 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.065 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.09 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.26 103.74 7.57 Favored 'General case' 0 C--O 1.249 1.079 0 CA-C-O 121.309 0.576 . . . . 0.0 110.12 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.5 tmm? -122.66 112.56 18.11 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.74 -175.78 47.37 Favored Glycine 0 CA--C 1.491 -1.443 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 66.6 mtt -120.31 100.81 47.32 Favored Pre-proline 0 C--N 1.3 -1.576 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.02 -16.86 25.41 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.406 2.07 . . . . 0.0 112.602 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 58.1 t30 60.96 -89.39 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 124.907 1.283 . . . . 0.0 109.762 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -112.41 108.5 17.68 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -67.85 -35.68 78.98 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -114.04 127.29 55.88 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.09 150.3 37.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -74.51 131.86 41.37 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.099 0.476 . . . . 0.0 111.352 -175.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.537 ' H ' HG13 ' A' ' 31' ' ' VAL . . . 107.51 -11.31 39.21 Favored Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.6 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -77.43 152.64 34.2 Favored 'General case' 0 C--O 1.241 0.625 0 O-C-N 122.823 -0.222 . . . . 0.0 111.079 -175.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.29 127.29 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.02 177.93 6.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.965 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.0 mmm -111.33 131.97 54.76 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.51 149.08 19.74 Favored Glycine 0 C--N 1.286 -2.229 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.158 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.494 ' HD3' ' OD2' ' A' ' 57' ' ' ASP . 23.1 ttt-85 -82.62 134.75 35.17 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 123.131 0.572 . . . . 0.0 111.123 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -83.55 121.93 76.63 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.416 ' CD ' HD21 ' A' ' 51' ' ' LEU . 18.8 Cg_endo -59.57 124.66 15.93 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.198 2.599 . . . . 0.0 111.602 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.5 -25.12 22.41 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -176.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.3 m -112.7 169.47 8.88 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 p -112.26 6.67 8.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 122.502 1.144 . . . . 0.0 108.453 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.1 mt -90.01 144.16 26.15 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.355 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 19' ' ' ARG . 17.3 m-85 -109.33 128.94 55.49 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.565 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -118.8 172.39 7.55 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -85.49 126.03 33.51 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 123.376 0.422 . . . . 0.0 109.895 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.38 163.79 34.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.959 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -113.29 130.51 56.23 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.537 HG13 ' H ' ' A' ' 13' ' ' GLY . 8.8 p -72.28 128.6 35.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 176.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.0 t -119.12 -28.45 5.47 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.61 -0.836 . . . . 0.0 112.062 -173.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.426 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 50.2 m -151.62 169.17 22.8 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 121.921 -0.487 . . . . 0.0 109.917 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -148.91 129.14 13.69 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -97.48 122.75 40.9 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.87 -41.77 70.96 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 123.958 0.786 . . . . 0.0 111.788 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.89 -49.92 74.27 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.588 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -92.9 -2.0 56.23 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.429 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.3 m80 58.21 42.46 21.92 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -104.92 133.74 49.2 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.399 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -103.51 120.71 41.39 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 52' ' ' ALA . 7.1 m -93.71 129.46 40.03 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.6 158.89 26.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.291 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -113.56 132.54 55.67 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -97.6 150.52 21.05 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -62.69 -17.4 60.58 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 122.102 0.953 . . . . 0.0 109.823 173.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.27 -1.9 22.67 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.129 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.28 -31.67 5.6 Favored Glycine 0 N--CA 1.443 -0.862 0 O-C-N 121.836 -0.54 . . . . 0.0 111.814 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.3 m -71.0 130.02 40.51 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 123.82 0.848 . . . . 0.0 110.802 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -102.23 151.33 22.34 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.467 171.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.416 HD21 ' CD ' ' A' ' 21' ' ' PRO . 39.4 tp -139.42 145.5 38.96 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.461 -175.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 42' ' ' THR . . . -110.7 134.55 52.36 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.243 171.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.4 176.84 8.54 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 123.641 0.777 . . . . 0.0 110.547 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -83.46 167.61 17.29 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 120.852 0.358 . . . . 0.0 111.408 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -60.08 -31.76 70.32 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.684 0.794 . . . . 0.0 110.998 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 m -76.62 -4.99 45.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.526 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.494 ' OD2' ' HD3' ' A' ' 19' ' ' ARG . 3.1 m-20 -105.63 3.38 29.11 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.335 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 mt -118.06 141.47 37.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 121.238 0.542 . . . . 0.0 111.09 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -129.52 168.16 16.79 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 172.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.0 mt -82.52 -176.21 6.12 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -53.28 -35.16 59.76 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.5 t -161.83 -72.19 0.06 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 174.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 p -137.54 -64.58 0.55 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.8 t80 63.05 14.89 8.0 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.038 1.335 . . . . 0.0 113.356 171.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -134.89 105.17 6.28 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 120.927 -1.108 . . . . 0.0 111.44 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--N 1.305 -1.338 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.957 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.842 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.09 135.02 39.88 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -129.8 -39.56 1.42 Allowed 'General case' 0 C--N 1.3 -1.543 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.91 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.27 85.76 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 118.19 -1.957 . . . . 0.0 115.898 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -115.32 95.47 42.79 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 170.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -86.73 -5.09 8.1 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 122.518 2.145 . . . . 0.0 111.072 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -81.82 167.38 19.09 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.931 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -63.62 145.31 55.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.445 ' NZ ' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -46.71 -48.58 20.24 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.085 0.954 . . . . 0.0 110.401 -175.216 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.409 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 92.6 m-85 -127.4 135.55 50.63 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 172.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.89 150.38 24.14 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -77.7 135.87 38.11 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 123.217 0.607 . . . . 0.0 112.182 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.611 ' H ' HG13 ' A' ' 31' ' ' VAL . . . 103.33 -14.35 54.69 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.433 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.542 ' O ' HG12 ' A' ' 31' ' ' VAL . 29.6 tt0 -79.17 156.74 28.08 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.862 0.465 . . . . 0.0 112.002 -174.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.0 p -90.87 129.04 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 172.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 m -134.1 171.55 17.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.9 mtp -111.11 132.3 54.39 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.236 173.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -125.49 146.3 16.11 Favored Glycine 0 C--N 1.281 -2.504 0 C-N-CA 120.184 -1.007 . . . . 0.0 111.668 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.426 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 75.5 ttt180 -79.89 132.11 36.01 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 23' ' ' SER . 47.5 t-105 -67.79 124.77 90.21 Favored Pre-proline 0 N--CA 1.433 -1.302 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -48.29 110.75 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 124.08 3.186 . . . . 0.0 114.137 -173.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.11 -22.02 40.79 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.909 -0.587 . . . . 0.0 113.024 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 20' ' ' TRP . 16.5 m -97.49 174.74 6.51 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -178.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.7 p -103.42 -9.01 9.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 122.097 0.951 . . . . 0.0 109.244 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -65.43 123.84 20.68 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.176 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 41.9 m-85 -104.19 132.22 50.67 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.076 175.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -119.88 157.86 27.85 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.569 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -95.59 125.25 40.06 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.6 m -135.51 163.83 34.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-O 120.892 0.377 . . . . 0.0 110.626 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -107.36 129.91 54.86 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.344 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.611 HG13 ' H ' ' A' ' 13' ' ' GLY . 6.2 p -72.29 127.06 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.697 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.7 m -112.38 -40.28 4.17 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.178 -170.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.2 t -151.74 -179.67 7.64 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -161.55 129.01 4.06 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 122.4 0.28 . . . . 0.0 110.761 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -91.95 122.09 34.14 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.06 -38.75 51.99 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 124.279 0.987 . . . . 0.0 109.816 -173.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.77 -57.3 13.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.428 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.6 m -98.87 -0.29 42.71 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.1 m80 66.59 43.92 2.39 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.631 0.772 . . . . 0.0 110.255 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.93 121.17 41.27 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.481 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 51.8 m-85 -93.8 122.89 36.75 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 m -92.92 129.21 38.91 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.428 HG12 ' HA ' ' A' ' 31' ' ' VAL . 35.8 m -126.85 158.61 37.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -107.66 133.13 52.54 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -97.89 165.41 11.94 Favored 'General case' 0 CA--C 1.508 -0.637 0 O-C-N 124.41 1.069 . . . . 0.0 111.53 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -61.57 -25.22 67.17 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 124.904 1.282 . . . . 0.0 110.415 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -83.44 -0.89 52.04 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.134 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.79 -33.27 5.29 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.979 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.8 m -56.06 131.25 46.99 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.885 1.274 . . . . 0.0 111.645 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -96.7 150.34 20.8 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 172.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.57 149.99 44.5 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 41' ' ' TYR . . . -109.56 135.3 50.76 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 172.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.69 166.17 25.48 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 123.18 0.592 . . . . 0.0 110.882 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.8 161.75 20.84 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.05 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -60.37 -30.69 69.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.6 t -74.52 -5.53 43.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.87 0.367 . . . . 0.0 110.743 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -95.86 -12.31 25.41 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 55.1 mt -99.76 143.01 14.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 120.967 0.413 . . . . 0.0 111.449 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -131.07 170.23 14.8 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 171.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.1 mt -84.0 -162.95 0.71 Allowed 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.16 -35.93 18.03 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 176.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 m -150.51 -62.89 0.2 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.1 m -159.29 177.5 10.96 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -75.86 116.11 16.23 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 123.629 0.581 . . . . 0.0 109.767 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -97.19 113.45 25.05 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? . . . . . 0 C--N 1.303 -1.444 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -179.825 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.902 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.74 123.43 40.5 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.9 mtt -145.35 123.82 12.4 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.916 0.388 . . . . 0.0 110.638 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.97 -83.34 1.64 Allowed Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 114.816 0.686 . . . . 0.0 114.816 174.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 63.8 mtt -135.23 165.52 35.83 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -172.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -73.79 98.1 1.04 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 N-CA-C 105.085 -2.698 . . . . 0.0 105.085 162.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -82.24 -9.0 59.65 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -166.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.64 ' HA ' ' OH ' ' A' ' 41' ' ' TYR . 12.8 ttm180 64.6 59.06 0.98 Allowed 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 -166.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -72.74 -19.75 61.32 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 112.586 -2.097 . . . . 0.0 109.24 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -123.05 138.69 54.61 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.29 -153.42 0.11 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 123.718 0.636 . . . . 0.0 110.761 -175.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -123.94 125.52 44.74 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 174.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.92 -5.22 68.81 Favored Glycine 0 C--N 1.311 -0.818 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.575 ' O ' HG12 ' A' ' 31' ' ' VAL . 43.3 tt0 -77.74 137.86 38.71 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 123.423 0.689 . . . . 0.0 110.265 -177.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.82 127.58 41.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 118.535 -1.266 . . . . 0.0 108.568 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.7 m -135.58 -176.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.918 -176.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 90.3 mtp -111.27 132.77 54.11 Favored 'General case' 0 C--O 1.204 -1.323 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -128.79 141.61 12.74 Favored Glycine 0 C--N 1.272 -2.986 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.573 ' HB3' ' OD1' ' A' ' 57' ' ' ASP . 15.6 ttp180 -75.1 144.34 42.93 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.46 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -81.42 119.79 76.53 Favored Pre-proline 0 N--CA 1.426 -1.671 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 173.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.4 ' HD3' HD21 ' A' ' 51' ' ' LEU . 12.2 Cg_endo -54.3 -25.38 38.6 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 C-N-CA 124.003 3.135 . . . . 0.0 114.214 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -78.86 -34.93 32.79 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.19 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.0 p -111.8 -164.95 0.95 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.071 0.462 . . . . 0.0 110.346 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.7 m -114.16 10.07 7.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.4 mt -93.86 145.51 24.56 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 34.8 m-85 -100.61 124.9 46.83 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.408 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -113.64 156.01 24.48 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -79.36 125.8 29.98 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.11 163.69 35.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -111.2 128.87 56.05 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 173.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 14' ' ' GLU . 10.8 p -73.8 136.95 24.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.6 t -122.37 -41.44 2.4 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 118.656 -1.218 . . . . 0.0 112.056 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.7 m -139.03 141.5 38.27 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.774 -0.771 . . . . 0.0 110.734 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -114.78 124.7 52.44 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.939 0.4 . . . . 0.0 111.161 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -96.25 122.59 39.27 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -97.42 -19.76 18.23 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.583 0.552 . . . . 0.0 111.528 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.44 -52.68 8.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.864 0.364 . . . . 0.0 111.429 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.7 m -99.5 -2.02 36.95 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.287 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 61.66 80.0 0.24 Allowed 'General case' 0 C--O 1.247 0.954 0 C-N-CA 123.667 0.787 . . . . 0.0 112.273 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -141.96 150.17 41.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.986 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.64 ' OH ' ' HA ' ' A' ' 8' ' ' ARG . 29.3 m-85 -119.63 116.93 27.01 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.5 m -87.01 129.0 35.07 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 31' ' ' VAL . 33.8 m -125.49 160.0 32.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 124.308 1.005 . . . . 0.0 108.633 -176.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HG3' ' HG2' ' A' ' 50' ' ' GLU . 50.3 tttp -124.95 135.74 53.11 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -95.01 159.04 15.21 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.571 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -61.3 -25.12 66.9 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.944 0.778 . . . . 0.0 110.418 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.53 -0.7 27.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.829 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.69 -39.34 2.77 Favored Glycine 0 C--O 1.248 1.0 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.513 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.0 m -54.77 136.14 46.61 Favored 'General case' 0 C--O 1.246 0.882 0 C-N-CA 124.395 1.078 . . . . 0.0 111.533 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' HG2' ' HG3' ' A' ' 44' ' ' LYS . 62.0 mt-10 -113.57 150.42 33.07 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.4 HD21 ' HD3' ' A' ' 21' ' ' PRO . 32.4 tp -139.5 145.66 39.01 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -175.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.3 133.66 52.77 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.74 172.52 12.58 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 123.369 0.667 . . . . 0.0 111.964 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.442 ' HG2' ' H ' ' A' ' 56' ' ' SER . 86.8 tttt -82.43 156.34 24.18 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 122.664 0.386 . . . . 0.0 110.031 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.573 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 41.5 tt0 -60.08 -31.95 70.49 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.948 0.88 . . . . 0.0 110.872 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.442 ' H ' ' HG2' ' A' ' 54' ' ' LYS . 4.0 m -76.6 -11.25 59.83 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.601 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.573 ' OD1' ' HB3' ' A' ' 19' ' ' ARG . 1.6 t70 -103.21 6.43 38.24 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -177.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mt -110.9 149.26 13.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.072 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -131.34 158.66 40.1 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.39 164.67 6.95 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -48.45 -32.32 7.6 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.3 m -143.11 -35.57 0.4 Allowed 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.707 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.0 t 60.96 34.85 19.27 Favored 'General case' 0 C--N 1.364 1.197 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -67.93 141.51 56.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 112.757 -2.019 . . . . 0.0 111.078 -171.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.508 ' HD3' ' C ' ' A' ' 65' ' ' LYS . 11.5 tmtt? -77.13 118.7 19.93 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 . . . . . 0 C--N 1.288 -2.089 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.709 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.94 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.77 103.91 12.5 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.466 0.651 . . . . 0.0 110.39 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -102.82 -25.59 13.45 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.908 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.21 -164.95 25.78 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.654 ' SD ' ' HA ' ' A' ' 9' ' ' LYS . 53.2 ttm -170.46 114.58 0.46 Allowed Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.04 158.79 41.78 Favored 'Trans proline' 0 C--O 1.251 1.141 0 C-N-CA 122.701 2.268 . . . . 0.0 112.059 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.415 ' C ' ' HD3' ' A' ' 8' ' ' ARG . 16.1 m120 74.58 -90.51 0.02 OUTLIER 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.693 1.197 . . . . 0.0 110.549 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.415 ' HD3' ' C ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -137.91 125.65 22.4 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.654 ' HA ' ' SD ' ' A' ' 5' ' ' MET . 77.0 tttt -82.34 -30.19 30.56 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -88.14 75.78 8.59 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.682 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.41 152.16 22.93 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.405 ' HA ' HG13 ' A' ' 31' ' ' VAL . 4.4 p-10 -46.74 123.66 5.32 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.115 0.884 . . . . 0.0 111.387 -177.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.31 -13.42 28.32 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.285 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.463 ' O ' HG12 ' A' ' 31' ' ' VAL . 7.6 tp10 -76.48 137.02 39.39 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 117.436 0.618 . . . . 0.0 109.571 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 p -95.19 127.68 46.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -135.37 -178.73 2.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 122.857 0.463 . . . . 0.0 111.159 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 83.4 mtp -110.85 133.01 53.71 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 57' ' ' ASP . . . -138.88 142.28 12.8 Favored Glycine 0 C--N 1.281 -2.496 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.796 -177.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.562 ' HD3' ' OD1' ' A' ' 57' ' ' ASP . 33.9 ttt-85 -75.59 132.21 40.5 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 125.115 1.366 . . . . 0.0 110.92 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 23' ' ' SER . 16.4 t-105 -86.25 122.91 72.18 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 172.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.464 ' CD ' HD21 ' A' ' 51' ' ' LEU . 18.9 Cg_endo -58.72 107.42 0.34 Allowed 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 123.178 2.585 . . . . 0.0 112.613 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.78 -29.93 8.53 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.266 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 20' ' ' TRP . 17.0 m -88.89 -10.93 46.09 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 122.442 -0.446 . . . . 0.0 111.549 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.9 t 75.32 -34.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 125.394 1.478 . . . . 0.0 112.485 175.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 17.3 mt -70.66 149.16 47.28 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -175.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.483 ' CE2' ' HG2' ' A' ' 59' ' ' ARG . 25.6 m-85 -108.07 115.8 30.79 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 113.865 -1.516 . . . . 0.0 107.42 175.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -108.53 172.51 6.8 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -84.72 126.13 33.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 m -134.98 164.04 34.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -126.1 131.23 52.14 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.179 -1.409 . . . . 0.0 108.706 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.521 ' HA ' HG12 ' A' ' 43' ' ' VAL . 12.3 p -69.71 129.48 34.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.653 0.74 . . . . 0.0 110.92 -175.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.5 m -106.05 -39.14 6.08 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.925 -174.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.2 m -155.65 162.8 40.53 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -139.58 119.39 13.33 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 120.908 0.385 . . . . 0.0 110.613 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -91.1 123.12 34.32 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -100.8 -1.13 35.69 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.773 0.797 . . . . 0.0 110.185 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.34 -54.64 5.06 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.518 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.3 m -98.53 -2.1 39.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.038 0.446 . . . . 0.0 110.021 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 59.8 69.9 0.67 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.64 1.176 . . . . 0.0 113.204 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -131.97 135.4 46.54 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.694 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -97.93 117.52 32.45 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 52' ' ' ALA . 17.0 m -93.36 129.71 39.39 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 31' ' ' VAL . 29.5 m -129.06 158.45 41.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -176.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 6.8 ttpm? -110.71 136.88 49.11 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -90.71 154.4 19.58 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.42 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.29 -20.96 63.5 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.814 1.246 . . . . 0.0 110.042 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.34 -1.0 31.14 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.594 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.78 -41.74 2.09 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.463 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.6 m -71.01 135.75 48.0 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.291 0.636 . . . . 0.0 111.501 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -94.85 153.16 17.85 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 173.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.464 HD21 ' CD ' ' A' ' 21' ' ' PRO . 32.9 tp -138.42 148.43 44.44 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.581 -176.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 42' ' ' THR . . . -109.71 134.37 52.07 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 171.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -140.63 166.99 23.23 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.801 -178.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -85.01 168.18 15.16 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.142 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.57 -30.57 69.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.485 0.66 . . . . 0.0 110.045 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.4 m -69.49 -11.62 60.98 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.09 0.956 . . . . 0.0 110.879 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.562 ' OD1' ' HD3' ' A' ' 19' ' ' ARG . 67.9 m-20 -100.91 1.99 40.4 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.411 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.2 mt -111.74 134.06 55.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.478 0.656 . . . . 0.0 112.491 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.483 ' HG2' ' CE2' ' A' ' 26' ' ' TYR . 56.1 mmt-85 -130.36 156.58 44.46 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 172.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mp -83.58 166.64 18.04 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 172.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -52.46 -35.38 52.43 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.1 m -113.98 14.87 18.51 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.119 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.5 m 52.32 71.77 0.45 Allowed 'General case' 0 C--N 1.355 0.833 0 CA-C-O 122.189 0.995 . . . . 0.0 108.892 -172.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -66.87 -46.12 75.99 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.188 -1.369 . . . . 0.0 113.555 -167.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 71.17 158.95 0.2 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.684 0.794 . . . . 0.0 110.653 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 . . . . . 0 C--N 1.31 -1.148 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.44 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.305 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.62 92.94 7.23 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.8 tpt -88.62 134.31 33.92 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.212 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.11 -174.39 42.98 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 65.1 mtt -124.34 94.74 44.56 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 117.37 0.585 . . . . 0.0 110.72 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.58 -26.6 4.67 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.749 2.299 . . . . 0.0 111.027 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -164.18 178.87 7.26 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 103.954 -2.61 . . . . 0.0 103.954 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.456 ' NE ' ' HD2' ' A' ' 34' ' ' TYR . 97.7 mtt180 -72.64 124.32 25.04 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.621 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -67.59 -55.34 13.78 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 176.667 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.522 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 36.3 m-85 -88.24 95.96 10.38 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.69 149.58 28.42 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.606 ' HA ' HG13 ' A' ' 31' ' ' VAL . 10.3 p-10 -61.78 127.52 31.8 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.693 0.759 . . . . 0.0 112.319 -173.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.7 -14.44 17.39 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.478 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.529 ' O ' HG12 ' A' ' 31' ' ' VAL . 32.4 tt0 -77.25 136.74 38.55 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.0 p -94.84 127.53 46.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.434 HG11 ' CD1' ' A' ' 10' ' ' TYR . 12.7 m -135.34 -176.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.374 -175.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.466 ' HG2' ' HA ' ' A' ' 61' ' ' GLN . 94.4 mmm -110.33 131.73 54.8 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 174.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -128.49 141.84 12.96 Favored Glycine 0 C--N 1.273 -2.949 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -89.58 136.19 33.17 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 24.8 t-105 -71.11 121.4 84.06 Favored Pre-proline 0 N--CA 1.434 -1.268 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.44 114.48 1.47 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 124.106 3.204 . . . . 0.0 114.299 -174.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.67 -30.52 9.35 Favored Glycine 0 C--O 1.242 0.656 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.379 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.3 m -96.13 175.5 6.44 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.3 p -105.65 -2.42 9.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 122.218 1.009 . . . . 0.0 108.986 176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.85 134.2 45.95 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -107.85 136.48 47.5 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.471 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -128.92 157.77 40.67 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.013 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -86.16 125.57 33.6 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.02 163.22 37.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -175.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -122.32 130.35 53.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.606 HG13 ' HA ' ' A' ' 12' ' ' ASP . 7.5 p -68.7 132.46 32.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.415 0.626 . . . . 0.0 111.181 -176.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.8 m -118.58 -38.21 3.17 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.237 -173.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.3 m -157.0 171.17 20.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.456 ' HD2' ' NE ' ' A' ' 8' ' ' ARG . 44.0 t80 -154.31 136.52 14.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 118.131 0.423 . . . . 0.0 111.734 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -97.39 121.73 39.62 Favored 'General case' 0 C--O 1.249 1.026 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 171.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -82.07 -23.72 35.65 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 124.073 0.858 . . . . 0.0 111.365 -170.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.0 -51.83 9.06 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.786 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.5 m -94.54 -0.6 54.47 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 33.4 m80 68.07 43.2 1.66 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.381 1.072 . . . . 0.0 110.916 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.76 115.83 30.91 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.882 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.522 ' CE2' ' HB2' ' A' ' 10' ' ' TYR . 65.2 m-85 -96.08 127.11 41.8 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.7 m -92.95 129.21 38.94 Favored 'General case' 0 N--CA 1.404 -2.751 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 31' ' ' VAL . 34.0 m -127.72 157.62 39.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -105.22 133.78 49.41 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -92.48 157.0 16.8 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.694 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.13 -23.08 66.35 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.786 0.803 . . . . 0.0 109.9 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.66 -1.94 10.35 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.46 1.104 . . . . 0.0 111.157 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.74 -23.81 18.08 Favored Glycine 0 C--O 1.227 -0.316 0 O-C-N 121.654 -0.654 . . . . 0.0 112.174 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.4 m -77.04 132.97 39.21 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 124.372 1.069 . . . . 0.0 111.259 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -93.79 150.19 20.59 Favored 'General case' 0 C--O 1.251 1.161 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.4 tp -139.48 149.97 44.62 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.24 134.72 51.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 173.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.428 ' CD1' HD11 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -141.32 166.21 25.39 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 124.114 0.966 . . . . 0.0 111.006 177.652 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 39' ' ' HIS . 97.5 mttt -82.91 161.42 21.85 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.618 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -60.69 -31.13 70.4 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.448 0.642 . . . . 0.0 110.8 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -75.57 -4.33 39.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.56 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -105.82 2.57 27.89 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.428 HD11 ' CD1' ' A' ' 53' ' ' LEU . 48.9 mt -114.03 146.97 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -132.45 159.2 40.02 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 172.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.6 mt -66.31 171.92 4.4 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 170.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.466 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 51.9 mt-30 -52.57 -37.69 58.44 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -175.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.8 t 176.03 -52.9 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.1 m -92.49 174.09 7.46 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.805 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -148.18 157.0 43.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 104.608 -2.368 . . . . 0.0 104.608 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -79.65 120.08 23.48 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.721 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 . . . . . 0 C--N 1.29 -1.979 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.296 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' HG11 ' A' ' 31' ' ' VAL . . . . . . . . 0 C--O 1.218 -0.553 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.475 ' HA ' HG13 ' A' ' 31' ' ' VAL . 6.7 p-10 -127.51 134.2 49.8 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.439 ' H ' HG13 ' A' ' 31' ' ' VAL . . . 94.78 -8.83 70.97 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -172.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.521 ' O ' HG12 ' A' ' 31' ' ' VAL . 24.8 tt0 -78.43 138.03 38.28 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.488 1.115 . . . . 0.0 112.071 -175.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 30' ' ' GLN . 4.3 p -91.1 128.12 43.08 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.273 174.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 m -135.49 -175.23 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.662 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 96.0 mmm -107.95 132.74 53.18 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.22 135.6 8.25 Favored Glycine 0 C--N 1.281 -2.484 0 C-N-CA 120.27 -0.966 . . . . 0.0 111.073 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 35.3 ttm180 -74.42 143.05 44.92 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 123.846 0.859 . . . . 0.0 109.626 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 . . . . . 0 N--CA 1.435 -1.177 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 175.539 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 18.3 mt . . . . . 0 CA--C 1.491 -1.304 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -113.35 131.16 56.08 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.543 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -117.92 172.84 7.13 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -95.33 125.22 39.8 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.1 m -135.34 163.28 36.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 60.8 tt0 -122.37 130.11 52.78 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 173.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 14' ' ' GLU . 7.6 p -72.42 128.1 35.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 123.321 0.388 . . . . 0.0 110.532 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.8 p -108.76 -46.47 3.64 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-O 120.711 0.291 . . . . 0.0 111.621 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -144.35 179.49 7.21 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.216 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -155.34 127.68 7.78 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 7.6 t70 -88.43 122.67 32.18 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 173.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -96.32 -13.91 22.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.27 -52.28 7.91 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.071 0.463 . . . . 0.0 110.257 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.416 ' HB2' HD23 ' A' ' 40' ' ' LEU . 15.9 m -99.7 -1.05 38.87 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.286 0.565 . . . . 0.0 111.085 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 59.61 71.35 0.58 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.115 0.966 . . . . 0.0 111.79 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 4.6 mm? -125.28 138.64 54.09 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.529 ' CE1' ' HB3' ' A' ' 55' ' ' GLU . 11.2 m-85 -108.93 130.04 55.44 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.0 m -93.25 128.63 39.32 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 31' ' ' VAL . 35.9 m -130.4 159.67 42.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 22.9 ttmm -119.63 133.81 55.49 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -88.77 167.43 13.3 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 123.643 0.59 . . . . 0.0 111.533 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -61.14 -22.57 64.81 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.339 1.055 . . . . 0.0 110.679 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.23 -0.1 34.88 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.476 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.32 -37.46 3.38 Favored Glycine 0 CA--C 1.509 -0.336 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.5 m -58.86 134.97 57.37 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 124.851 1.26 . . . . 0.0 110.771 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -108.67 151.16 26.53 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.6 tp -139.92 159.32 42.44 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.6 135.28 51.47 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 171.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.8 170.25 16.1 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -82.29 161.8 22.5 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.529 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -60.87 -30.22 70.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.933 0.397 . . . . 0.0 111.422 174.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 m -69.75 -12.04 61.32 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.542 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -95.77 -12.52 25.23 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mt -102.37 135.47 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.736 -176.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -130.02 168.46 16.68 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.798 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 C--N 1.313 -1.004 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.439 -179.86 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.813 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.418 ' HA ' HG13 ' A' ' 31' ' ' VAL . 6.9 p-10 -56.54 127.39 31.02 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.6 0.562 . . . . 0.0 111.796 -174.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.18 -8.09 48.63 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.474 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.4 ' O ' HG12 ' A' ' 31' ' ' VAL . 8.9 tp10 -77.01 138.82 39.83 Favored 'General case' 0 N--CA 1.431 -1.377 0 O-C-N 122.567 -0.372 . . . . 0.0 110.11 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 p -94.05 127.09 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.1 m -135.45 179.05 4.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.696 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.0 mtp -111.24 132.74 54.12 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.84 150.89 19.16 Favored Glycine 0 C--N 1.285 -2.284 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.326 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 29.5 ttp180 -85.35 139.85 31.25 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.948 0.404 . . . . 0.0 110.625 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 41.1 t-105 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 175.635 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 11.5 mt . . . . . 0 CA--C 1.5 -0.943 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.521 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 67.0 m-85 -127.84 107.27 9.73 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 123.707 0.629 . . . . 0.0 110.037 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -98.64 163.8 12.5 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.959 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.76 124.09 39.63 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.43 164.94 31.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.168 -172.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -114.74 130.8 56.89 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 43' ' ' VAL . 14.3 p -71.16 128.42 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.0 m -108.5 -35.43 6.48 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.049 -172.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.8 t -156.63 174.54 15.31 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -149.22 117.88 6.59 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 123.426 0.69 . . . . 0.0 109.507 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -88.08 122.23 31.41 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -97.69 -8.63 28.31 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.762 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.48 -49.67 9.67 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.293 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.4 t -98.61 -2.19 39.09 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.991 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 70.7 m80 59.71 63.4 1.51 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.979 0.912 . . . . 0.0 111.945 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -127.45 127.86 44.8 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.854 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -98.08 120.12 37.91 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.6 m -87.62 130.42 34.78 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 31' ' ' VAL . 34.7 m -128.67 157.6 41.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -108.18 133.04 53.0 Favored 'General case' 0 C--O 1.264 1.829 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -97.18 154.93 17.07 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 124.237 0.961 . . . . 0.0 110.215 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -61.95 -25.03 67.35 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.814 0.846 . . . . 0.0 109.384 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.64 -0.69 21.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.354 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.91 -18.59 50.23 Favored Glycine 0 CA--C 1.504 -0.654 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.136 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.6 m -78.65 130.38 35.8 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 123.046 0.538 . . . . 0.0 109.919 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.41 148.66 25.23 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 170.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.2 tp -140.52 152.06 45.27 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -173.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.63 134.5 51.87 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 170.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.23 164.86 28.94 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.254 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.84 166.98 17.48 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -30.88 70.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.427 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -74.5 -1.51 21.6 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.201 0.524 . . . . 0.0 111.943 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -101.06 -13.24 18.3 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.7 mt -102.57 133.37 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.627 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -122.61 168.79 11.74 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 113.987 -1.46 . . . . 0.0 107.602 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.302 -1.499 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.828 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.644 ' HA ' HG13 ' A' ' 31' ' ' VAL . 4.1 p30 -72.88 139.46 46.9 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.822 0.344 . . . . 0.0 111.363 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.86 -13.24 34.84 Favored Glycine 0 N--CA 1.429 -1.776 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.093 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.472 ' O ' HG12 ' A' ' 31' ' ' VAL . 8.7 tp10 -77.9 147.32 35.1 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.2 127.33 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 174.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 m -135.04 174.97 12.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.953 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.1 mtp -111.61 132.88 54.25 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 172.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.43 149.86 19.56 Favored Glycine 0 C--N 1.278 -2.655 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.927 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.432 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 47.2 ttp85 -79.7 137.12 36.96 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 . . . . . 0 N--CA 1.426 -1.665 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 176.583 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 N--CA 1.44 -0.952 0 N-CA-C 110.755 -0.091 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.432 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 57.4 m-85 -110.55 129.19 55.85 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.529 0.68 . . . . 0.0 111.242 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -122.87 156.56 34.38 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.608 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.89 124.93 35.12 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.66 169.54 20.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 122.98 0.512 . . . . 0.0 110.087 -174.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -115.26 130.48 56.92 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 173.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.644 HG13 ' HA ' ' A' ' 12' ' ' ASP . 7.3 p -72.39 128.65 35.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.8 t -108.89 -31.41 7.68 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.619 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -165.53 -176.9 4.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -148.97 132.37 16.6 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 123.548 0.739 . . . . 0.0 109.667 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -97.49 121.43 39.38 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -86.41 -21.91 26.86 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.94 -49.49 51.36 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.032 0.444 . . . . 0.0 110.496 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.6 m -97.47 -2.03 42.93 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.71 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 59.98 45.68 11.88 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.54 0.686 . . . . 0.0 110.84 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.95 134.55 52.49 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.372 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.617 ' CE1' ' HB3' ' A' ' 55' ' ' GLU . 26.9 m-85 -102.47 127.49 49.49 Favored 'General case' 0 CA--C 1.48 -1.745 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.3 m -93.06 129.16 39.11 Favored 'General case' 0 N--CA 1.4 -2.933 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -125.0 159.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -121.32 135.5 55.09 Favored 'General case' 0 C--N 1.272 -2.775 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -90.17 162.3 15.33 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.408 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -61.8 -24.05 66.61 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.628 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -82.42 0.7 40.92 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.474 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.12 -31.52 7.88 Favored Glycine 0 C--O 1.238 0.357 0 C-N-CA 121.506 -0.378 . . . . 0.0 112.377 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 m -56.11 130.03 42.47 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 124.917 1.287 . . . . 0.0 111.03 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.2 150.46 25.08 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.978 175.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.9 tp -139.86 152.87 46.81 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.538 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.07 134.61 51.98 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.18 173.75 11.18 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 123.136 0.574 . . . . 0.0 111.244 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -82.72 157.02 23.46 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.62 0.248 . . . . 0.0 110.492 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.617 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -61.25 -31.09 70.88 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.169 0.509 . . . . 0.0 110.906 173.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.0 m -73.15 -12.05 60.75 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.723 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -95.4 -5.89 42.17 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.8 mt -102.62 133.6 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-O 121.296 0.569 . . . . 0.0 111.285 -176.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -124.43 161.9 25.05 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 173.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.1 mt . . . . . 0 C--N 1.297 -1.683 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.898 179.658 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.452 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -60.44 121.68 12.71 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.397 0.618 . . . . 0.0 112.161 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.497 ' H ' HG13 ' A' ' 31' ' ' VAL . . . 115.68 -14.34 17.47 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.647 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 31' ' ' VAL . 26.5 tt0 -77.02 141.05 40.51 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-N 116.893 0.347 . . . . 0.0 111.42 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.87 127.74 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 106.689 -1.596 . . . . 0.0 106.689 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.6 173.54 14.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.568 -173.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.419 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 47.0 ttm -111.2 131.85 54.79 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 172.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.8 149.96 19.45 Favored Glycine 0 C--N 1.283 -2.415 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.246 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.413 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 48.5 ttp180 -89.41 146.7 24.49 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 123.634 0.774 . . . . 0.0 109.0 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 . . . . . 0 C--N 1.306 -1.319 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.747 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.433 -1.312 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 50.5 m-85 -118.23 142.53 47.37 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.552 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -135.17 164.95 26.54 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -95.73 124.54 39.8 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.1 m -135.42 173.84 13.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.531 -172.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -115.25 131.26 56.98 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.855 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.497 HG13 ' H ' ' A' ' 13' ' ' GLY . 11.2 p -71.26 127.73 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -103.2 -44.36 5.21 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.445 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -157.73 173.12 17.31 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -150.52 126.02 10.19 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 123.372 0.669 . . . . 0.0 109.54 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -96.93 122.23 39.68 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 171.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -84.32 -28.36 27.14 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -174.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.85 -48.87 43.04 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.813 0.339 . . . . 0.0 111.194 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.4 m -94.54 -1.86 52.62 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.674 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 60.01 63.72 1.39 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.373 1.069 . . . . 0.0 111.736 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -128.55 125.66 38.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.688 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -97.94 118.35 34.32 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.7 m -94.17 129.98 40.55 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 31' ' ' VAL . 33.5 m -126.82 158.6 37.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -109.71 133.5 53.06 Favored 'General case' 0 C--O 1.271 2.225 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -93.22 162.19 14.11 Favored 'General case' 0 CA--C 1.496 -1.104 0 O-C-N 124.584 1.177 . . . . 0.0 110.75 175.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -62.2 -24.19 67.07 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.1 -0.954 . . . . 0.0 112.004 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -78.65 -0.19 28.99 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.423 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.6 -2.83 86.35 Favored Glycine 0 C--O 1.221 -0.707 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 m -79.32 129.96 34.97 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 122.967 0.507 . . . . 0.0 110.016 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -90.46 152.13 21.09 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 172.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.4 tp -137.77 145.03 41.93 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.03 133.98 52.62 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 173.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.07 172.59 12.46 Favored 'General case' 0 C--N 1.276 -2.627 0 O-C-N 123.763 0.665 . . . . 0.0 110.666 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -83.87 166.11 18.18 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.51 -32.81 70.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.041 0.448 . . . . 0.0 110.567 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.6 m -77.37 -6.43 53.29 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.058 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -88.69 -18.89 26.94 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.1 mt -100.97 130.76 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.298 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 17' ' ' MET . 74.1 mtt85 -135.0 158.73 43.58 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.258 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.7 mt . . . . . 0 C--N 1.29 -2.019 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 168.546 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.942 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.511 ' HA ' HG13 ' A' ' 31' ' ' VAL . 2.9 p30 -77.3 146.22 36.95 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.136 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.17 -9.52 63.3 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 31' ' ' VAL . 10.2 tp10 -78.67 143.39 36.34 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 122.493 0.317 . . . . 0.0 111.249 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 30' ' ' GLN . 5.5 p -94.91 126.64 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 173.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 59' ' ' ARG . 16.9 m -135.13 -177.7 2.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.314 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 87.7 mtp -111.92 131.72 55.2 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 173.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.99 143.95 14.69 Favored Glycine 0 C--N 1.27 -3.116 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -76.05 141.14 42.14 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 . . . . . 0 N--CA 1.428 -1.532 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 N--CA 1.435 -1.196 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -111.99 133.2 54.31 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.444 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -122.97 155.19 37.28 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.551 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -85.25 125.37 32.82 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.15 163.71 35.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 63.1 tt0 -119.3 130.21 55.27 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 174.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.511 HG13 ' HA ' ' A' ' 12' ' ' ASP . 8.1 p -72.27 130.56 35.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.5 t -119.68 -29.56 5.01 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.18 -176.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.45 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 16.2 m -144.07 157.18 44.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -139.63 121.89 15.94 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.338 0.113 . . . . 0.0 110.697 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.8 122.33 41.9 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 174.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -83.09 -20.4 34.96 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.001 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.04 -50.82 37.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.0 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 m -97.07 -2.57 42.98 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.27 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 t60 58.98 46.73 13.14 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.494 1.118 . . . . 0.0 108.6 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mp -114.1 142.34 46.33 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.117 -175.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.4 ' CE1' ' HB3' ' A' ' 55' ' ' GLU . 45.5 m-85 -111.99 128.15 56.09 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 7.0 m -93.19 129.08 39.33 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 176.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.91 159.54 28.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -120.97 133.83 55.28 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -92.95 162.28 14.13 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.823 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -62.24 -21.38 65.12 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.29 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.06 -0.6 32.04 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.128 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.12 -1.06 86.38 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.5 m -79.26 135.31 36.73 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 123.888 0.875 . . . . 0.0 110.934 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -100.48 151.5 21.49 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 171.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 tp -138.86 145.47 40.03 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.23 133.36 53.31 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 172.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.426 ' CD1' HD11 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -141.45 167.21 22.71 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -84.27 157.44 21.56 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.965 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.4 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -60.47 -25.48 66.06 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 176.416 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 m -70.7 -6.29 36.11 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.469 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -112.96 7.05 18.06 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.465 ' C ' ' HD2' ' A' ' 59' ' ' ARG . 41.0 mt -118.48 135.39 59.04 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.658 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.465 ' HD2' ' C ' ' A' ' 58' ' ' ILE . 3.7 mpt_? -129.08 166.44 19.26 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 171.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mp . . . . . 0 C--N 1.294 -1.833 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.33 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -74.51 131.86 41.37 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.099 0.476 . . . . 0.0 111.352 -175.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.537 ' H ' HG13 ' A' ' 31' ' ' VAL . . . 107.51 -11.31 39.21 Favored Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.6 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -77.43 152.64 34.2 Favored 'General case' 0 C--O 1.241 0.625 0 O-C-N 122.823 -0.222 . . . . 0.0 111.079 -175.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.29 127.29 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.02 177.93 6.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.965 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.0 mmm -111.33 131.97 54.76 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.51 149.08 19.74 Favored Glycine 0 C--N 1.286 -2.229 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.158 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.494 ' HD3' ' OD2' ' A' ' 57' ' ' ASP . 23.1 ttt-85 -82.62 134.75 35.17 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 123.131 0.572 . . . . 0.0 111.123 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 . . . . . 0 C--N 1.315 -0.918 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 175.411 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.1 mt . . . . . 0 N--CA 1.432 -1.339 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 19' ' ' ARG . 17.3 m-85 -109.33 128.94 55.49 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.565 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -118.8 172.39 7.55 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -85.49 126.03 33.51 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 123.376 0.422 . . . . 0.0 109.895 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.38 163.79 34.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.959 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -113.29 130.51 56.23 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.537 HG13 ' H ' ' A' ' 13' ' ' GLY . 8.8 p -72.28 128.6 35.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 176.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.0 t -119.12 -28.45 5.47 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.61 -0.836 . . . . 0.0 112.062 -173.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.426 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 50.2 m -151.62 169.17 22.8 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 121.921 -0.487 . . . . 0.0 109.917 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -148.91 129.14 13.69 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -97.48 122.75 40.9 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.87 -41.77 70.96 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 123.958 0.786 . . . . 0.0 111.788 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.89 -49.92 74.27 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.588 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -92.9 -2.0 56.23 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.429 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.3 m80 58.21 42.46 21.92 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -104.92 133.74 49.2 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.399 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -103.51 120.71 41.39 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 52' ' ' ALA . 7.1 m -93.71 129.46 40.03 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.6 158.89 26.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.291 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -113.56 132.54 55.67 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -97.6 150.52 21.05 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -62.69 -17.4 60.58 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 122.102 0.953 . . . . 0.0 109.823 173.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.27 -1.9 22.67 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.129 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.28 -31.67 5.6 Favored Glycine 0 N--CA 1.443 -0.862 0 O-C-N 121.836 -0.54 . . . . 0.0 111.814 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.3 m -71.0 130.02 40.51 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 123.82 0.848 . . . . 0.0 110.802 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -102.23 151.33 22.34 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.467 171.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.4 tp -139.42 145.5 38.96 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.461 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 42' ' ' THR . . . -110.7 134.55 52.36 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.243 171.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.4 176.84 8.54 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 123.641 0.777 . . . . 0.0 110.547 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -83.46 167.61 17.29 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 120.852 0.358 . . . . 0.0 111.408 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -60.08 -31.76 70.32 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.684 0.794 . . . . 0.0 110.998 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 m -76.62 -4.99 45.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.526 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.494 ' OD2' ' HD3' ' A' ' 19' ' ' ARG . 3.1 m-20 -105.63 3.38 29.11 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.335 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 mt -118.06 141.47 37.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 121.238 0.542 . . . . 0.0 111.09 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -129.52 168.16 16.79 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 172.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 C--N 1.309 -1.18 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.612 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.017 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -77.7 135.87 38.11 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 123.217 0.607 . . . . 0.0 112.182 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.611 ' H ' HG13 ' A' ' 31' ' ' VAL . . . 103.33 -14.35 54.69 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.433 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.542 ' O ' HG12 ' A' ' 31' ' ' VAL . 29.6 tt0 -79.17 156.74 28.08 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.862 0.465 . . . . 0.0 112.002 -174.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.0 p -90.87 129.04 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 172.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 m -134.1 171.55 17.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.9 mtp -111.11 132.3 54.39 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.236 173.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -125.49 146.3 16.11 Favored Glycine 0 C--N 1.281 -2.504 0 C-N-CA 120.184 -1.007 . . . . 0.0 111.668 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.426 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 75.5 ttt180 -79.89 132.11 36.01 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 . . . . . 0 N--CA 1.433 -1.302 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 175.7 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 N--CA 1.431 -1.398 0 CA-C-O 120.736 0.303 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 41.9 m-85 -104.19 132.22 50.67 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.076 175.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -119.88 157.86 27.85 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.569 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -95.59 125.25 40.06 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.6 m -135.51 163.83 34.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-O 120.892 0.377 . . . . 0.0 110.626 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -107.36 129.91 54.86 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.344 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.611 HG13 ' H ' ' A' ' 13' ' ' GLY . 6.2 p -72.29 127.06 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.697 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.7 m -112.38 -40.28 4.17 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.178 -170.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.2 t -151.74 -179.67 7.64 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -161.55 129.01 4.06 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 122.4 0.28 . . . . 0.0 110.761 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -91.95 122.09 34.14 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.06 -38.75 51.99 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 124.279 0.987 . . . . 0.0 109.816 -173.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.77 -57.3 13.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.428 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.6 m -98.87 -0.29 42.71 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.1 m80 66.59 43.92 2.39 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.631 0.772 . . . . 0.0 110.255 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.93 121.17 41.27 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.481 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 51.8 m-85 -93.8 122.89 36.75 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 m -92.92 129.21 38.91 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.428 HG12 ' HA ' ' A' ' 31' ' ' VAL . 35.8 m -126.85 158.61 37.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -107.66 133.13 52.54 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -97.89 165.41 11.94 Favored 'General case' 0 CA--C 1.508 -0.637 0 O-C-N 124.41 1.069 . . . . 0.0 111.53 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -61.57 -25.22 67.17 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 124.904 1.282 . . . . 0.0 110.415 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -83.44 -0.89 52.04 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.134 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.79 -33.27 5.29 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.979 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.8 m -56.06 131.25 46.99 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.885 1.274 . . . . 0.0 111.645 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -96.7 150.34 20.8 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 172.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.57 149.99 44.5 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 41' ' ' TYR . . . -109.56 135.3 50.76 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 172.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.69 166.17 25.48 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 123.18 0.592 . . . . 0.0 110.882 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.8 161.75 20.84 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.05 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -60.37 -30.69 69.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.6 t -74.52 -5.53 43.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.87 0.367 . . . . 0.0 110.743 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -95.86 -12.31 25.41 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 55.1 mt -99.76 143.01 14.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 120.967 0.413 . . . . 0.0 111.449 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -131.07 170.23 14.8 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 171.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.294 -1.831 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 173.938 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.547 0 CA-C-O 120.669 0.271 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -123.94 125.52 44.74 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 174.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.92 -5.22 68.81 Favored Glycine 0 C--N 1.311 -0.818 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.575 ' O ' HG12 ' A' ' 31' ' ' VAL . 43.3 tt0 -77.74 137.86 38.71 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 123.423 0.689 . . . . 0.0 110.265 -177.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.82 127.58 41.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 118.535 -1.266 . . . . 0.0 108.568 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.7 m -135.58 -176.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.918 -176.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 90.3 mtp -111.27 132.77 54.11 Favored 'General case' 0 C--O 1.204 -1.323 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -128.79 141.61 12.74 Favored Glycine 0 C--N 1.272 -2.986 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.573 ' HB3' ' OD1' ' A' ' 57' ' ' ASP . 15.6 ttp180 -75.1 144.34 42.93 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.46 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 . . . . . 0 N--CA 1.426 -1.671 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 173.59 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.4 mt . . . . . 0 N--CA 1.435 -1.188 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 34.8 m-85 -100.61 124.9 46.83 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.408 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -113.64 156.01 24.48 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -79.36 125.8 29.98 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.11 163.69 35.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -111.2 128.87 56.05 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 173.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 14' ' ' GLU . 10.8 p -73.8 136.95 24.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.6 t -122.37 -41.44 2.4 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 118.656 -1.218 . . . . 0.0 112.056 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.7 m -139.03 141.5 38.27 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.774 -0.771 . . . . 0.0 110.734 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -114.78 124.7 52.44 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.939 0.4 . . . . 0.0 111.161 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -96.25 122.59 39.27 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -97.42 -19.76 18.23 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.583 0.552 . . . . 0.0 111.528 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.44 -52.68 8.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.864 0.364 . . . . 0.0 111.429 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.7 m -99.5 -2.02 36.95 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.287 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 61.66 80.0 0.24 Allowed 'General case' 0 C--O 1.247 0.954 0 C-N-CA 123.667 0.787 . . . . 0.0 112.273 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -141.96 150.17 41.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.986 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.573 ' CE1' ' HB2' ' A' ' 55' ' ' GLU . 29.3 m-85 -119.63 116.93 27.01 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.5 m -87.01 129.0 35.07 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 31' ' ' VAL . 33.8 m -125.49 160.0 32.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 124.308 1.005 . . . . 0.0 108.633 -176.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HG3' ' HG2' ' A' ' 50' ' ' GLU . 50.3 tttp -124.95 135.74 53.11 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -95.01 159.04 15.21 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.571 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -61.3 -25.12 66.9 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.944 0.778 . . . . 0.0 110.418 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.53 -0.7 27.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.829 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.69 -39.34 2.77 Favored Glycine 0 C--O 1.248 1.0 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.513 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.0 m -54.77 136.14 46.61 Favored 'General case' 0 C--O 1.246 0.882 0 C-N-CA 124.395 1.078 . . . . 0.0 111.533 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.436 ' HG2' ' HG3' ' A' ' 44' ' ' LYS . 62.0 mt-10 -113.57 150.42 33.07 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.4 tp -139.5 145.66 39.01 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -175.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.3 133.66 52.77 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.74 172.52 12.58 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 123.369 0.667 . . . . 0.0 111.964 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.442 ' HG2' ' H ' ' A' ' 56' ' ' SER . 86.8 tttt -82.43 156.34 24.18 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 122.664 0.386 . . . . 0.0 110.031 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.573 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 41.5 tt0 -60.08 -31.95 70.49 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.948 0.88 . . . . 0.0 110.872 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.442 ' H ' ' HG2' ' A' ' 54' ' ' LYS . 4.0 m -76.6 -11.25 59.83 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.601 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.573 ' OD1' ' HB3' ' A' ' 19' ' ' ARG . 1.6 t70 -103.21 6.43 38.24 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -177.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mt -110.9 149.26 13.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.072 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -131.34 158.66 40.1 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.9 mt . . . . . 0 C--N 1.318 -0.804 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.264 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.342 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.405 ' HA ' HG13 ' A' ' 31' ' ' VAL . 4.4 p-10 -46.74 123.66 5.32 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.115 0.884 . . . . 0.0 111.387 -177.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.31 -13.42 28.32 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.285 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.463 ' O ' HG12 ' A' ' 31' ' ' VAL . 7.6 tp10 -76.48 137.02 39.39 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 117.436 0.618 . . . . 0.0 109.571 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 p -95.19 127.68 46.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -135.37 -178.73 2.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 122.857 0.463 . . . . 0.0 111.159 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 83.4 mtp -110.85 133.01 53.71 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 57' ' ' ASP . . . -138.88 142.28 12.8 Favored Glycine 0 C--N 1.281 -2.496 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.796 -177.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.562 ' HD3' ' OD1' ' A' ' 57' ' ' ASP . 33.9 ttt-85 -75.59 132.21 40.5 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 125.115 1.366 . . . . 0.0 110.92 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 16.4 t-105 . . . . . 0 C--N 1.303 -1.446 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 172.992 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 17.3 mt . . . . . 0 N--CA 1.428 -1.527 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.483 ' CE2' ' HG2' ' A' ' 59' ' ' ARG . 25.6 m-85 -108.07 115.8 30.79 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 113.865 -1.516 . . . . 0.0 107.42 175.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -108.53 172.51 6.8 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -84.72 126.13 33.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 m -134.98 164.04 34.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -126.1 131.23 52.14 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.179 -1.409 . . . . 0.0 108.706 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.521 ' HA ' HG12 ' A' ' 43' ' ' VAL . 12.3 p -69.71 129.48 34.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.653 0.74 . . . . 0.0 110.92 -175.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.5 m -106.05 -39.14 6.08 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.925 -174.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.2 m -155.65 162.8 40.53 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -139.58 119.39 13.33 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 120.908 0.385 . . . . 0.0 110.613 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -91.1 123.12 34.32 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -100.8 -1.13 35.69 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.773 0.797 . . . . 0.0 110.185 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.34 -54.64 5.06 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.518 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.3 m -98.53 -2.1 39.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.038 0.446 . . . . 0.0 110.021 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 59.8 69.9 0.67 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.64 1.176 . . . . 0.0 113.204 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -131.97 135.4 46.54 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.694 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -97.93 117.52 32.45 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 52' ' ' ALA . 17.0 m -93.36 129.71 39.39 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 31' ' ' VAL . 29.5 m -129.06 158.45 41.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -176.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 6.8 ttpm? -110.71 136.88 49.11 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -90.71 154.4 19.58 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.42 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.29 -20.96 63.5 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.814 1.246 . . . . 0.0 110.042 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.34 -1.0 31.14 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.594 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.78 -41.74 2.09 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.463 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.6 m -71.01 135.75 48.0 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.291 0.636 . . . . 0.0 111.501 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -94.85 153.16 17.85 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 173.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.9 tp -138.42 148.43 44.44 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.581 -176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 42' ' ' THR . . . -109.71 134.37 52.07 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 171.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -140.63 166.99 23.23 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.801 -178.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -85.01 168.18 15.16 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.142 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.57 -30.57 69.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.485 0.66 . . . . 0.0 110.045 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.4 m -69.49 -11.62 60.98 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.09 0.956 . . . . 0.0 110.879 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.562 ' OD1' ' HD3' ' A' ' 19' ' ' ARG . 67.9 m-20 -100.91 1.99 40.4 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.411 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.2 mt -111.74 134.06 55.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.478 0.656 . . . . 0.0 112.491 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.483 ' HG2' ' CE2' ' A' ' 26' ' ' TYR . 56.1 mmt-85 -130.36 156.58 44.46 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 172.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 C--N 1.297 -1.7 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 172.857 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.181 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.606 ' HA ' HG13 ' A' ' 31' ' ' VAL . 10.3 p-10 -61.78 127.52 31.8 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.693 0.759 . . . . 0.0 112.319 -173.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.7 -14.44 17.39 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.478 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.529 ' O ' HG12 ' A' ' 31' ' ' VAL . 32.4 tt0 -77.25 136.74 38.55 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.0 p -94.84 127.53 46.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.7 m -135.34 -176.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.374 -175.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.4 mmm -110.33 131.73 54.8 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -128.49 141.84 12.96 Favored Glycine 0 C--N 1.273 -2.949 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -89.58 136.19 33.17 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 24.8 t-105 . . . . . 0 N--CA 1.434 -1.268 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.829 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.433 -1.276 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -107.85 136.48 47.5 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.471 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -128.92 157.77 40.67 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.013 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -86.16 125.57 33.6 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.02 163.22 37.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -175.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -122.32 130.35 53.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.606 HG13 ' HA ' ' A' ' 12' ' ' ASP . 7.5 p -68.7 132.46 32.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.415 0.626 . . . . 0.0 111.181 -176.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.8 m -118.58 -38.21 3.17 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.237 -173.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.3 m -157.0 171.17 20.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -154.31 136.52 14.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 118.131 0.423 . . . . 0.0 111.734 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -97.39 121.73 39.62 Favored 'General case' 0 C--O 1.249 1.026 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 171.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -82.07 -23.72 35.65 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 124.073 0.858 . . . . 0.0 111.365 -170.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.0 -51.83 9.06 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.786 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.5 m -94.54 -0.6 54.47 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 33.4 m80 68.07 43.2 1.66 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.381 1.072 . . . . 0.0 110.916 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.76 115.83 30.91 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.882 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -96.08 127.11 41.8 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.7 m -92.95 129.21 38.94 Favored 'General case' 0 N--CA 1.404 -2.751 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 31' ' ' VAL . 34.0 m -127.72 157.62 39.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -105.22 133.78 49.41 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -92.48 157.0 16.8 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.694 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.13 -23.08 66.35 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.786 0.803 . . . . 0.0 109.9 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.66 -1.94 10.35 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.46 1.104 . . . . 0.0 111.157 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.74 -23.81 18.08 Favored Glycine 0 C--O 1.227 -0.316 0 O-C-N 121.654 -0.654 . . . . 0.0 112.174 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.4 m -77.04 132.97 39.21 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 124.372 1.069 . . . . 0.0 111.259 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -93.79 150.19 20.59 Favored 'General case' 0 C--O 1.251 1.161 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.4 tp -139.48 149.97 44.62 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.24 134.72 51.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 173.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.428 ' CD1' HD11 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -141.32 166.21 25.39 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 124.114 0.966 . . . . 0.0 111.006 177.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 39' ' ' HIS . 97.5 mttt -82.91 161.42 21.85 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.618 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -60.69 -31.13 70.4 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.448 0.642 . . . . 0.0 110.8 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -75.57 -4.33 39.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.56 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -105.82 2.57 27.89 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.428 HD11 ' CD1' ' A' ' 53' ' ' LEU . 48.9 mt -114.03 146.97 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -132.45 159.2 40.02 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 172.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 C--O 1.255 1.364 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 170.47 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.017 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.15 -14.29 18.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.678 0.275 . . . . 0.0 110.308 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 73.43 -55.88 0.67 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.798 1.239 . . . . 0.0 112.728 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.35 86.85 0.73 Allowed Glycine 0 C--N 1.3 -1.455 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.0 tpt -159.05 79.26 2.89 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.126 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' A' ' 8' ' ' ARG . 63.0 Cg_endo -80.22 -20.84 8.24 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 121.802 1.668 . . . . 0.0 112.079 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 177.24 -48.86 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.53 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -103.2 -166.39 1.26 Allowed 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 169.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -80.89 -28.61 35.89 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.43 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 98.6 m-85 -125.57 162.57 24.64 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.878 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -84.19 -167.76 1.89 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.475 ' HA ' HG13 ' A' ' 31' ' ' VAL . 6.7 p-10 -127.51 134.2 49.8 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.439 ' H ' HG13 ' A' ' 31' ' ' VAL . . . 94.78 -8.83 70.97 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -172.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.521 ' O ' HG12 ' A' ' 31' ' ' VAL . 24.8 tt0 -78.43 138.03 38.28 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.488 1.115 . . . . 0.0 112.071 -175.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 30' ' ' GLN . 4.3 p -91.1 128.12 43.08 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.273 174.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 m -135.49 -175.23 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.662 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 96.0 mmm -107.95 132.74 53.18 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.22 135.6 8.25 Favored Glycine 0 C--N 1.281 -2.484 0 C-N-CA 120.27 -0.966 . . . . 0.0 111.073 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 35.3 ttm180 -74.42 143.05 44.92 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 123.846 0.859 . . . . 0.0 109.626 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -81.67 123.57 80.48 Favored Pre-proline 0 N--CA 1.435 -1.177 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -36.75 -47.49 1.39 Allowed 'Trans proline' 0 CA--C 1.542 0.907 1 C-N-CA 125.584 4.189 . . . . 0.0 116.501 -173.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.28 -9.02 65.72 Favored Glycine 0 C--N 1.313 -0.701 0 C-N-CA 120.109 -1.044 . . . . 0.0 113.869 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.8 t -113.91 179.78 3.86 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.935 0.398 . . . . 0.0 110.31 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.8 m -107.12 0.44 9.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 172.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 18.3 mt -73.84 145.05 45.22 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.826 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -113.35 131.16 56.08 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.543 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -117.92 172.84 7.13 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -95.33 125.22 39.8 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.1 m -135.34 163.28 36.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 60.8 tt0 -122.37 130.11 52.78 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 173.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 14' ' ' GLU . 7.6 p -72.42 128.1 35.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 123.321 0.388 . . . . 0.0 110.532 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.8 p -108.76 -46.47 3.64 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-O 120.711 0.291 . . . . 0.0 111.621 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -144.35 179.49 7.21 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.216 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -155.34 127.68 7.78 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 7.6 t70 -88.43 122.67 32.18 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 173.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -96.32 -13.91 22.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.27 -52.28 7.91 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.071 0.463 . . . . 0.0 110.257 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.416 ' HB2' HD23 ' A' ' 40' ' ' LEU . 15.9 m -99.7 -1.05 38.87 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.286 0.565 . . . . 0.0 111.085 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 59.61 71.35 0.58 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.115 0.966 . . . . 0.0 111.79 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . 4.6 mm? -125.28 138.64 54.09 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.529 ' CE1' ' HB3' ' A' ' 55' ' ' GLU . 11.2 m-85 -108.93 130.04 55.44 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.0 m -93.25 128.63 39.32 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 31' ' ' VAL . 35.9 m -130.4 159.67 42.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 22.9 ttmm -119.63 133.81 55.49 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -88.77 167.43 13.3 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 123.643 0.59 . . . . 0.0 111.533 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -61.14 -22.57 64.81 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.339 1.055 . . . . 0.0 110.679 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.23 -0.1 34.88 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.476 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.32 -37.46 3.38 Favored Glycine 0 CA--C 1.509 -0.336 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.5 m -58.86 134.97 57.37 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 124.851 1.26 . . . . 0.0 110.771 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -108.67 151.16 26.53 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.6 tp -139.92 159.32 42.44 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.6 135.28 51.47 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 171.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.8 170.25 16.1 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -82.29 161.8 22.5 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.529 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -60.87 -30.22 70.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.933 0.397 . . . . 0.0 111.422 174.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 m -69.75 -12.04 61.32 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.542 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -95.77 -12.52 25.23 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mt -102.37 135.47 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.736 -176.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -130.02 168.46 16.68 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.798 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.52 153.99 22.0 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.439 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -54.9 -34.63 63.27 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 122.012 0.91 . . . . 0.0 108.901 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.4 t -142.09 136.07 29.76 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 170.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.8 t -74.45 -11.22 60.18 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.649 0.738 . . . . 0.0 109.12 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -93.89 96.49 9.76 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -120.11 133.04 55.62 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.592 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 . . . . . 0 C--N 1.299 -1.62 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.556 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.948 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.38 113.42 2.89 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.0 ttt -78.71 -35.41 44.94 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.465 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.1 -178.84 43.65 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 88.8 mtp -134.05 136.99 27.27 Favored Pre-proline 0 C--N 1.299 -1.609 0 CA-C-N 117.481 0.64 . . . . 0.0 110.129 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.43 -31.35 94.64 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.58 2.187 . . . . 0.0 110.368 171.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -72.77 127.54 32.84 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 172.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -68.96 91.41 0.47 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -171.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -76.13 -34.78 59.43 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 173.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -94.14 82.53 4.16 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 114.299 -1.319 . . . . 0.0 108.419 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.12 151.1 40.17 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.799 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.418 ' HA ' HG13 ' A' ' 31' ' ' VAL . 6.9 p-10 -56.54 127.39 31.02 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.6 0.562 . . . . 0.0 111.796 -174.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.18 -8.09 48.63 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.474 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.4 ' O ' HG12 ' A' ' 31' ' ' VAL . 8.9 tp10 -77.01 138.82 39.83 Favored 'General case' 0 N--CA 1.431 -1.377 0 O-C-N 122.567 -0.372 . . . . 0.0 110.11 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 p -94.05 127.09 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.1 m -135.45 179.05 4.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.696 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.0 mtp -111.24 132.74 54.12 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.84 150.89 19.16 Favored Glycine 0 C--N 1.285 -2.284 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.326 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 29.5 ttp180 -85.35 139.85 31.25 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.948 0.404 . . . . 0.0 110.625 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 41.1 t-105 -81.55 120.82 78.98 Favored Pre-proline 0 N--CA 1.43 -1.457 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.405 ' CD ' HD21 ' A' ' 51' ' ' LEU . 10.0 Cg_endo -52.12 126.89 21.63 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.877 3.051 . . . . 0.0 113.175 -176.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.51 -37.56 3.48 Favored Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 m -95.75 175.69 6.42 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-O 121.158 0.504 . . . . 0.0 109.884 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.6 p -111.48 14.46 8.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 122.569 1.176 . . . . 0.0 108.141 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 11.5 mt -76.43 145.57 39.22 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.226 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.521 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 67.0 m-85 -127.84 107.27 9.73 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 123.707 0.629 . . . . 0.0 110.037 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -98.64 163.8 12.5 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.959 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.76 124.09 39.63 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.43 164.94 31.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.168 -172.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -114.74 130.8 56.89 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 43' ' ' VAL . 14.3 p -71.16 128.42 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.0 m -108.5 -35.43 6.48 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.049 -172.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.8 t -156.63 174.54 15.31 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -149.22 117.88 6.59 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 123.426 0.69 . . . . 0.0 109.507 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -88.08 122.23 31.41 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -97.69 -8.63 28.31 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.762 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.48 -49.67 9.67 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.293 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.4 t -98.61 -2.19 39.09 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.991 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 70.7 m80 59.71 63.4 1.51 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.979 0.912 . . . . 0.0 111.945 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -127.45 127.86 44.8 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.854 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -98.08 120.12 37.91 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.6 m -87.62 130.42 34.78 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 31' ' ' VAL . 34.7 m -128.67 157.6 41.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -108.18 133.04 53.0 Favored 'General case' 0 C--O 1.264 1.829 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -97.18 154.93 17.07 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 124.237 0.961 . . . . 0.0 110.215 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -61.95 -25.03 67.35 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.814 0.846 . . . . 0.0 109.384 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.64 -0.69 21.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.354 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.91 -18.59 50.23 Favored Glycine 0 CA--C 1.504 -0.654 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.136 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.6 m -78.65 130.38 35.8 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 123.046 0.538 . . . . 0.0 109.919 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.41 148.66 25.23 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 170.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.405 HD21 ' CD ' ' A' ' 21' ' ' PRO . 46.2 tp -140.52 152.06 45.27 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -173.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.63 134.5 51.87 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 170.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.23 164.86 28.94 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.254 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.84 166.98 17.48 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -30.88 70.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.427 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -74.5 -1.51 21.6 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.201 0.524 . . . . 0.0 111.943 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -101.06 -13.24 18.3 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.7 mt -102.57 133.37 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.627 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -122.61 168.79 11.74 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 113.987 -1.46 . . . . 0.0 107.602 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.4 mt -81.72 -175.3 5.49 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 64' ' ' PHE . 63.5 tt0 -60.19 -18.87 51.28 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 122.976 0.511 . . . . 0.0 111.721 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.5 t 73.35 -46.78 0.65 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.09 1.356 . . . . 0.0 111.75 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.8 p -89.74 13.08 15.2 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.233 0.54 . . . . 0.0 109.962 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 61' ' ' GLN . 58.7 t80 -65.91 104.94 1.19 Allowed 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -78.47 154.35 30.64 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.576 0.703 . . . . 0.0 112.454 -172.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 . . . . . 0 C--N 1.294 -1.823 0 CA-C-O 117.508 -1.234 . . . . 0.0 108.14 174.561 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.761 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.44 -45.47 62.56 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.352 0.596 . . . . 0.0 110.051 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 71.4 mtm -94.28 91.03 6.54 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.09 -43.61 2.19 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.046 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 63.2 mtm -137.74 88.94 15.71 Favored Pre-proline 0 C--N 1.313 -1.001 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -72.18 -32.88 10.07 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 121.904 1.736 . . . . 0.0 108.387 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 174.28 -56.93 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.52 ' HG2' ' CD2' ' A' ' 34' ' ' TYR . 91.0 mtt180 -114.01 130.46 56.54 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.566 172.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -87.29 -37.7 16.94 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 122.314 1.054 . . . . 0.0 108.476 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -119.07 130.04 55.4 Favored 'General case' 0 N--CA 1.41 -2.433 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.39 150.47 23.17 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.644 ' HA ' HG13 ' A' ' 31' ' ' VAL . 4.1 p30 -72.88 139.46 46.9 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.822 0.344 . . . . 0.0 111.363 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.86 -13.24 34.84 Favored Glycine 0 N--CA 1.429 -1.776 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.093 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.472 ' O ' HG12 ' A' ' 31' ' ' VAL . 8.7 tp10 -77.9 147.32 35.1 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.2 127.33 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 174.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 m -135.04 174.97 12.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.953 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.406 ' HG3' ' HA ' ' A' ' 61' ' ' GLN . 84.1 mtp -111.61 132.88 54.25 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 172.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.43 149.86 19.56 Favored Glycine 0 C--N 1.278 -2.655 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.927 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.432 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 47.2 ttp85 -79.7 137.12 36.96 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -82.44 122.1 78.72 Favored Pre-proline 0 N--CA 1.426 -1.665 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.494 ' CD ' HD21 ' A' ' 51' ' ' LEU . 31.0 Cg_endo -66.17 109.54 1.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.045 2.497 . . . . 0.0 111.147 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.59 -53.81 0.75 Allowed Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.934 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.4 p -86.81 -22.41 25.87 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.243 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.8 t 70.07 14.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.356 0 CA-C-O 122.616 1.198 . . . . 0.0 109.76 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt -87.68 159.18 18.62 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.755 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.432 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 57.4 m-85 -110.55 129.19 55.85 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.529 0.68 . . . . 0.0 111.242 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -122.87 156.56 34.38 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.608 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.89 124.93 35.12 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.66 169.54 20.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 122.98 0.512 . . . . 0.0 110.087 -174.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -115.26 130.48 56.92 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 173.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.644 HG13 ' HA ' ' A' ' 12' ' ' ASP . 7.3 p -72.39 128.65 35.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.8 t -108.89 -31.41 7.68 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.619 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -165.53 -176.9 4.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.52 ' CD2' ' HG2' ' A' ' 8' ' ' ARG . 30.5 t80 -148.97 132.37 16.6 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 123.548 0.739 . . . . 0.0 109.667 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -97.49 121.43 39.38 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -86.41 -21.91 26.86 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.94 -49.49 51.36 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.032 0.444 . . . . 0.0 110.496 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.6 m -97.47 -2.03 42.93 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.71 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 59.98 45.68 11.88 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.54 0.686 . . . . 0.0 110.84 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.95 134.55 52.49 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.372 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.617 ' CE1' ' HB3' ' A' ' 55' ' ' GLU . 26.9 m-85 -102.47 127.49 49.49 Favored 'General case' 0 CA--C 1.48 -1.745 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.3 m -93.06 129.16 39.11 Favored 'General case' 0 N--CA 1.4 -2.933 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -125.0 159.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -121.32 135.5 55.09 Favored 'General case' 0 C--N 1.272 -2.775 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -90.17 162.3 15.33 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.408 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -61.8 -24.05 66.61 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.628 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -82.42 0.7 40.92 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.474 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.12 -31.52 7.88 Favored Glycine 0 C--O 1.238 0.357 0 C-N-CA 121.506 -0.378 . . . . 0.0 112.377 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 m -56.11 130.03 42.47 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 124.917 1.287 . . . . 0.0 111.03 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.2 150.46 25.08 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.978 175.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.494 HD21 ' CD ' ' A' ' 21' ' ' PRO . 37.9 tp -139.86 152.87 46.81 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.538 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.07 134.61 51.98 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.18 173.75 11.18 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 123.136 0.574 . . . . 0.0 111.244 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -82.72 157.02 23.46 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.62 0.248 . . . . 0.0 110.492 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.617 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -61.25 -31.09 70.88 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.169 0.509 . . . . 0.0 110.906 173.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.0 m -73.15 -12.05 60.75 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.723 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -95.4 -5.89 42.17 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.8 mt -102.62 133.6 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-O 121.296 0.569 . . . . 0.0 111.285 -176.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -124.43 161.9 25.05 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 173.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.1 mt -78.01 164.04 25.41 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.898 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.406 ' HA ' ' HG3' ' A' ' 17' ' ' MET . 19.3 tm0? -60.5 -36.65 78.85 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.7 t -111.73 95.93 5.78 Favored 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 102.978 -2.971 . . . . 0.0 102.978 167.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -63.33 -18.78 64.0 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -169.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -91.27 97.19 10.97 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -81.27 109.79 16.12 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.865 0.84 . . . . 0.0 112.264 -175.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 . . . . . 0 N--CA 1.412 -2.351 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.908 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.601 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.88 179.98 4.46 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.7 tpt -89.09 128.22 35.75 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.33 -40.46 76.34 Favored Glycine 0 N--CA 1.468 0.775 0 O-C-N 123.699 0.624 . . . . 0.0 112.741 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.66 92.87 29.77 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 175.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.38 -46.05 16.27 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.05 2.5 . . . . 0.0 111.651 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -143.26 -55.42 0.4 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.452 ' HD2' ' OH ' ' A' ' 41' ' ' TYR . 46.6 mtm105 -127.43 153.25 46.51 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 173.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 9' ' ' LYS . 7.4 tmtt? -98.34 -41.71 7.71 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -84.63 95.99 9.06 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.176 -170.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.43 150.75 23.58 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.533 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -60.44 121.68 12.71 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.397 0.618 . . . . 0.0 112.161 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.497 ' H ' HG13 ' A' ' 31' ' ' VAL . . . 115.68 -14.34 17.47 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.647 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 31' ' ' VAL . 26.5 tt0 -77.02 141.05 40.51 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-N 116.893 0.347 . . . . 0.0 111.42 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.87 127.74 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 106.689 -1.596 . . . . 0.0 106.689 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.6 173.54 14.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.568 -173.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.419 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 47.0 ttm -111.2 131.85 54.79 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 172.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.8 149.96 19.45 Favored Glycine 0 C--N 1.283 -2.415 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.246 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.413 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 48.5 ttp180 -89.41 146.7 24.49 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 123.634 0.774 . . . . 0.0 109.0 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -83.04 123.17 77.84 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.496 ' HD2' HD21 ' A' ' 51' ' ' LEU . 11.0 Cg_endo -55.44 120.85 8.9 Favored 'Trans proline' 0 C--O 1.247 0.959 0 C-N-CA 123.356 2.704 . . . . 0.0 112.663 -175.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.84 -21.62 33.72 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.398 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.8 m -112.02 176.88 4.84 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 122.262 0.225 . . . . 0.0 110.994 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.7 p -105.99 -7.56 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.658 0.742 . . . . 0.0 110.473 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.07 138.84 41.08 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 50.5 m-85 -118.23 142.53 47.37 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.552 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -135.17 164.95 26.54 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -95.73 124.54 39.8 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.1 m -135.42 173.84 13.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.531 -172.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -115.25 131.26 56.98 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.855 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.497 HG13 ' H ' ' A' ' 13' ' ' GLY . 11.2 p -71.26 127.73 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -103.2 -44.36 5.21 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.445 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -157.73 173.12 17.31 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -150.52 126.02 10.19 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 123.372 0.669 . . . . 0.0 109.54 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -96.93 122.23 39.68 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 171.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -84.32 -28.36 27.14 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -174.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.85 -48.87 43.04 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.813 0.339 . . . . 0.0 111.194 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.4 m -94.54 -1.86 52.62 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.674 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 60.01 63.72 1.39 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.373 1.069 . . . . 0.0 111.736 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -128.55 125.66 38.75 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.688 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.452 ' OH ' ' HD2' ' A' ' 8' ' ' ARG . 21.2 m-85 -97.94 118.35 34.32 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.7 m -94.17 129.98 40.55 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 31' ' ' VAL . 33.5 m -126.82 158.6 37.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -109.71 133.5 53.06 Favored 'General case' 0 C--O 1.271 2.225 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -93.22 162.19 14.11 Favored 'General case' 0 CA--C 1.496 -1.104 0 O-C-N 124.584 1.177 . . . . 0.0 110.75 175.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -62.2 -24.19 67.07 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.1 -0.954 . . . . 0.0 112.004 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -78.65 -0.19 28.99 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.423 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.6 -2.83 86.35 Favored Glycine 0 C--O 1.221 -0.707 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 m -79.32 129.96 34.97 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 122.967 0.507 . . . . 0.0 110.016 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -90.46 152.13 21.09 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 172.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.496 HD21 ' HD2' ' A' ' 21' ' ' PRO . 48.4 tp -137.77 145.03 41.93 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.03 133.98 52.62 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 173.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.07 172.59 12.46 Favored 'General case' 0 C--N 1.276 -2.627 0 O-C-N 123.763 0.665 . . . . 0.0 110.666 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -83.87 166.11 18.18 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.51 -32.81 70.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.041 0.448 . . . . 0.0 110.567 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.6 m -77.37 -6.43 53.29 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.058 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -88.69 -18.89 26.94 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.1 mt -100.97 130.76 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.298 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 17' ' ' MET . 74.1 mtt85 -135.0 158.73 43.58 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.258 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.46 HD11 ' HE3' ' A' ' 9' ' ' LYS . 77.7 mt -83.95 172.82 11.71 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 168.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -60.32 -31.35 70.2 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.6 m -116.98 22.95 12.23 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.568 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.4 m -77.22 134.93 38.47 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.538 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -152.75 167.09 30.16 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -123.17 84.68 2.3 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 173.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 . . . . . 0 C--O 1.244 0.777 0 C-N-CA 125.881 1.672 . . . . 0.0 110.27 -177.326 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.859 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.36 22.95 3.21 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.314 0.578 . . . . 0.0 109.556 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ptm -70.77 177.32 3.65 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.486 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.88 -108.14 2.45 Favored Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 -174.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.0 ttm 65.06 97.05 0.04 OUTLIER Pre-proline 0 C--N 1.319 -0.729 0 C-N-CA 124.072 0.949 . . . . 0.0 112.696 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -89.44 -158.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 122.639 2.226 . . . . 0.0 109.017 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -88.74 22.71 2.54 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.712 0.768 . . . . 0.0 111.101 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -155.94 84.4 1.02 Allowed 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HE3' ' OH ' ' A' ' 10' ' ' TYR . 59.3 tttp -69.06 -29.11 67.16 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.815 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.467 ' OH ' ' HE3' ' A' ' 9' ' ' LYS . 89.2 m-85 -121.29 115.62 23.32 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.81 149.9 44.85 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.511 ' HA ' HG13 ' A' ' 31' ' ' VAL . 2.9 p30 -77.3 146.22 36.95 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.136 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.17 -9.52 63.3 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 31' ' ' VAL . 10.2 tp10 -78.67 143.39 36.34 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 122.493 0.317 . . . . 0.0 111.249 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 30' ' ' GLN . 5.5 p -94.91 126.64 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 173.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 59' ' ' ARG . 16.9 m -135.13 -177.7 2.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.314 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 87.7 mtp -111.92 131.72 55.2 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 173.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.99 143.95 14.69 Favored Glycine 0 C--N 1.27 -3.116 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -76.05 141.14 42.14 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -79.9 120.8 81.06 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.413 ' CD ' HD21 ' A' ' 51' ' ' LEU . 36.2 Cg_endo -65.27 94.43 0.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.029 2.486 . . . . 0.0 112.073 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.4 -43.78 0.61 Allowed Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.9 p -110.96 -171.71 1.88 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.8 p -105.73 8.04 9.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.017 0.913 . . . . 0.0 108.635 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.3 mt -74.38 143.35 44.86 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.851 -176.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -111.99 133.2 54.31 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.444 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -122.97 155.19 37.28 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.551 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -85.25 125.37 32.82 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.15 163.71 35.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 63.1 tt0 -119.3 130.21 55.27 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 174.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.511 HG13 ' HA ' ' A' ' 12' ' ' ASP . 8.1 p -72.27 130.56 35.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.5 t -119.68 -29.56 5.01 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.18 -176.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.45 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 16.2 m -144.07 157.18 44.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -139.63 121.89 15.94 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.338 0.113 . . . . 0.0 110.697 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.8 122.33 41.9 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 174.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -83.09 -20.4 34.96 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.001 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.04 -50.82 37.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.0 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 m -97.07 -2.57 42.98 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.27 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 t60 58.98 46.73 13.14 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.494 1.118 . . . . 0.0 108.6 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mp -114.1 142.34 46.33 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.117 -175.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 10' ' ' TYR . 45.5 m-85 -111.99 128.15 56.09 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 7.0 m -93.19 129.08 39.33 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 176.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.91 159.54 28.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -120.97 133.83 55.28 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -92.95 162.28 14.13 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.823 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -62.24 -21.38 65.12 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.29 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.06 -0.6 32.04 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.128 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.12 -1.06 86.38 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.5 m -79.26 135.31 36.73 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 123.888 0.875 . . . . 0.0 110.934 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -100.48 151.5 21.49 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 171.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.413 HD21 ' CD ' ' A' ' 21' ' ' PRO . 29.5 tp -138.86 145.47 40.03 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.23 133.36 53.31 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 172.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' CD1' HD11 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -141.45 167.21 22.71 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -84.27 157.44 21.56 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.965 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.4 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -60.47 -25.48 66.06 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 176.416 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 m -70.7 -6.29 36.11 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.469 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -112.96 7.05 18.06 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.465 ' C ' ' HD2' ' A' ' 59' ' ' ARG . 41.0 mt -118.48 135.39 59.04 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.658 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.465 ' HD2' ' C ' ' A' ' 58' ' ' ILE . 3.7 mpt_? -129.08 166.44 19.26 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 171.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mp -82.92 179.6 7.72 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -61.17 -28.65 69.28 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 172.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 m 59.87 22.7 11.68 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 124.949 1.299 . . . . 0.0 112.721 169.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.9 m -94.13 163.59 13.4 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -68.12 116.97 9.34 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.234 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -69.81 166.45 19.33 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.38 -173.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 N--CA 1.426 -1.659 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.065 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.09 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.26 103.74 7.57 Favored 'General case' 0 C--O 1.249 1.079 0 CA-C-O 121.309 0.576 . . . . 0.0 110.12 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.5 tmm? -122.66 112.56 18.11 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.74 -175.78 47.37 Favored Glycine 0 CA--C 1.491 -1.443 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 66.6 mtt -120.31 100.81 47.32 Favored Pre-proline 0 C--N 1.3 -1.576 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.02 -16.86 25.41 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.406 2.07 . . . . 0.0 112.602 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 58.1 t30 60.96 -89.39 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 124.907 1.283 . . . . 0.0 109.762 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -112.41 108.5 17.68 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -67.85 -35.68 78.98 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -114.04 127.29 55.88 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.09 150.3 37.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -74.51 131.86 41.37 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.099 0.476 . . . . 0.0 111.352 -175.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.537 ' H ' HG13 ' A' ' 31' ' ' VAL . . . 107.51 -11.31 39.21 Favored Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.6 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -77.43 152.64 34.2 Favored 'General case' 0 C--O 1.241 0.625 0 O-C-N 122.823 -0.222 . . . . 0.0 111.079 -175.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.29 127.29 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.02 177.93 6.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.965 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.0 mmm -111.33 131.97 54.76 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.51 149.08 19.74 Favored Glycine 0 C--N 1.286 -2.229 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.158 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.494 ' HD3' ' OD2' ' A' ' 57' ' ' ASP . 23.1 ttt-85 -82.62 134.75 35.17 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 123.131 0.572 . . . . 0.0 111.123 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -83.55 121.93 76.63 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.416 ' CD ' HD21 ' A' ' 51' ' ' LEU . 18.8 Cg_endo -59.57 124.66 15.93 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.198 2.599 . . . . 0.0 111.602 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.5 -25.12 22.41 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -176.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.3 m -112.7 169.47 8.88 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 p -112.26 6.67 8.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 122.502 1.144 . . . . 0.0 108.453 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.1 mt -90.01 144.16 26.15 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.355 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 19' ' ' ARG . 17.3 m-85 -109.33 128.94 55.49 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.565 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -118.8 172.39 7.55 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -85.49 126.03 33.51 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 123.376 0.422 . . . . 0.0 109.895 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.38 163.79 34.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.959 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -113.29 130.51 56.23 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.537 HG13 ' H ' ' A' ' 13' ' ' GLY . 8.8 p -72.28 128.6 35.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 176.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.0 t -119.12 -28.45 5.47 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.61 -0.836 . . . . 0.0 112.062 -173.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.426 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 50.2 m -151.62 169.17 22.8 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 121.921 -0.487 . . . . 0.0 109.917 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -148.91 129.14 13.69 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -97.48 122.75 40.9 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.87 -41.77 70.96 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 123.958 0.786 . . . . 0.0 111.788 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.89 -49.92 74.27 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.588 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -92.9 -2.0 56.23 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.429 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.3 m80 58.21 42.46 21.92 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -104.92 133.74 49.2 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.399 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -103.51 120.71 41.39 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 52' ' ' ALA . 7.1 m -93.71 129.46 40.03 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.6 158.89 26.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.291 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -113.56 132.54 55.67 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -97.6 150.52 21.05 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -62.69 -17.4 60.58 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 122.102 0.953 . . . . 0.0 109.823 173.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.27 -1.9 22.67 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.129 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.28 -31.67 5.6 Favored Glycine 0 N--CA 1.443 -0.862 0 O-C-N 121.836 -0.54 . . . . 0.0 111.814 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.3 m -71.0 130.02 40.51 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 123.82 0.848 . . . . 0.0 110.802 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -102.23 151.33 22.34 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.467 171.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.416 HD21 ' CD ' ' A' ' 21' ' ' PRO . 39.4 tp -139.42 145.5 38.96 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.461 -175.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 42' ' ' THR . . . -110.7 134.55 52.36 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.243 171.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.4 176.84 8.54 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 123.641 0.777 . . . . 0.0 110.547 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -83.46 167.61 17.29 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 120.852 0.358 . . . . 0.0 111.408 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -60.08 -31.76 70.32 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.684 0.794 . . . . 0.0 110.998 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 m -76.62 -4.99 45.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.526 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.494 ' OD2' ' HD3' ' A' ' 19' ' ' ARG . 3.1 m-20 -105.63 3.38 29.11 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.335 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 mt -118.06 141.47 37.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 121.238 0.542 . . . . 0.0 111.09 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -129.52 168.16 16.79 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 172.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.0 mt -82.52 -176.21 6.12 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -53.28 -35.16 59.76 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.5 t -161.83 -72.19 0.06 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 174.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 p -137.54 -64.58 0.55 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.8 t80 63.05 14.89 8.0 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.038 1.335 . . . . 0.0 113.356 171.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -134.89 105.17 6.28 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 120.927 -1.108 . . . . 0.0 111.44 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--N 1.305 -1.338 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.957 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.842 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.09 135.02 39.88 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -129.8 -39.56 1.42 Allowed 'General case' 0 C--N 1.3 -1.543 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.91 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.27 85.76 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 118.19 -1.957 . . . . 0.0 115.898 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -115.32 95.47 42.79 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 170.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -86.73 -5.09 8.1 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 122.518 2.145 . . . . 0.0 111.072 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -81.82 167.38 19.09 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.931 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -63.62 145.31 55.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.445 ' HB2' ' NZ ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -46.71 -48.58 20.24 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.085 0.954 . . . . 0.0 110.401 -175.216 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.409 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 92.6 m-85 -127.4 135.55 50.63 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 172.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.89 150.38 24.14 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -77.7 135.87 38.11 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 123.217 0.607 . . . . 0.0 112.182 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.611 ' H ' HG13 ' A' ' 31' ' ' VAL . . . 103.33 -14.35 54.69 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.433 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.542 ' O ' HG12 ' A' ' 31' ' ' VAL . 29.6 tt0 -79.17 156.74 28.08 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.862 0.465 . . . . 0.0 112.002 -174.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.0 p -90.87 129.04 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 172.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 m -134.1 171.55 17.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.9 mtp -111.11 132.3 54.39 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.236 173.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -125.49 146.3 16.11 Favored Glycine 0 C--N 1.281 -2.504 0 C-N-CA 120.184 -1.007 . . . . 0.0 111.668 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.426 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 75.5 ttt180 -79.89 132.11 36.01 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 23' ' ' SER . 47.5 t-105 -67.79 124.77 90.21 Favored Pre-proline 0 N--CA 1.433 -1.302 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -48.29 110.75 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 124.08 3.186 . . . . 0.0 114.137 -173.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.11 -22.02 40.79 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.909 -0.587 . . . . 0.0 113.024 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 20' ' ' TRP . 16.5 m -97.49 174.74 6.51 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -178.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.7 p -103.42 -9.01 9.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 122.097 0.951 . . . . 0.0 109.244 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -65.43 123.84 20.68 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.176 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 19' ' ' ARG . 41.9 m-85 -104.19 132.22 50.67 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.076 175.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -119.88 157.86 27.85 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.569 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -95.59 125.25 40.06 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.6 m -135.51 163.83 34.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-O 120.892 0.377 . . . . 0.0 110.626 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -107.36 129.91 54.86 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.344 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.611 HG13 ' H ' ' A' ' 13' ' ' GLY . 6.2 p -72.29 127.06 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.697 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.7 m -112.38 -40.28 4.17 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.178 -170.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.2 t -151.74 -179.67 7.64 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -161.55 129.01 4.06 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 122.4 0.28 . . . . 0.0 110.761 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -91.95 122.09 34.14 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.06 -38.75 51.99 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 124.279 0.987 . . . . 0.0 109.816 -173.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.77 -57.3 13.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.428 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.6 m -98.87 -0.29 42.71 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.1 m80 66.59 43.92 2.39 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.631 0.772 . . . . 0.0 110.255 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.93 121.17 41.27 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.481 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 51.8 m-85 -93.8 122.89 36.75 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 m -92.92 129.21 38.91 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.428 HG12 ' HA ' ' A' ' 31' ' ' VAL . 35.8 m -126.85 158.61 37.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -107.66 133.13 52.54 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -97.89 165.41 11.94 Favored 'General case' 0 CA--C 1.508 -0.637 0 O-C-N 124.41 1.069 . . . . 0.0 111.53 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -61.57 -25.22 67.17 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 124.904 1.282 . . . . 0.0 110.415 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -83.44 -0.89 52.04 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.134 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.79 -33.27 5.29 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.979 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.8 m -56.06 131.25 46.99 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.885 1.274 . . . . 0.0 111.645 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -96.7 150.34 20.8 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 172.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.57 149.99 44.5 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 41' ' ' TYR . . . -109.56 135.3 50.76 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 172.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.69 166.17 25.48 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 123.18 0.592 . . . . 0.0 110.882 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.8 161.75 20.84 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.05 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -60.37 -30.69 69.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.6 t -74.52 -5.53 43.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.87 0.367 . . . . 0.0 110.743 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -95.86 -12.31 25.41 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 55.1 mt -99.76 143.01 14.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 120.967 0.413 . . . . 0.0 111.449 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -131.07 170.23 14.8 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 171.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.1 mt -84.0 -162.95 0.71 Allowed 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.16 -35.93 18.03 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 176.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 m -150.51 -62.89 0.2 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.1 m -159.29 177.5 10.96 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -75.86 116.11 16.23 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 123.629 0.581 . . . . 0.0 109.767 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -97.19 113.45 25.05 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? . . . . . 0 C--N 1.303 -1.444 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -179.825 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.902 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.74 123.43 40.5 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.9 mtt -145.35 123.82 12.4 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.916 0.388 . . . . 0.0 110.638 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.97 -83.34 1.64 Allowed Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 114.816 0.686 . . . . 0.0 114.816 174.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 63.8 mtt -135.23 165.52 35.83 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -172.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -73.79 98.1 1.04 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 N-CA-C 105.085 -2.698 . . . . 0.0 105.085 162.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -82.24 -9.0 59.65 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -166.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.64 ' HA ' ' OH ' ' A' ' 41' ' ' TYR . 12.8 ttm180 64.6 59.06 0.98 Allowed 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 -166.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -72.74 -19.75 61.32 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 112.586 -2.097 . . . . 0.0 109.24 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -123.05 138.69 54.61 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.29 -153.42 0.11 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 123.718 0.636 . . . . 0.0 110.761 -175.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -123.94 125.52 44.74 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 174.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.92 -5.22 68.81 Favored Glycine 0 C--N 1.311 -0.818 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.575 ' O ' HG12 ' A' ' 31' ' ' VAL . 43.3 tt0 -77.74 137.86 38.71 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 123.423 0.689 . . . . 0.0 110.265 -177.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.82 127.58 41.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 118.535 -1.266 . . . . 0.0 108.568 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.7 m -135.58 -176.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.918 -176.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 90.3 mtp -111.27 132.77 54.11 Favored 'General case' 0 C--O 1.204 -1.323 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -128.79 141.61 12.74 Favored Glycine 0 C--N 1.272 -2.986 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.573 ' HB3' ' OD1' ' A' ' 57' ' ' ASP . 15.6 ttp180 -75.1 144.34 42.93 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.46 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -81.42 119.79 76.53 Favored Pre-proline 0 N--CA 1.426 -1.671 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 173.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.4 ' HD3' HD21 ' A' ' 51' ' ' LEU . 12.2 Cg_endo -54.3 -25.38 38.6 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 C-N-CA 124.003 3.135 . . . . 0.0 114.214 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -78.86 -34.93 32.79 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.19 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.0 p -111.8 -164.95 0.95 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.071 0.462 . . . . 0.0 110.346 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.7 m -114.16 10.07 7.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.4 mt -93.86 145.51 24.56 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 34.8 m-85 -100.61 124.9 46.83 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.408 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -113.64 156.01 24.48 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -79.36 125.8 29.98 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.11 163.69 35.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -111.2 128.87 56.05 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 173.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 14' ' ' GLU . 10.8 p -73.8 136.95 24.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.6 t -122.37 -41.44 2.4 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 118.656 -1.218 . . . . 0.0 112.056 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.7 m -139.03 141.5 38.27 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.774 -0.771 . . . . 0.0 110.734 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -114.78 124.7 52.44 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.939 0.4 . . . . 0.0 111.161 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -96.25 122.59 39.27 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -97.42 -19.76 18.23 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.583 0.552 . . . . 0.0 111.528 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.44 -52.68 8.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.864 0.364 . . . . 0.0 111.429 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.7 m -99.5 -2.02 36.95 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.287 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 61.66 80.0 0.24 Allowed 'General case' 0 C--O 1.247 0.954 0 C-N-CA 123.667 0.787 . . . . 0.0 112.273 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -141.96 150.17 41.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.986 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.64 ' OH ' ' HA ' ' A' ' 8' ' ' ARG . 29.3 m-85 -119.63 116.93 27.01 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.5 m -87.01 129.0 35.07 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 31' ' ' VAL . 33.8 m -125.49 160.0 32.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 124.308 1.005 . . . . 0.0 108.633 -176.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HG3' ' HG2' ' A' ' 50' ' ' GLU . 50.3 tttp -124.95 135.74 53.11 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -95.01 159.04 15.21 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.571 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -61.3 -25.12 66.9 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.944 0.778 . . . . 0.0 110.418 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.53 -0.7 27.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.829 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.69 -39.34 2.77 Favored Glycine 0 C--O 1.248 1.0 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.513 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.0 m -54.77 136.14 46.61 Favored 'General case' 0 C--O 1.246 0.882 0 C-N-CA 124.395 1.078 . . . . 0.0 111.533 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' HG2' ' HG3' ' A' ' 44' ' ' LYS . 62.0 mt-10 -113.57 150.42 33.07 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.4 HD21 ' HD3' ' A' ' 21' ' ' PRO . 32.4 tp -139.5 145.66 39.01 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -175.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.3 133.66 52.77 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.74 172.52 12.58 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 123.369 0.667 . . . . 0.0 111.964 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.442 ' HG2' ' H ' ' A' ' 56' ' ' SER . 86.8 tttt -82.43 156.34 24.18 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 122.664 0.386 . . . . 0.0 110.031 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.573 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 41.5 tt0 -60.08 -31.95 70.49 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.948 0.88 . . . . 0.0 110.872 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.442 ' H ' ' HG2' ' A' ' 54' ' ' LYS . 4.0 m -76.6 -11.25 59.83 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.601 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.573 ' OD1' ' HB3' ' A' ' 19' ' ' ARG . 1.6 t70 -103.21 6.43 38.24 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -177.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mt -110.9 149.26 13.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.072 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -131.34 158.66 40.1 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.39 164.67 6.95 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -48.45 -32.32 7.6 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.3 m -143.11 -35.57 0.4 Allowed 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.707 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.0 t 60.96 34.85 19.27 Favored 'General case' 0 C--N 1.364 1.197 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -67.93 141.51 56.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 112.757 -2.019 . . . . 0.0 111.078 -171.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.508 ' C ' ' HD3' ' A' ' 65' ' ' LYS . 11.5 tmtt? -77.13 118.7 19.93 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 C--N 1.288 -2.089 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.709 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.94 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.77 103.91 12.5 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.466 0.651 . . . . 0.0 110.39 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -102.82 -25.59 13.45 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.908 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.21 -164.95 25.78 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.654 ' SD ' ' HA ' ' A' ' 9' ' ' LYS . 53.2 ttm -170.46 114.58 0.46 Allowed Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.04 158.79 41.78 Favored 'Trans proline' 0 C--O 1.251 1.141 0 C-N-CA 122.701 2.268 . . . . 0.0 112.059 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.415 ' C ' ' HD3' ' A' ' 8' ' ' ARG . 16.1 m120 74.58 -90.51 0.02 OUTLIER 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.693 1.197 . . . . 0.0 110.549 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.415 ' HD3' ' C ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -137.91 125.65 22.4 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.654 ' HA ' ' SD ' ' A' ' 5' ' ' MET . 77.0 tttt -82.34 -30.19 30.56 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -88.14 75.78 8.59 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.682 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.41 152.16 22.93 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.405 ' HA ' HG13 ' A' ' 31' ' ' VAL . 4.4 p-10 -46.74 123.66 5.32 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.115 0.884 . . . . 0.0 111.387 -177.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.31 -13.42 28.32 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.285 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.463 ' O ' HG12 ' A' ' 31' ' ' VAL . 7.6 tp10 -76.48 137.02 39.39 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 117.436 0.618 . . . . 0.0 109.571 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 p -95.19 127.68 46.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -135.37 -178.73 2.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 122.857 0.463 . . . . 0.0 111.159 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 83.4 mtp -110.85 133.01 53.71 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 57' ' ' ASP . . . -138.88 142.28 12.8 Favored Glycine 0 C--N 1.281 -2.496 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.796 -177.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.562 ' HD3' ' OD1' ' A' ' 57' ' ' ASP . 33.9 ttt-85 -75.59 132.21 40.5 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 125.115 1.366 . . . . 0.0 110.92 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 23' ' ' SER . 16.4 t-105 -86.25 122.91 72.18 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 172.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.464 ' CD ' HD21 ' A' ' 51' ' ' LEU . 18.9 Cg_endo -58.72 107.42 0.34 Allowed 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 123.178 2.585 . . . . 0.0 112.613 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.78 -29.93 8.53 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.266 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 20' ' ' TRP . 17.0 m -88.89 -10.93 46.09 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 122.442 -0.446 . . . . 0.0 111.549 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.9 t 75.32 -34.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 125.394 1.478 . . . . 0.0 112.485 175.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 17.3 mt -70.66 149.16 47.28 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -175.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.483 ' CE2' ' HG2' ' A' ' 59' ' ' ARG . 25.6 m-85 -108.07 115.8 30.79 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 113.865 -1.516 . . . . 0.0 107.42 175.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -108.53 172.51 6.8 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -84.72 126.13 33.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 m -134.98 164.04 34.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -126.1 131.23 52.14 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.179 -1.409 . . . . 0.0 108.706 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.521 ' HA ' HG12 ' A' ' 43' ' ' VAL . 12.3 p -69.71 129.48 34.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.653 0.74 . . . . 0.0 110.92 -175.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.5 m -106.05 -39.14 6.08 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.925 -174.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.2 m -155.65 162.8 40.53 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -139.58 119.39 13.33 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 120.908 0.385 . . . . 0.0 110.613 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -91.1 123.12 34.32 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -100.8 -1.13 35.69 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.773 0.797 . . . . 0.0 110.185 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.34 -54.64 5.06 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.518 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.3 m -98.53 -2.1 39.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.038 0.446 . . . . 0.0 110.021 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 59.8 69.9 0.67 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.64 1.176 . . . . 0.0 113.204 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -131.97 135.4 46.54 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.694 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -97.93 117.52 32.45 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 52' ' ' ALA . 17.0 m -93.36 129.71 39.39 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 31' ' ' VAL . 29.5 m -129.06 158.45 41.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -176.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 6.8 ttpm? -110.71 136.88 49.11 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -90.71 154.4 19.58 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.42 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.29 -20.96 63.5 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.814 1.246 . . . . 0.0 110.042 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.34 -1.0 31.14 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.594 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.78 -41.74 2.09 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.463 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.6 m -71.01 135.75 48.0 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.291 0.636 . . . . 0.0 111.501 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -94.85 153.16 17.85 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 173.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.464 HD21 ' CD ' ' A' ' 21' ' ' PRO . 32.9 tp -138.42 148.43 44.44 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.581 -176.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 42' ' ' THR . . . -109.71 134.37 52.07 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 171.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -140.63 166.99 23.23 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.801 -178.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -85.01 168.18 15.16 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.142 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.57 -30.57 69.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.485 0.66 . . . . 0.0 110.045 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.4 m -69.49 -11.62 60.98 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.09 0.956 . . . . 0.0 110.879 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.562 ' OD1' ' HD3' ' A' ' 19' ' ' ARG . 67.9 m-20 -100.91 1.99 40.4 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.411 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.2 mt -111.74 134.06 55.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.478 0.656 . . . . 0.0 112.491 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.483 ' HG2' ' CE2' ' A' ' 26' ' ' TYR . 56.1 mmt-85 -130.36 156.58 44.46 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 172.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mp -83.58 166.64 18.04 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 172.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -52.46 -35.38 52.43 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.1 m -113.98 14.87 18.51 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.119 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.5 m 52.32 71.77 0.45 Allowed 'General case' 0 C--N 1.355 0.833 0 CA-C-O 122.189 0.995 . . . . 0.0 108.892 -172.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -66.87 -46.12 75.99 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.188 -1.369 . . . . 0.0 113.555 -167.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 71.17 158.95 0.2 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.684 0.794 . . . . 0.0 110.653 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 . . . . . 0 C--N 1.31 -1.148 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.44 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.305 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.62 92.94 7.23 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.8 tpt -88.62 134.31 33.92 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.212 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.11 -174.39 42.98 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 65.1 mtt -124.34 94.74 44.56 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 117.37 0.585 . . . . 0.0 110.72 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.58 -26.6 4.67 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.749 2.299 . . . . 0.0 111.027 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -164.18 178.87 7.26 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 103.954 -2.61 . . . . 0.0 103.954 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.456 ' NE ' ' HD2' ' A' ' 34' ' ' TYR . 97.7 mtt180 -72.64 124.32 25.04 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.621 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -67.59 -55.34 13.78 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 176.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.522 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 36.3 m-85 -88.24 95.96 10.38 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.69 149.58 28.42 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.606 ' HA ' HG13 ' A' ' 31' ' ' VAL . 10.3 p-10 -61.78 127.52 31.8 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.693 0.759 . . . . 0.0 112.319 -173.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.7 -14.44 17.39 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.478 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.529 ' O ' HG12 ' A' ' 31' ' ' VAL . 32.4 tt0 -77.25 136.74 38.55 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.0 p -94.84 127.53 46.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.434 HG11 ' CD1' ' A' ' 10' ' ' TYR . 12.7 m -135.34 -176.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.374 -175.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.466 ' HG2' ' HA ' ' A' ' 61' ' ' GLN . 94.4 mmm -110.33 131.73 54.8 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 174.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -128.49 141.84 12.96 Favored Glycine 0 C--N 1.273 -2.949 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -89.58 136.19 33.17 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 24.8 t-105 -71.11 121.4 84.06 Favored Pre-proline 0 N--CA 1.434 -1.268 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.44 114.48 1.47 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 124.106 3.204 . . . . 0.0 114.299 -174.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.67 -30.52 9.35 Favored Glycine 0 C--O 1.242 0.656 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.379 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.3 m -96.13 175.5 6.44 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.3 p -105.65 -2.42 9.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 122.218 1.009 . . . . 0.0 108.986 176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.85 134.2 45.95 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -107.85 136.48 47.5 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.471 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -128.92 157.77 40.67 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.013 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -86.16 125.57 33.6 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.02 163.22 37.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -175.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -122.32 130.35 53.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.606 HG13 ' HA ' ' A' ' 12' ' ' ASP . 7.5 p -68.7 132.46 32.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.415 0.626 . . . . 0.0 111.181 -176.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.8 m -118.58 -38.21 3.17 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.237 -173.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.3 m -157.0 171.17 20.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.456 ' HD2' ' NE ' ' A' ' 8' ' ' ARG . 44.0 t80 -154.31 136.52 14.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 118.131 0.423 . . . . 0.0 111.734 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -97.39 121.73 39.62 Favored 'General case' 0 C--O 1.249 1.026 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 171.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -82.07 -23.72 35.65 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 124.073 0.858 . . . . 0.0 111.365 -170.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.0 -51.83 9.06 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.786 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.5 m -94.54 -0.6 54.47 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 33.4 m80 68.07 43.2 1.66 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.381 1.072 . . . . 0.0 110.916 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.76 115.83 30.91 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.882 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.522 ' CE2' ' HB2' ' A' ' 10' ' ' TYR . 65.2 m-85 -96.08 127.11 41.8 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.7 m -92.95 129.21 38.94 Favored 'General case' 0 N--CA 1.404 -2.751 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 31' ' ' VAL . 34.0 m -127.72 157.62 39.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -105.22 133.78 49.41 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -92.48 157.0 16.8 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.694 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.13 -23.08 66.35 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.786 0.803 . . . . 0.0 109.9 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.66 -1.94 10.35 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.46 1.104 . . . . 0.0 111.157 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.74 -23.81 18.08 Favored Glycine 0 C--O 1.227 -0.316 0 O-C-N 121.654 -0.654 . . . . 0.0 112.174 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.4 m -77.04 132.97 39.21 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 124.372 1.069 . . . . 0.0 111.259 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -93.79 150.19 20.59 Favored 'General case' 0 C--O 1.251 1.161 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.4 tp -139.48 149.97 44.62 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.24 134.72 51.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 173.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.428 ' CD1' HD11 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -141.32 166.21 25.39 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 124.114 0.966 . . . . 0.0 111.006 177.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 39' ' ' HIS . 97.5 mttt -82.91 161.42 21.85 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.618 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -60.69 -31.13 70.4 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.448 0.642 . . . . 0.0 110.8 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -75.57 -4.33 39.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.56 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -105.82 2.57 27.89 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.428 HD11 ' CD1' ' A' ' 53' ' ' LEU . 48.9 mt -114.03 146.97 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -132.45 159.2 40.02 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 172.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.6 mt -66.31 171.92 4.4 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 170.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.466 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 51.9 mt-30 -52.57 -37.69 58.44 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -175.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.8 t 176.03 -52.9 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.1 m -92.49 174.09 7.46 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.805 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -148.18 157.0 43.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 104.608 -2.368 . . . . 0.0 104.608 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -79.65 120.08 23.48 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.721 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 . . . . . 0 C--N 1.29 -1.979 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.296 . . . . . . . . 0 0 . 1 stop_ save_